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iAbstract
An injury to the cervical region of the spinal cord can cause paralysis affecting all four
limbs, termed tetraplegia. People with tetraplegia also have paralysis or impaired function
of the major respiratory muscles, namely the diaphragm and intercostal and abdominal
muscles. This often reduces respiratory function, with associated respiratory complications a
leading cause of morbidity and mortality for this population. Abdominal Functional Electrical
Stimulation (AFES), the application of electrical pulses to the abdominal muscles causing
them to contract, has been shown to improve respiratory function in tetraplegia. Despite these
positive results, further work is needed to establish AFES as a standard clinical treatment.
The aim of this thesis is to support the clinical introduction of AFES. This was achieved
by addressing two primary objectives. Firstly, the development of new technologies and
protocols to optimise AFES for use in a clinical setting. Secondly, the clinical evaluation of
these technologies and protocols with tetraplegic patients.
For research purposes, AFES has typically been applied manually, requiring an operator
to synchronise stimulation with respiratory activity. One important step necessary for the
clinical introduction of AFES is the development of an automated AFES device that can
apply stimulation in synchrony with the users respiratory activity, with different stimulation
parameters applied for different breath types such as a quiet breath and a cough. In this
thesis, the signal from a non-intrusive respiratory effort belt, worn around the chest, was
used to develop a statistical classification algorithm capable of classifying respiratory activity
in real-time, and applying AFES in synchrony with the user’s respiratory activity. The
effectiveness of AFES can also be enhanced by stimulating at the abdominal muscle motor
points. In this thesis the positions of the abdominal motor points were located systematically
for the first time, in ten able bodied and five tetraplegic participants.
To aid the clinical introduction of AFES it is necessary to establish the patient groups who
would benefit most from this intervention, and to develop appropriate clinical protocols.
This is addressed in two clinical studies, where the feasibility and effectiveness of AFES to
improve the respiratory function of the acute ventilator dependant and sub-acute tetraplegic
populations was demonstrated. In the first study, conducted with 10 acute ventilator
dependant tetraplegics, AFES was applied on alternate weeks for a total duration of eight
weeks. This resulted in acute improvements in breathing and led to a longitudinal increase
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in respiratory function over the study duration. It was found that participants weaned from
mechanical ventilation on average 11 days faster than matched historic controls.
Previous work, which investigated the effect of a three week AFES training programme on
the respiratory function of people with sub-acute tetraplegia, suggested that an extended
AFES training programme may be more effective. In the second clinical study in this thesis,
a continuous eight week AFES training protocol (combined with a six week control period)
was evaluated with three sub-acute tetraplegic participants. The application of AFES led
to an acute increase in respiratory function, with a longitudinal improvement in respiratory
function observed throughout the study. In a single participant case study, the feasibility
of combining AFES with assisted coughing delivered by mechanical insuﬄation-exsuﬄation
was demonstrated for the first time. This was shown to lead to an acute improvement in
respiratory function at six of the eight assessment sessions, indicating that this technique
could be used to aid secretion removal.
This thesis highlights the feasibility and effectiveness of AFES to improve the respiratory
function of the acute ventilator dependant and sub-acute tetraplegic populations. The clinical
protocols that enable AFES to be used with these patient groups, and the technological
developments detailed throughout this thesis, are an important step towards the introduction
of AFES as a regular treatment modality.
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Contributions
• In this thesis novel Abdominal Functional Electrical Stimulation (AFES) protocols and
technologies are developed and implemented, and it is shown that they can help improve
the respiratory function of the acute ventilator dependant and sub-acute tetraplegic
population. Demonstration of the feasibility and effectiveness of these technologies
and protocols is a necessary step towards the implementation of AFES as a clinical
treatment modality. As such, a key contribution of this thesis is proof of feasibility.
• By using the respiratory data recorded from 10 able bodied participants a novel
algorithm for non-intrusive real-time breathing pattern detection and classification has
been designed and tested. The use of a non-intrusive sensor, coupled with an improved
and less operator reliant classification algorithm, makes this method more suited to a
clinical setting than previous work where the signal from an intrusive spirometer was
used for breathing pattern classification.
• Neuromuscular electrical stimulation has been used for the first time to systematically
detect the position of the motor points of the abdominal muscles. By applying single
pulse electrical stimulation to the rectus abdominis and external oblique muscles, the
position of the motor points of these muscles were successfully located in 10 able bodied
and five tetraplegic participants. The position of the motor points of these muscles,
along with the repeatability and uniformity of the position, is presented. The results
of this study suggest that this method could be used to accurately detect the position
of the abdominal muscle motor points to select the optimum electrode location for the
application of AFES.
• In the main clinical study of this thesis the feasibility of using AFES to improve the
respiratory function of acute ventilator dependant tetraplegics is shown. To use AFES
with this patient group a number of adaptations to standard AFES protocols were
required. Novel engineering solutions to allow AFES to be synchronised with mechanical
ventilation, or with the user’s own breathing, are presented. A novel training protocol,
designed to improve respiratory function while allowing the effectiveness of AFES to be
evaluated, was also developed. The gains in respiratory function achieved using these
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novel technologies and protocols with 10 tetraplegic participants, who appeared to wean
faster from mechanical ventilation than matched historic controls, suggest that acute
ventilator dependent tetraplegic patients are a new treatment group who would benefit
from the use of an AFES intervention during the early stage post-injury. The feasibility
of using AFES to assist ventilator weaning for the chronic tetraplegic population who
retain some diaphragm function is also demonstrated in a case study.
• Previous work has demonstrated that three weeks of AFES training with sub-acute
and chronic tetraplegic participants did not appear to be sufficiently long to achieve the
maximum benefit from an AFES training program. In this thesis the feasibility of using
an eight week AFES training program to improve the respiratory function of people
with sub-acute tetraplegia is demonstrated in a case series with three participants. The
training effect shown in this study provides evidence for a potential future role of a
prolonged AFES training program to improve the respiratory function of all tetraplegic
participants.
• An engineering method to integrate AFES with mechanical insuﬄation-exsuﬄation,
a clinical treatment modality commonly used to simulate cough and aid secretion
clearance, is described and demonstrated in a case study with one sub-acute tetraplegic
participant. These results indicate that, with a further refinement of the protocol and
technology, the combination of these two treatment modalities could be used to help
clear the airway of people with tetraplegia more effectively.
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1Chapter 1
Introduction
“If you can’t explain your physics to a barmaid it is probably not very good physics.”
Ernest Rutherford
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1.1 Summary
Damage to the spinal cord, which results in a Spinal Cord Injury (SCI), is a life changing
event that can have a profound effect on a person’s quality of life. An injury to the cervical
(neck) region of the spinal cord can cause paralysis or impaired function of all four limbs, a
condition termed tetraplegia. In this chapter the prevalence of SCI is outlined, along with a
description of the different classifications of SCI. How muscles work, along with the impact
of tetraplegia on muscle function, particularly respiratory function, is described. Ways of
measuring this respiratory function are also presented. The principles of Functional Electrical
Stimulation (FES), with a focus on how it can be used to cause a contraction of paralysed
muscles, are given. FES applied to the abdominal muscles, known as Abdominal Functional
Electrical Stimulation (AFES), can be used to improve the respiratory function of people
with tetraplegia and is described. This chapter concludes by outlining the aims of this thesis.
1.2 Spinal Cord Injury
The central nervous system is the part of the nervous system consisting of the brain and the
spinal cord. An injury to the central nervous system can result in paralysis. A stroke, which
is a loss of brain function due to a distrubance in blood supply to the brain, is the leading
cause of paralysis in the United States of America (USA) [1]. Paralysis after stroke occurs
due to the damaged brain no longer sending signals to muscles in the body. In the USA the
second leading cause of paralysis, after stroke, is Spinal Cord Injury (SCI) [1]. Unlike a stroke,
paralysis after SCI is caused by direct trauma to the spinal cord, resulting in a disruption in
the pathway between a muscle and the brain. The effects of an SCI vary greatly. However,
many people with SCI experience at least some loss of function (i.e. paralysis) and sensation.
Advances in medical care over the last decades have resulted in increased survival rates and
life expectancy for the spinal cord injured population [2]. This has led to an increase in the
number of people living with an SCI, with the effective treatment of SCI, and its associated
complications, becoming an increasingly important issue for society.
1.2.1 Prevalence
SCI most commonly affects young, active individuals, with the highest prevalence of new
SCIs in people between 20 and 40 years of age [3]. The Spinal Injuries Association for the
United Kingdom (UK) and Ireland estimates that there are over 40, 000 people (0.06 percent
of the UK population) living with an SCI in the UK1. Of these 40, 000, slightly over 3, 000
reside in Scotland (0.06 percent of the Scottish population) [4]. In the year 2011-2012, there
were 99 newly spinal cord injured patients admitted to the Queen Elizabeth National Spinal
Injuries Unit (QENSIU) [4], the sole centre for treating SCIs in Scotland and one of 12
dedicated SCI centres in the UK. These 99 injuries represent an annual rate of 18 new SCIs
1http://www.spinal.co.uk/page/Some-basic-facts-about-SCI (Accessed May 2014)
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per million of population. In comparison, the National Spinal Cord Injury Statistical Center
in the USA reported that in 2012, there were approximately 12, 000 new cases of SCI in
the USA2, representing an annual rate of 37 new SCIs per million of population. Using the
estimate developed by Lasfargues et al. [5], in 2013 there were approximately 270, 000 people
living with an SCI in the USA. This represents approximately 0.08 percent of the American
population, correlating with the data from the UK.
The etiology of an SCI can be classed as either traumatic or non traumatic. The most
common causes of non traumatic SCI are spinal multiple sclerosis, cervical spondylosis (spinal
stenosis) and amyotrophic lateral sclerosis (motor neuron disease), with tumour compression,
infectious abscesses and vascular malformations less common causes [6, 7]. Traumatic SCIs
result from trauma to the spinal cord. In the UK falls are the leading cause of traumatic
SCI, followed by Road Traffic Accidents (RTAs) and sporting injuries [4]3. In contrast, RTAs
are the primary cause of traumatic SCI in the USA, followed by falls and violence [8]. The
etiology of traumatic SCIs in Scotland, the UK and the USA is shown in Table 1.1.
Table 1.1: Number of traumatic spinal cord injuries in Scotland, the United Kingdom (UK)
and United States of America (USA) caused by falls, Road Traffic Accidents (RTAs), sports
and other etiologies in 2012. Results are expressed as a percentage of all reported traumatic
spinal cord injuries.
Region Year Causes
Falls RTA Sports Others
Scotland 2012 55% 21% 8% 16%
UK (inc. Scotland) 2012 46% 39% 10% 5%
USA 2012 21% 44% 10% 25%
Traumatic SCIs have a greater prevalence in males than females, with multi center studies
showing a male to female ratio of approximately four to one [9, 10]. Compared to traumatic
SCIs, non traumatic SCIs are associated with an older age at injury [11] and have an almost
equal prevalence amongst males and females [12]. Of the 99 patients admitted to the QENSIU
in 2011-2012 with an SCI, 35 percent (n = 35) had an SCI of a non traumatic nature [4].
This agrees with the findings of other incidence studies [11, 13], where approximately one
third of SCIs were found to have a non traumatic etiology.
1.2.2 Anatomy of the Spinal Cord
Humans are born with 33 vertebrae in the spinal column, consisting of seven cervical
vertebrae, 12 thoracic vertebrae, five lumbar vertebrae, five sacral vertebrae and four
coccygeal vertebrae. The cervical, thoracic and lumbar vertebrae are separated by
intervertebral discs, which are not present between the sacral or coccygeal vertebrae. This
leads to both the sacral and coccygeal vertebrae fusing in adult life to form two bones, known
2https://www.nscisc.uab.edu/ (Accessed May 2014)
3http://www.spinal.co.uk/page/Some-basic-facts-about-SCI (Accessed May 2014)
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as the sacrum and coccyx (or tailbone). In adult humans the cervical vertebrae are located
in the neck, the thoracic vertebrae are located between the shoulders and middle back and
the lumbar vertebrae are situated in the lower back, above the sacrum and the coccyx. These
vertebrae are shown in Figure 1.1.
Figure 1.1: Vertebrae of the adult spinal cord, highlighting the cervical, thoracic and lumbar
vertebrae, along with the sacrum and the coccyx. Also shown is the level of the spinal cord
from which the nerves emanate that control various muscles and functions of the body.
Humans have 31 left-right pairs of spinal nerves, which carry motor, sensory and autonomic
signals between the spinal cord and the body. These consist of eight cervical nerve pairs
(C1-8), 12 thoracic pairs (T1-12), five lumbar pairs (L1-5), five sacral pairs (S1-5) and one
coccygeal pair. These spinal nerves exit the spinal cord between adjacent vertebrae, except
for the first cervical nerve, referred to as C1, which exits above the first cervical vertebrae.
Therefore, the cervical nerves are all numbered according to the vertebrae below the nerve,
except for C8 which exists between C7 and T1, while the thoracic, lumbar and sacral nerves
are all numbered according to the vertebrae above.
1.2.3 Paralysis
There are two main factors that determine the severity of an SCI, namely the injury level
and completeness of injury.
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1.2.3.1 Injury Level
The neurological level of injury is defined in the International Standards for Neurological
Classification of Spinal Cord Injury as ‘the most caudal segment of the spinal cord with
normal sensory and antigravity motor function on both sides of the body’ [14]. Neurological
level is often further defined by both sensory and motor levels. The International Standards
describe the sensory level as ‘the most caudal, normally innervated dermatome for both pin
prick and light touch sensation’ and the motor level as ‘the lowest key muscle function that
has a grade of at least three’ (see Table 1.2 in Section 1.2.3.2 for more information on muscle
scoring). The sensory and motor level of an SCI can differ, as can the sensory or motor level
on either side of the body. When the scores differ on either side of the body, the different
levels are reported individually. An injury level reported as C5/6 would imply an injury level
of C5 on one side of the body and C6 on the other. The level at which skeletal damage to
the vertebrae occurs, termed skeletal level, may differ from the neurological level of injury.
Different muscles are innervated from descending levels of the spinal cord, as shown in
Figure 1.1. The more cranial the level of injury the more severe the impairment after SCI,
as a larger number of muscles will no longer be capable of being innervated from the spinal
cord.
1.2.3.2 Completeness of Injury
The severity of an SCI is commonly described using the five level American Spinal Injuries
Association (ASIA) Impairment Scale (AIS), based on the degree of sensory and motor
sparing. According to the AIS, an injury is sensory and motor complete, classed as AIS
A, if there is no function or sensation in muscles controlled by the nerves emanating from the
spinal cord at S4-S5. As these are the most caudal nerves emanating from the spinal cord
that are responsible for movement (the coccygeal nerve is only responsible for sensation), any
function or sensation in the muscles controlled by these nerves indicates that the pathway
between the brain and the most caudal portion of the spinal cord is still intact and that the
injury is incomplete. If sensation, but not function, is preserved below the injury, the injury is
classified as sensory incomplete, and classed as AIS B. If function and sensation is preserved
below the level of injury, the injury is defined as motor and sensory incomplete and classed
from AIS C to AIS E based on the level of muscle function. To determine this level of muscle
function a range of movement tests are performed, either against gravity or with caregiver
support depending on the level of impairment. Muscles are scored and classed using the six
point scale described in Table 1.2. The chart used to record AIS is shown in Figure 1.2.
Traditionally it was believed that a complete SCI severed the connection between the brain
and the spinal cord, preventing any signals from the brain reaching their destination. An
incomplete SCI was believed to disrupt the path from the brain to the spinal cord, with some
signals still able to reach their destination. It is now emerging that even in complete SCI some
signals may travel through the damaged site in the spinal cord [15]. Although these signals do
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Table 1.2: Explanation of ASIA Impairment Scale (AIS) muscle function scoring scale [14].
If more than 50% of the key muscle groups below the neurological level of injury have a score
of less than 3, the injury is classed as AIS C. If more than 50% of the key muscle groups
have a score ≥ 3, the injury is classed as AIS D. If function and sensation are normal this is
classed as AIS E
Muscle score Definition AIS Level
0 Total paralysis.
C1 Palpable or visible contraction.
2 Active movement, full range of motion (ROM) with
gravity eliminated.
3 Active movement, full ROM against gravity.
D
4 Active movement, full ROM against gravity and
moderate resistance in a muscle specific position.
5 (Normal) active movement, full ROM against gravity
and full resistance in a muscle specific position
expected from an otherwise unimpaired person.
E
0 = absent
1 = altered
2 = normal
NT = not testable
Figure 1.2: ASIA Impairment Scale scoring chart (taken from http://asia-spinalinjury.
org/ in May 2014).
not result in movement, believed to be because their amplitude is below the threshold required
to generate an action potential (see Section 1.3), they do reach their destination. As there is
no movement, or function, these injuries can be described as functionally complete. It appears
that almost no SCI is neurologically complete, whereby there is no connection between the
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brain and a muscle. Approximately 50 percent of SCIs are classed as complete [16]. Whether
an SCI is complete or incomplete can have a large effect on a patient’s rehabilitation and
their neurological, functional and social outcomes [17].
Patients with an SCI can also be grouped according to the time after injury. Acute SCI
generally refers to the immediate post-injury period when there is continuing tissue damage
and the patient is in spinal shock. Spinal shock causes an immediate loss of reflexes and
resulting flaccid paralysis in the muscles below the level of injury that return over time [18].
The acute phase of injury generally lasts for up to four weeks [19]. During the phase where
the spinal cord undergoes a reparative process and there is continuing neurological recovery
an SCI can be classified as sub-acute. The sub-acute phase typically begins around four
weeks after injury and continues for three to six months. When inflammation has stabilised
and neurological recovery has reached a plateau an SCI can be classified as chronic, which
typically does not occur until three to six months after injury [20]. While there is debate
as to the exact time frame for these classifications [21], within this thesis acute SCI will be
defined as any SCI up to four weeks post injury, sub-acute SCI will be defined as any SCI
between four weeks and three months post injury and chronic SCI will be defined as any SCI
greater than three months post injury.
1.2.4 Tetraplegia
An injury to the spinal cord in the cervical (C1 to C7) region can cause tetraplegia4.
Tetraplegia is defined as ‘impairment or loss of motor and/or sensory function in the cervical
segments of the spinal cord’ [14], and results in paralysis or impairment of all four limbs. An
injury to the spinal cord in the thoracic or lumbar region can cause paraplegia. Paraplegia
is defined as ‘impairment or loss of motor and/or sensory function in the thoracic, lumbar
or sacral (but not cervical) segments of the spinal cord’ [14], and results in paralysis or
impairment of the legs. Due to the paralysis affecting all four limbs, tetraplegia is a more
serious injury than paraplegia, with the extent of remaining upper limb function depending on
the neurological level of injury. Approximately half of all SCIs result in tetraplegia, although
the exact figure has been increasing in recent years with one study finding that 56.6 percent
of SCIs resulted in tetraplegia between 2000 and 2003 compared to 53.5 percent between
1973 and 1979 [22]. This rise can be attributed to improved medical care, which has led to
increased survival rates at the scene and in hospital, for people with tetraplegia.
Tetraplegia is associated with a significantly higher health care cost than paraplegia [22]. A
primary reason for this is that tetraplegia leaves patients particularly susceptible to secondary
complications of SCI, such as chronic pain, bladder and bowel dysfunction, pressure ulcers,
autonomic dysreflexia and respiratory complications [23, 24]. These secondary complications
place a large financial burden on the local health care provider [25] and are attributed to
approximately 30 physician visits per year [26]. As well as these high costs, secondary
4Tetraplegia is commonly referred to as quadriplegia in the USA
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complications can also leave the patient with a perceived reduction in their quality of life [27].
Of these secondary complications, respiratory complications are a leading cause of morbidity
and mortality for the tetraplegic population [2, 28, 29, 30]. Therefore, a reduction in the
rates of respiratory complications will improve the patient’s quality of life and reduce the
financial burden on the local health care provider.
For people with tetraplegia, secondary complications have a different prevalence depending on
whether the etiology of the injury is traumatic or non traumatic [31]. However, the prevalence
of respiratory complication observed in the acute care and rehabilitation setting are similar
for both cases [13]. Therefore, this thesis, which will seek methods to reduce the prevalence
of respiratory complications and improve respiratory function in the tetraplegic population in
the acute care setting, will make no distinction between traumatic and non traumatic SCIs.
1.3 Muscle Anatomy
The human body contains three types of muscle; skeletal, cardiac and smooth. Of these three
muscle types, skeletal muscle is the only one that is under voluntary control and as such will
be the only muscle type discussed in this thesis.
Each muscle of the body is supplied by a nerve that contains motor, sensory and sympathetic
nerve cells, used to supply movement, sensation and control the autonomic nervous system,
respectively. The nerve cells that control movement are called motor neurons and can be
split into Upper Motor Neurons (UMNs) and Lower Motor Neurons (LMNs). UMNs carry
motor information from the brain to the spinal cord, while LMNs branch out from the spinal
cord to carry motor information to different muscles as shown in Figure 1.3.
A lesion that affects either the UMNs or LMNs will result in a decrease or loss of voluntary
control of the muscles that they supply. Due to a lack of inhibition of the reflex pathways,
normally provided by the UMNs, an UMN lesion causes hyperactive or abnormal reflexes.
This results in spastic paralysis, which increases muscle tone. An UMN lesion occurs in
approximately 50 percent of SCIs [16], causing a motor complete SCI where paralysis affects
all the muscles innervated below this lesion.
Due to damage of the reflex pathways an LMN lesion causes absent or decreased reflexes. This
results in flaccid paralysis, which decreases muscle tone. In SCI an LMN lesion is observed
either i) at the point where the LMNs exit the spinal cord or ii) to the nerves away from
the spinal cord. LMN lesions at the spinal cord are usually caused by fractured vertebrae
damaging the nerve, with SCIs in the upper cervical area (C5 and above) particularly prone
to an LMN lesion caused by this method. An LMN lesion to the nerves away from the
spinal cord is especially common for the nerves that exit through the vertebrae of the lower
lumbar spine (L3 and below), where the LMNs are again damaged due to severe fractures of
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Figure 1.3: Diagram of the route of a motor signal (light blue) from the brain to a muscle.
The signal passes from the brain down the spinal cord (red) via Upper Motor Neurons. It
then travels down a nerve (orange) via Lower Motor Neurons, before entering a muscle. The
point at which a nerve enters a muscle is called the motor point.
these vertebrae. An LMN lesion usually presents as localised weakness of muscles innervated
by nerves affected by the lesion. Importantly, as the use of electrical stimulation to cause a
muscle contraction requires an intact pathway between the stimulated nerve and its associated
muscle, electrical stimulation cannot be used to cause a muscle contraction in the presence
of LMN damage. Therefore, electrical stimulation will only be used with patients who have
not suffered LMN damage within this thesis.
The neuromuscular junction, or motor point, is the location where a nerve enters a muscle
as shown in Figure 1.3. A muscle is made up of contractile cells, often called fibres as they
are so long, which are joined by connective tissue. Skeletal muscle fibres can be divided into
two categories, Type I (slow twitch) and Type II (fast twitch). Type I fibres contain large
amounts of myoglobin, a protein found in muscles that carries oxygen. Therefore, Type I
fibres have a large supply of oxygen. Type II fibres contain only small amounts of myoglobin
and hence oxygen. Type I fibres are smaller than Type II fibres and are largely fatigue
resistant due to their large supply of oxygen, while the decreased oxygen supply to a Type II
fibre results in rapid fatigue. Type I fibres are designed for endurance, while Type II fibres
are designed for power and speed. The percentage of each type of muscle fibre within the
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body varies from person to person. Typically sprint athletes will have more Type II fibres,
while endurance athletes will have more Type I fibres. The combination of an LMN with all
of its corresponding muscle fibres is called a motor unit. Motor units can vary in size from
small units, with small diameter axons, to large units, with larger diameter axons. Small
motor units, which contain only a few fibres, are used to achieve precise movements. The
activation of additional larger motor units results in a larger muscle contraction, allowing
more powerful tasks to be executed. All motor units contain only one type of muscle fibre.
Small motor units tend to be made up of Type I muscle fibres, with larger motor units more
likely to be made up of Type II muscle fibres. Henneman’s size principle states that the
natural recruitment order of motor units is from smallest to largest (fewest fibres to most
fibres) [32].
In the able bodied population a muscle contraction is activated by an electrical signal sent
from the brain, via the spinal cord, to the nerve controlling the muscle as shown in Figure 1.3.
This electrical signal creates an action potential, a short lasting increase in electrical potential
of a cell, which starts a chain of electrochemical events that cause a muscle contraction. A
muscle can be made to contract in two ways. When a single stimulus of adequate strength
is applied to a muscle this generates a twitch contraction. If stimulation pulses are delivered
at a frequency of greater than 12.5 Hz this generates a constant tetanic contraction because
the muscle does not have time to relax between individual twitches.
1.4 Respiratory Function
Respiration, or breathing, provides oxygen to the body and removes carbon dioxide. As air
naturally resides in the area of lowest pressure, the respiratory muscles are used to increase
or decrease the pressure around the lungs, called the intrathoracic pressure. The decrease
of intrathoracic pressure to a pressure lower than that outside the body causes air to flow
into the lungs, a process called inhalation. An increase in the intrathoracic pressure to a
pressure greater than that outside the body causes air to flow out of the lungs, a process
called exhalation.
The two most common types of breathing are quiet breathing and coughing. A cough is
used to clear the airway, while a quiet breath is taken during normal relaxed breathing. To
generate the power required to clear the airways, a cough has a greater peak expiratory air
flow rate than a quiet breath, with this peak flow rate reached earlier in the exhalation. The
exhalation length of a cough is often shorter than the exhalation length of a quiet breath.
The difference between these two breath types is shown in Figure 1.4.
1.4.1 Respiratory Muscles
The main muscles used for respiration are the diaphragm and the intercostal and abdominal
muscles, with the location of each of these muscles shown in Figure 1.5.
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Figure 1.4: A measurement of respiratory flow, recorded using a spirometer, highlighting the
difference in peak expiratory flow rate, and the time point where this peak expiratory flow
rate occurs, during quiet breathing (blue) and coughing (red).
Figure 1.5: Respiratory muscle anatomy. Highlighted are the rectus abdominis muscles
(green), the external oblique muscles (purple), the internal oblique muscles (pink), which are
situated under the external oblique muscles, and the transversus abdominis muscles (yellow),
which are situated under the internal oblique muscles. These muscles are situated in the same
location on both sides of the body and make up the abdominal muscles. The intercostal
muscles (red), which are interwoven around the ribs on both sides of the body, and the
diaphragm (blue) are also shown.
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The diaphragm is situated across the bottom of the rib cage, separating the thoracic and
abdominal cavity, and takes the form of a dome shaped thin layer of muscle. The diaphragm
aids inspiration by contracting to increase the volume of the thoracic cavity, reducing
the intrathoracic pressure and causing an inhalation. The diaphragm is responsible for
approximately 65 percent of a persons vital capacity (see Section 1.4.2) [33].
During quiet breathing, exhalation is passive. The return of the diaphragm to its original
position, coupled with the elastic recoil of the lungs, acts to increase intrathoracic pressure and
cause exhalation. A forced exhalation, such as that observed during exercise or coughing, is
an active process. During a forced exhalation, a contraction of the intercostal and abdominal
muscles, coupled with the return of the diaphragm to its original position and the elastic
recoil of the lungs, increases the intrathoracic pressure, causing exhalation.
The intercostal muscles are a network of interwoven muscles, located between the ribs. They
are composed of the external, internal and innermost intercostal muscles, and are innervated
by 24 separate nerves. Each nerve innervates muscles that have both an inspiratory and
expiratory function. The external intercostal muscles aid inhalation by pulling the ribcage
upwards and outwards, increasing the diameter of the chest and decreasing intrathoracic
pressure. The internal and innermost intercostal muscles aid forced exhalation by pulling the
ribcage downwards and inward, increasing intrathoracic pressure. The intercostal muscles
are responsible for approximately 35 percent of a persons vital capacity [34].
The abdominal muscle group consists of four muscles situated within the abdomen, namely
the transversus abdominis, the rectus abdominis and the internal and external oblique
muscles. The location of these muscles within the abdominal cavity is shown in Figure 1.5.
The abdominal muscles support forced exhalation by drawing the abdominal contents inward,
increasing intrathoracic pressure and pushing the diaphragm upwards.
The diaphragm is innervated by the phrenic nerve, originating from the spinal cord at C3
to C5. The intercostal muscles are innervated by the intercostal nerves, originating from the
spinal cord at T1 to T11, and the abdominal muscles are innervated by the thoracoabdominal
nerves, originating from the spinal cord at T7 to T11. People with motor complete tetraplegia
will have paralysed intercostal and abdominal muscles. If the neurological level of injury is
C3, C4 or C5 they will have impaired diaphragm function. If the neurological level of injury is
C1 or C2 they will have no diaphragm function and will be unable to breathe independently.
Damage to the LMNs within the phrenic, intercostal or thoracoabdominal nerves would result
in an inability to activate the diaphragm, intercostal or abdominal muscles respectively.
1.4.2 Measures of Respiratory Function
A number of measures can be used to evaluate the status of a persons respiratory function,
with these measures varying between people depending on sex, age, height and weight [35].
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A summary of these respiratory measurements is presented in Table 1.3, with each of these
respiratory measurements explained in further detail in this section.
Table 1.3: Summary of different measurements of respiratory function. The acronym used
for each measure throughout this thesis, what the tests measure and whether this measure
relates to the strength of the inspiratory or expiratory muscles is given.
Measurement Acronym Measurement of Muscles
Peak Expiratory Flow PEF Maximum Expiratory Flow Rate Expiratory
During Normal Breath
Cough Peak Flow CPF Maximum Expiratory Flow Rate Expiratory
During Cough
Maximum Expiratory MEP Maximum Pressure During Expiratory
Pressure Exhalation
Maximum Inspiratory MIP Maximum Pressure During Inspiratory
Pressure Inhalation
Forced Vital Capacity FVC Actively Exhaled Volume Inspiratory
Vital Capacity VC Passively Exhaled Volume Inspiratory
Forced Exhaled Volume FEV1 Actively Exhaled Volume Expiratory
in 1 Second in First Second
Tidal Volume VT Exhaled Volume of Inspiratory
Normal Breath
The volume of air exhaled in each normal breath is called Tidal Volume (VT ), and is measured
in litres (L). A healthy adult has an VT of approximately 0.5 L [36, 37]. To normalise
respiratory function across a group weight corrected tidal volume (VT /kg), which is a persons
VT divided by their body weight, is often reported [38, 39] and will be used for all group
comparisons in this thesis.
Respiratory failure leads to some patients with tetraplegia requiring mechanical ventilation,
a method to assist or replace spontaneous breathing (see Section 2.3.1 for more information).
VT plays an important role during mechanical ventilation, with a VT /kg of approximately
8 to 15 ml/kg applied to ensure adequate ventilation [38]. During mechanical ventilation,
an VT /kg of greater than 15 ml/kg has been linked to complications such as barotrauma
(alveolar rupture due to high pressure) and pulmonary edema (fluid accumulation in the
lungs). However, some research suggests that a high VT /kg may be useful in treating
atelectasis (collapse of part of the lung), a common complication after SCI [39].
Cough Peak Flow (CPF) is the maximum rate at which a person can exhale air from their
lungs during a cough, while Peak Expiratory Flow (PEF) is the maximum rate at which a
person can exhale air from their lungs when exhaling as forcefully and as quickly as possible.
As both CPF and PEF are measures of the rate at which air leaves the lungs, both can be
used to detect obstruction of the airways. As both are taken during an active exhalation,
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whereby the participant actively exhales, they also give an indication of the strength of the
expiratory muscles. Both CPF and PEF are measured in litres per second (L/s), although
litres per minute (L/min) may sometimes be reported. An example of a typical PEF trace
recorded from a healthy adult male and female is shown in Figure 1.6.
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Figure 1.6: Peak Expiratory Flow (marked with black circle) recorded from a healthy, 183 cm
tall, 26 year old male (blue) and a healthy, 170 cm tall, 26 year old female (red).
Maximum Expiratory Pressure (MEP), the maximum pressure generated against resistance
during an exhalation, can be used to measure the strength of the expiratory muscles, while
Maximum Inspiratory Pressure (MIP), the maximum pressure generated against resistance
during an inhalation, can be used to measure the strength of the inspiratory muscles. Both
MEP and MIP are recorded using a pressure meter and are measured in centimeters of
water (cmH2O). For males MEP and MIP vary depending on age, while for females MEP
and MIP vary depending on height [40].
As well as the aforementioned flow and pressure measurements, respiratory function can also
be evaluated using a number of volumetric measurements, with some of these measurements
shown in Figure 1.7.
Vital Capacity (VC), the total volume of air exhaled after inhaling to total lung capacity
and exhaling passively, and Forced Vital Capacity (FVC), the total volume of air exhaled
after inhaling to maximum lung capacity and exhaling as forcefully as possible, can be used
to evaluate the strength of the inspiratory muscles [41]. For people with tetraplegia, severe
impairment or paralysis of the respiratory muscle prevents them from inhaling to total lung
capacity. This results in people with tetraplegia only being able to inhale to a percentage of
their lung capacity, denoted here as their functional lung capacity. VC and FVC can be used
to assess the degree of respiratory muscle impairment after SCI. In this thesis, tetraplegic
patients will be asked to inhale as fully as possible, to what will be their functional lung
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Figure 1.7: Example respiratory measurements highlighting: Forced Vital Capacity (FVC),
Vital Capacity (VC), Tidal Volume (VT ), Residual Volume (REV) (the volume of air which
permanently resides in the lungs), total lung capacity (the maximum volume of the lungs),
inspiratory reserve volume (the additional volume of air that can be inhaled at the end of a
normal inhalation) and functional residual capacity (the volume of air which remains in the
lungs after a normal exhalation).
capacity, and then exhale fully to establish VC and FVC. As FVC is recorded during an
active exhalation, the exhalation length during an FVC manoeuvre is normally shorter than
when measuring VC , as shown in Figure 1.7. Both FVC and VC are measured in L, with
only a small difference in the values recorded from both tests. As with VT , to allow a
comparison between different people weight corrected forced vital capacity (FVC/kg) and
weight corrected vital capacity (VC/kg) are often reported [42], and will be used for all group
comparisons in this thesis.
From an FVC manoeuvre, the Forced Exhaled Volume in one second (FEV1) can also be
measured. FEV1, which is the volume of air which can be exhaled from the lungs in the
first second of a forced exhalation, provides an indication of the strength of the expiratory
muscles. FEV1 is measured in L/s, and is approximately 80 percent of a persons FVC [43].
An example of an FVC and FEV1 recording is shown in Figure 1.8.
All of the aforementioned measures of respiratory function, except for MIP and MEP which
require a pressure meter, can be recorded using a spirometer, which is a device use to measure
the volume, or flow, of air inhaled and exhaled by the lungs. PEF is also often measured
using a peak flow meter. Miller et al. [44] have shown that peak flow meters can have a large
inter device variability, hence the use of a spirometer is now becoming the ‘gold standard’
for PEF measurement. The predicted values of respiratory function for a healthy 30 year old
male and female are shown in Table 1.4.
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Figure 1.8: Example of Forced Exhaled Volume in one second (FEV1) recorded during a
Forced Vital Capacity (FVC) manoeuvre recorded from a 170 cm tall, 30 year old male.
Table 1.4: Predicted values of Peak Expiratory Flow (PEF), Maximum Expiratory Pressure
(MEP), Maximum Inspiratory Pressure (MIP), Forced Vital Capacity (FVC), Forced Exhaled
Volume in one second (FEV1) and Tidal Volume VT for a healthy, 180 cm tall, 30 year old
male and a healthy, 160 cm tall, 30 year old female [35, 37, 40, 43].
Respiratory Measure Male Female
PEF 10.5 L/s 6.8 L/s
MEP 153 cmH2O 91 cmH2O
MIP 111 cmH2O 71 cmH2O
FVC 5.6 L 3.7 L
FEV1 4.6 L/s 3.1 L/s
VT 0.5 L 0.4 L
1.4.3 Respiratory Function in Tetraplegia
Paralysis, or severe impairment, of the main respiratory muscles leaves many people with
tetraplegia with reduced respiratory function. A person with tetraplegia is likely to have
an FVC of less than 50 percent of the predicted value for a healthy adult, and a reduced
VT [30]. This reduced respiratory function leaves many people with tetraplegia unable to
effectively clear their airways through cough, leading to a build up of secretions in the lungs
and airways and making people with tetraplegia prone to respiratory infections. These
respiratory infections often lead to the development of respiratory complications such as
pneumonia (inflammation of the alveoli often caused by respiratory infection) and atelectasis
(collapse or closure of the lung resulting in poor gas exchange often caused by a mucus plug
in the lungs). Dryden et al. found that in a six year follow up study, 33.8 percent of people
with an SCI developed at least one case of pneumonia [45]. This increased susceptibility to
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respiratory complications makes them a leading cause of morbidity and mortality for people
with tetraplegia [28], while placing a cost burden on the local health care provider [25].
Mechanical ventilation reduces a patient’s quality of life, delays rehabilitation and places
a large financial burden on the local health care provider [27]. Dasta et al. estimate that
mechanical ventilation costs the health care provider an additional $1500 per day based on the
USA hospital system [46]. People with tetraplegia who have a very high level complete injury
(C2 and above) will have no diaphragm function (see Section 1.4.1). For these patients chronic
use of mechanical ventilation is necessary to support respiratory function. For many other
tetraplegic patients who retain some diaphragm function (injury C3 and below) mechanical
ventilation is required to assist respiration in the acute stage of injury due to respiratory
failure [47]. Most of these patients require only short periods of mechanical ventilation and
will wean from ventilation within a number of weeks. For some, particularly those with a
greater reduction in diaphragm function, the weaning process can take longer and sometimes
requires the chronic use of mechanical ventilation. As these patients retain some level of
diaphragm function, and hence have the ability to breathe independently, with assistance
they should eventually wean from ventilation.
It is clear that an improvement in the respiratory function of people with tetraplegia would
not only improve the patient’s quality of life, but would also result in a significant cost saving
for the local health care provider.
“Improvements in respiration and the elimination of ventilator-dependence are extremely
important to the quality of life, and this topic should be at the forefront of research.”
Kim Anderson [48]
Therefore, the poor respiratory function of the spinal cord injured population requires to be
addressed.
This is currently achieved clinically using a number of methods. For those who lack the ability
to breathe independently due to severely impaired diaphragm function mechanical ventilation
is the clinically accepted method to assist respiration. This can be applied either invasively,
by attaching the ventilator to a endotracheal or tracheostomy tube, or non-invasively, using
an orofacial mask. For those who retain the ability to breathe spontaneously but have reduced
respiratory function resulting in an ineffective cough manually assisted coughing, mechanical
insuﬄation-exsuﬄation or tracheal suctioning are all used to simulate a cough and clear
secretions from the airways. For these patients, respiratory muscle training, which typically
uses restrictive air flow devices to train the muscles used for inspiration and expiration, is
also used clinically to try and improve respiratory function. As discussed in Chapter 2, none
of these methods are a panacea, with a non-invasive, reliable alternative still to be introduced
clinically.
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1.5 Functional Electrical Stimulation
Neuromuscular Electrical Stimulation (NMES) is the application of a train of electrical pulses
to a motor nerve, causing contraction of the associated muscle. NMES can be used in health
care for one of three purposes: to aid diagnosis, as a therapeutic tool, and/or to restore lost
or damaged function [49]. The concept of Functional Electrical Stimulation (FES) was first
proposed by Liberson et al. [50] to describe the use of NMES to activate muscles in a precise
sequence to achieve a functional task, in this case for the correction of foot drop, alluding
to the third of these health care uses. Transcutaneous Electrical Nerve Stimulation (TENS)
also comes under the canopy of NMES. Unlike FES, TENS is used as a therapeutic treatment
without a functional outcome, primarily being used for pain relief.
1.5.1 Principles of FES
For people who have paralysis that does not result in LMN damage, the pathways from the
spinal cord to the nerves remain intact below the level of injury (i.e. below the neurological
level of injury in SCI and below the level of the brain in stroke). This means that although
a muscle may be paralysed and no longer under voluntary control, it still retains the ability
to contract. FES can be used to provide an electrical signal to a nerve, which generates an
action potential and causes these paralysed muscles to contract. Note, electrical stimulation
is applied to the nerve rather than the muscle itself as the stimulation threshold required to
generate a nerve fibre action potential is significantly lower than that required to generate a
muscle fibre action potential. FES may also be used to initiate a reflex, rather than muscle,
response, such as when stimulating the peroneal nerve to initiate the nociceptive withdrawal
reflex and correct foot drop.
When using FES to achieve a muscle contraction, the optimum muscle contraction is
usually observed when stimulation is applied close to the motor point of the muscle (see
Section 1.3) [51]. Studies have shown that placing the stimulating electrodes at the motor
point maximises force output and minimises discomfort [52, 53]. In implanted systems
stimulation may be applied to the nerve directly, away from the motor point, to achieve
a similar effect. The effect that FES has on the way muscles are recruited is less clear. It is
believed that the use of FES leads to a ‘reverse recruitment order’, where larger diameter,
Type II (see Section 1.3), motor units are recruited preferentially to smaller diameter, Type
I, motor units [51, 54]. According to Bickel et al. [55], the theory of ‘reverse recruitment
order’ is based on the finding that FES appears to lead to faster muscle fatigue than normal
muscle recruitment. This appears to indicate that large motor units, which are more easily
depolarised (depolarisation is the process required to generate an action potential) [55] and
are more prone to fatigue than smaller motor units, are being recruited preferentially. Bickel
et al. argue that motor unit recruitment with FES is actually random, with motor units
being recruited in a non selective way. They state that increased levels of muscle fatigue
observed during FES is caused by the repeated application of the same stimulation parameters
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continuing to recruit the same motor units. Whether FES does follow the reverse recruitment
order or activates motor units at random, it is working differently to the body’s natural
recruitment order as: large muscle fibres are being recruited during FES more often than
during natural recruitment; the same muscle fibres are being recruited repeatedly as opposed
to natural recruitment where alternating fibres are recruited to avoid fatigue and all recruited
fibres are being activated synchronously rather than individually as observed during natural
recruitment. Therefore, the use of FES can lead to an increased level of muscle fatigue
compared to natural recruitment. This means that to maintain a constant muscle contraction
when using FES for an extended period of time the stimulation charge must be increased.
1.5.1.1 Electrodes
FES can be delivered in three ways i) via electrodes placed on the skin (transcutaneous or
surface stimulation), ii) via electrodes inserted through the skin (percutaneous stimulation)
or iii) via electrodes implanted into the body and placed around or in close proximity to the
nerve (implanted devices) [51]. Transcutaneous stimulation is simple and non-invasive, but
it can be affected by poor selectivity of the correct muscle and can lead to skin irritation if
improperly applied. Percutaneous stimulation allows for a greater selectivity of the correct
motor unit. However, the needle electrodes used to deliver stimulation can be prone to
failure, with Knutson et al. [56] reporting that in a study involving the insertion of 858
electrodes, 222 (26%) had to be removed due to failure. Implanted devices are designed for
long term use, with their implantation involving an invasive and sometimes extensive surgical
procedure. They apply stimulation via one of four types of electrode i) epimysial electrodes
which are sutured directly onto the target muscles and are useful for the activation of thin
muscles, ii) epineural electrodes which are sutured to tissue around the nerve and can be
used to stimulate the nerve directly, iii) intraneural electrodes which penetrate into the nerve
(currently only used in research applications) or iv) cuff electrodes which are placed directly
around the nerve trunk and are the most common method of implanted stimulation. These
implanted electrodes allow for more targeted stimulation than transcutaneous electrodes,
with a much lower stimulation charge required to invoke a response. However, they create
greater safety and biocompatability issues, involve extensive surgery and are expensive.
There are two types of transcutaneous electrode configuration, monopolar and bipolar. In
a bipolar electrode configuration the active electrode and reference electrode are situated
close together, forming a small electrical circuit. In a monopolar configuration, the active
electrode is positioned on top of the target nerve, with the reference electrode positioned
somewhere along the neural pathway. While a bipolar configuration allows for targeting of
specific motor units, monopolar configurations are popular when using electrode arrays, as
only one reference electrode is required.
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1.5.1.2 Stimulation Parameters
The stimulation parameters required to envoke an effective muscle contraction vary depending
on the electrode type and target muscle. Each electrical stimulation pulse can be characterised
by its pulsewidth, current, waveform and frequency.
Pulsewidth, also referred to as pulse duration, is the duration of each stimulation pulse and
is normally in the range of 100 to 500 microseconds (µs). Stimulation current is the current
applied during each stimulation pulse and for transcutaneous stimulation is normally in the
range of 10 to 100 mA. The charge (Q) delivered during each electrical stimulation pulse is
the stimulation current (I) multiplied by the pulsewidth (P ), as shown in Equation 1.1, and
is measured in Coulombs.
Q = I×P (1.1)
As can be seen in Equation 1.1, the charge delivered during each stimulation pulse can be
increased by increasing the pulsewidth or the stimulation current. An increase in charge will
lead to an increase in muscle fibre recruitment and result in a greater force being generated.
The production of a greater force results in faster muscle fatigue, therefore it is important to
only apply as much force as necessary to complete the desired task.
The waveform can either be biphasic, with a positive and negative charge, or monophasic,
which applies only a positive or negative charge. A biphasic waveform is widely regarded
as safer as the polarity of the charge entering the body is balanced. As such, for chronic
applications electrical stimulation should always be charge balanced. This can be achieved
through either: a monophasic charge balanced waveform, where a large short stimulating
pulse (which activates the motor units) is followed by a longer period of small current in the
opposing direction resulting in an overall neutral charge; or a biphasic waveform, where a
stimulating current pulse in one direction is followed by a similar, charge balancing, pulse in
the opposite direction. An example of these two waveforms is shown in Figure 1.9.
Stimulators are designed to work with either a fixed current or fixed voltage output, with
the charge that is applied to the nerve depending on the impedance created by the contact
with the skin. A voltage regulated stimulator applies a constant voltage (V) following the
principles of Ohm’s law, shown in Equation 1.2.
V = I×R (1.2)
As can be seen in Equation 1.2, when using a voltage regulated stimulator an increase in
impedance (R) results in a decrease in the current (I) being delivered to the skin. A current
regulated stimulator is not affected by a change in impedance. This results in a constant
current being delivered to the skin, and in turn the nerve, generating a consistent muscle
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Figure 1.9: Example of electrical stimulation waveforms. A stimulating pulse (shown in
black) is applied with a current amplitude of 10 mA, a pulsewidth of 200 µs and a frequency
of 100 Hz. This stimulating pulse is charge balanced by a biphasic pulse (shown in red) and
a monophasic charge balanced pulse (shown in blue).
contraction. If the electrode becomes dislodged or damaged this current may be applied over
a smaller surface area, resulting in an increase in the current density applied to the skin.
In the most extreme case this could cause skin burns or tissue damage, however modern
stimulators are designed to detect these situations and to limit the current accordingly. A
voltage regulated stimulator does not allow control of the current being applied to the nerve,
meaning that a consistent muscle contraction is not guaranteed. Therefore, when choosing
between a current or voltage regulated stimulator a balance has to be struck between the
risk of damage to the skin or tissue and the need for a consistent muscle contraction. While
in a transcutaneous system voltage regulation will almost certainly prevent damage to the
skin, with due vigilance current regulated stimulation can be used safely and achieve a far
more consistent muscle contraction. Almost all implanted systems use current regulated
stimulation as there is less variability in impedance, resulting in less chance of tissue damage,
and a constant muscle contraction is of upmost importance.
Depending on stimulation frequency, electrical stimulation is capable of generating either a
tetanic (constant) or twitch (intermittent) muscle contraction (see Section 1.3). To achieve a
tetanic contraction the stimulation frequency must be greater than 12.5 Hz [51]. The greater
the stimulation frequency above 12.5 Hz, the stronger the force generated. Due to an increase
in the amount of time for which a fibre is recruited, increased stimulation frequency will result
in faster muscle fatigue resulting in a decline in force.
FES has been used for a number of clinical applications. One of the most successful of these
has been the use of FES to improve ambulation in patients who suffer from foot drop caused
CHAPTER 1. INTRODUCTION 22
by a stroke or SCI [57]. FES has also been used to stimulate i) the triceps to improve
upper limb function [58, 59] ii) muscles of the upper leg as an exercise modality after stroke
and SCI [60, 61], and iii) the sacral nerve roots to improve bladder and bowel function
after SCI [62, 63]. In tetraplegic patients who lack the ability to breathe independently and
are reliant on chronic mechanical ventilation FES has been applied to the phrenic nerve or
diaphragm to generate an artificial breathing pattern, enhancing inhalation and enabling the
removal of mechanical ventilation [64, 65, 66]. This thesis will focus on the use of FES of the
abdominal muscles to improve respiration in tetraplegia.
1.5.2 Abdominal FES
FES has previously been used to activate the abdominal muscles. This has been achieved
using: an implanted system to activate their thoracic nerve roots at the spinal cord [67, 68];
magnetic stimulation of these thoracic nerve roots [69] and the transcutaneous application
of FES to the abdominal muscles, a technique called Abdominal Functional Electrical
Stimulation (AFES). AFES is commonly applied to either, or both of, the rectus abdominis
and external oblique muscle groups (see Section 1.4.1). It has been suggested that AFES
training increases muscle mass, providing greater support to the abdominal contents. As the
abdominal contents act as a pivot point for the diaphragm when it contracts, the greater
support provided to them by the abdominal muscles places the diaphragm in a more efficient
position after contraction [70]. It is also possible that by achieving an acute increase in
respiratory function, AFES is assisting motor relearning, teaching the body a more efficient
method of respiration. A typical electrode placement for a transcutaneous AFES system is
shown in Figure 1.10.
Figure 1.10: Electrode placement for abdominal stimulation showing four pairs of electrodes,
positioned to stimulate the rectus abdominis and external oblique muscles on either side of
the body.
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As the abdominal muscles are an important muscle group for forced exhalation and cough,
the strengthening of this muscle group can lead to an improvement in respiratory function.
The application of AFES has been shown to achieve an acute increase in quiet breathing
and cough function [71, 72]. The use of an AFES training program has also been shown to
achieve longitudinal changes in quiet breathing and cough function [70, 73]. Despite these
positive results AFES has yet to be introduced as a standard clinical treatment modality.
This thesis will focus on the development of new technology and protocols to aid the clinical
introduction of AFES with the tetraplegic population.
1.6 Aim and Objectives
The overall aim of this thesis is to add evidence to support the clinical introduction of AFES to
improve the respiratory function of both acute ventilator dependent and sub-acute tetraplegic
patients. This aim will be achieved by developing and implementing new technologies and
protocols, which will firstly be tested with the able bodied population, and then developed
for use with tetraplegic patients. The feasibility and effectiveness of these technologies and
protocols to improve respiratory function will be investigated with acute ventilator dependent
and sub-acute tetraplegic patients.
The objectives that will lead to the accomplishment of this aim are:
1. Technological development To develop technology capable of overcoming the
challenges that exist in using AFES with the tetraplegic population. This new
technology should include systems capable of synchronising AFES with the respiratory
activity of both acute ventilator dependant and sub-acute tetraplegics and a system that
can be used to identify the motor points of the abdominal muscles. The integration of
AFES with existing methods for improving the cough of sub-acute tetraplegic patients
will also be addressed.
2. Clinical evaluation To evaluate and develop the optimum protocols for the use of
AFES with the tetraplegic population. Clinical studies will be undertaken to establish
whether the use of novel protocols, which incorporate the new technology developed in
objective 1, are feasible, and whether they can be used to improve respiratory function.
An investigation into the optimum duration of an AFES training program will also be
undertaken.
1.6.1 Thesis Outline
These aims will be addressed in the chapters of this thesis, which are outlined below.
Chapter 2 : A review of studies investigating the effect of paralysis on respiration in
tetraplegia is provided in this chapter. Various methods that have been employed to help
improve the respiratory function of people with tetraplegia are reviewed, with a particular
focus on AFES. The open questions surrounding the use of this technique, and possible
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developments that should improve this techniques effectiveness, are presented here.
Chapter 3 : The experimental methods used throughout this thesis are presented here.
This includes a description of the methods used to measure respiratory function, the methods
used to record respiratory activity and a description of the AFES system. An overview of the
statistical methods used in this thesis is also given. This chapter also includes a small study
investigating the optimum set up parameters for using a respiratory effort belt to measure
respiratory function.
Chapter 4 : In this chapter the use of non-intrusive sensors for the real-time detection
and classification of respiratory activity is explored. A range of non-intrusive sensors are
evaluated to assess their suitability for real-time detection of respiratory activity. The non-
intrusive sensors found to be capable of real-time detection of respiratory activity are then
used to develop a statistical classification algorithm to classify respiratory activity, capable
of differentiating between a cough and quiet breath in real-time.
Chapter 5 : A novel application of NMES to locate the position of the motor points
of the abdominal muscles is presented here. The feasibility of using this technique for
abdominal muscle motor point detection is demonstrated with 10 able bodied and five
tetraplegic participants. The repeatability and uniformity of these motor point positions
is evaluated and compared for both groups, with the implications of these results discussed.
The repeatability of this technique is demonstrated and the potential of this technique to
improve the effectiveness of AFES research is discussed.
Chapter 6 : This chapter begins by documenting a single participant case study, used
to demonstrate the feasibility of using AFES to assist ventilator weaning for the tetraplegic
population who retain some diaphragm function. A larger feasibility study investigating the
use of AFES to improve the respiratory function of acute ventilator dependant tetraplegics
and assist weaning from mechanical ventilation is then presented. This is the main clinical
study conducted for this thesis. The engineering methods developed to allow the automatic
synchronisation of AFES with mechanical ventilation or the participant’s respiratory activity
are described. The improvements in respiratory function gained during the eight week
study are presented, along with the weaning outcomes for all participants and their matched
controls. The potential future applications and implications of this new technique are also
discussed.
Chapter 7 : A randomised crossover study investigating the effect of AFES training on
respiratory function is described here. The feasibility of using five times weekly AFES training
sessions for a period of eight weeks is demonstrated with three tetraplegic participants. The
results achieved during the intervention and a four week control period are presented and
discussed. A novel method of combining AFES with mechanical insuﬄation-exsuﬄation to
CHAPTER 1. INTRODUCTION 25
improve cough is also described.
Chapter 8 : This chapter draws on all the work presented in this thesis to provide a
balanced assessment of the use of AFES to improve the respiratory function of people with
tetraplegia. The limitations of AFES, along with the potential future work generated by the
research presented here, are also discussed in this chapter.
Chapter 9 : The main conclusions of this thesis are summarised.
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Chapter 2
Literature Review
“One never notices what has been done; one can only see what remains to be done.”
Marie Curie
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2.1 Summary
Paralysis, or severe impairment, of the respiratory muscles causes many people with
tetraplegia to have reduced respiratory function. Associated respiratory complications are
a leading cause of morbidity and mortality for the tetraplegic population. This literature
review begins by describing research conducted into the effect of tetraplegia on respiratory
function. A number of techniques are available to improve the respiratory function of people
with tetraplegia. None of these techniques are without drawbacks. The function, benefits
and practicality of each system is discussed in detail, with a specific focus on abdominal
functional electrical stimulation.
2.2 Respiratory Function in Tetraplegia
An injury to the cervical region of the spinal cord, termed tetraplegia, leads to paralysis, or
severe impairment, of the abdominal and intercostal muscles, as well as paralysis or reduced
function of the diaphragm. As these are the main muscles used for respiration, people with
tetraplegia often have reduced respiratory function and an inability to generate an effective
cough.
A number of studies have compared the predicted values of respiratory function for the able
bodied population (see Section 1.4.2) with the respiratory function of people with tetraplegia.
A summary of the results from a selection of these studies is shown in Table 2.1.
Table 2.1: Summary of studies investigating respiratory function in tetraplegia. The Forced
Vital Capacity (FVC), Forced Exhaled Volume in one second (FEV1), Peak Expiratory Flow
(PEF), Tidal Volume (VT ), Maximum Inspiratory Pressure (MIP) and Maximum Expiratory
Pressure (MEP) of people with tetraplegia, compared to the predicted value for the able
bodied population, is shown. The injury levels of the participants and the minimum time
post injury is also shown.
Author Injury Time Post FVC FEV1 PEF VT MIP MEP
Level Injury
Spungen et al. [36] Tetra > 2 years 52% 52% - 74% 65% 36%
Langbein et al. [71] C5-C7 > 1 year 64% 67% 60% - - -
Linn et al. [74] C2-C5 > 1 year 49% 52% 42% - - -
C6-C8 > 1 year 62% 69% 54% - - -
Baydur et al. [75] C3-C8 > 8 months 57% 65% - - - -
Thomaz et al. [76] C4-C8 > 2 months 55% - - - - -
Linn et al. [77] C3-C5 > 1 year 49% - - - - -
C6-C8 > 1 year 73% - - - - -
It should be noted that the studies presented in Table 2.1 did not exclude tetraplegic
patients who had Lower Motor Neuron (LMN) damage. As intact LMNs are necessary for
Functional Electrical Stimulation (FES) to be successful, some of the candidates in these
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studies may not have been eligible for the Abdominal Functional Electrical Stimulation
(AFES) studies conducted in this thesis. Patients with LMN damage will have flaccid
paralysis, meaning that disuse atrophy occurs quickly after injury (see Section 1.3 for further
details regarding LMN damage). As a result, these patients may display different levels of
respiratory function compared to those without LMN damage, with the possibility that due
to severe muscle atrophy the respiratory muscles, and hence respiratory function, are more
severely compromised in these patients. Therefore, caution should be exercised when making
a quantitative comparison of the respiratory function of participants in AFES studies with
studies investigating the respiratory function of the general tetraplegic population, such as
those detailed in Table 2.1. Within this thesis, the results of the studies presented in Table 2.1
will be used to provide a qualitative indication of the effect of tetraplegia on respiratory
function.
As can be seen from Table 2.1 tetraplegia reduces respiratory function to a level well below
the predicted values for the able bodied population, with this reduction in function shown to
increase with ascending injury level [74, 77]. This reduced respiratory function has a direct
impact on the ability of people with tetraplegia to generate an effective cough, leading to an
inability to effectively clear the airway of secretions. This poor secretion clearance is a key
factor in respiratory complications being a leading cause of morbidity and mortality for this
population [2, 28, 29, 30] with a mortality rate of 21 percent [78].
Fishburn et al. [79] found that of 30 tetraplegic patients studied in the first 30 days post
injury, 17 (57%) developed atelectasis or pneumonia. In a study investigating the number
of respiratory complications observed in 261 tetraplegic patients in the first six weeks after
injury Jackson and Groomes [80] found that 175 of the 261 (67%) participants developed a
respiratory complication, with atelectasis (36%) and pneumonia (31%) the most common.
These cases of atelectasis and pneumonia were found to occur on average 18 and 25 days
post injury. This shows that respiratory complications are a common occurrence in the acute
stage of injury. An early intervention which acts to improve respiratory function is likely to
be beneficial in preventing respiratory complications in this patient group.
2.3 Clinical Methods to Support Respiration
A number of methods are currently employed in the clinical setting to compensate for
the reduction in respiratory function caused by tetraplegia. For tetraplegic patients who
are unable to breathe independently mechanical ventilation is used to provide artificial
respiration. For people with tetraplegia who are unable to generate an effective cough,
manually assisted coughing, mechanical insuﬄation-exsuﬄation and tracheal suctioning are
all used to aid secretion removal.
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2.3.1 Mechanical Ventilation
Respiratory failure leads to some patients with tetraplegia requiring mechanical ventilation
in the acute stage of injury. This respiratory failure is commonly caused by paralysis or
severe impairment of the respiratory muscles, the neurological level of Spinal Cord Injury
(SCI) ascending one or two levels because of bleeding or swelling in the area of the trauma
(reducing function of respiratory muscles not originally affected by the SCI) and subsequent
respiratory complications [47]. Gay [81] reports that of the 12, 000 new cases of SCI per
year in the United States of America (USA), more than 2, 700 lead to the patient requiring
mechanical ventilation. Claxton et al. [82] reported that of 72 patients with tetraplegia, 29
(40%) required mechanical ventilation due to respiratory failure. Twenty six (90%) of these
cases of ventilation occurred less than four days post injury, indicating that respiratory failure
primarily occurs soon after injury.
For tetraplegic patients who require mechanical ventilation in the acute stage of injury the
paralysis of the intercostal muscles becomes spastic over time, resulting in the chest wall
becoming more rigid and no longer collapsing during inspiration [47]. Vital Capacity (VC)
has also been reported to improve significantly in the weeks following injury [83]. These two
factors combine to mean that many of these patients will wean from mechanical ventilation.
Gay states that of the 2, 700 SCI patients who require mechanical ventilation annually in the
USA, 2, 000 will wean from mechanical ventilation and 500 will become ventilator dependant
(with the other 200 patients dying in the acute stage of injury) [81]. The duration of
mechanical ventilation varies significantly between patients, with no clearly defined prediction
methods. Claxton et al. [82] found that patients required mechanical ventilation for an
average duration of 11 ± 31 days, showing a wide range of ventilation durations. Current
understanding is that injury level, age and sex may be the best indicators of this ventilation
duration [39, 38, 42]. Therefore, while many people with tetraplegia will require ventilation
in the acute stage after injury the majority of these patients will wean from ventilation.
However, there is a wide variation in the duration of ventilation, with this duration not easy
to predict.
Mechanical ventilation is associated with an increase in the likelihood of developing a
respiratory infection [84], with Krause et al. [85] reporting that the mortality rate for people
with an SCI was approximately three and a half times greater if they required mechanical
ventilation. The need for ventilation also reduces a persons quality of life, can delay
rehabilitation [27] and leads to an increased cost for the health care provider of approximately
£1000 per ventilated day [46].
Several methods are used to promote weaning from mechanical ventilation. Intermittent
Mandatory Ventilation (IMV) involves the degree of ventilatory support being decreased
over time until the patient is eventually disconnected from the ventilator and required to
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breathe independently. Spontaneous Breathing Trials (SBTs) (often referred to as t-piecing
due to the use of a t-piece to provide oxygen) encourage the patient to breathe on their own
several times a day. The duration of initial SBTs will be short due to the patient suffering
respiratory muscle fatigue. As the respiratory muscles regain strength the duration of each
SBT is increased until the patient no longer requires the support of mechanical ventilation [86].
When using IMV there is no clear point at which to remove mechanical ventilation. This
results in SBTs freeing a patient from ventilation up to three times faster than IMV [84]. The
addition of an intervention to strengthen the abdominal muscles during the weaning process
may lead to an improvement in respiratory function and result in a reduced time to wean.
An improvement in respiratory function resulting in earlier weaning from, or avoidance of,
mechanical ventilation will i) improve the patient’s quality of life ii) allow the patient to
begin rehabilitation earlier iii) reduce the likelihood of the patient developing respiratory
complications and iv) result in a significant cost saving for the local health care provider.
To evaluate the effectiveness of an intervention in enabling faster weaning from mechanical
ventilation it is necessary to clarify when a person has successfully weaned. Narh et al. [38]
suggest that someone has weaned from mechanical ventilation after seven days without
ventilatory support. Within the Queen Elizabeth National Spinal Injuries Unit it has been
observed that most people who achieve a period of 24 hours without ventilatory support
will require no further mechanical ventilation, with the exception being people who suffer
from comorbidities such as respiratory complications. Twenty four hours of ventilator free
breathing was also used by Martin et al. [87] to define successful weaning. Therefore, by
comparing the time to achieve both 24 hours and seven days without ventilatory support for
patients who receive an intervention with a control group, matched with each patient based
on injury level, age and sex, it should be possible to assess the effectiveness of an intervention
in enabling faster weaning from ventilation.
2.3.2 Assisted Secretion Removal
In the clinical setting antibiotics, mucolytics (medicines that make mucus less sticky and easier
to cough up) and the application of number of drugs via a nebuliser are all used to break
up secretions and assist secretion removal. Another approach to assist secretion removal for
tetraplegic patients is to apply a manual intervention. Currently manually assisted coughing,
mechanical insuﬄation-exsuﬄation or, in the case when a tracheostomy is present, tracheal
suctioning, are commonly used to aid secretion removal in the clinical setting.
2.3.2.1 Manually Assisted Coughing
Manually assisted coughing involves the manual compression of the thoracoabdominal cavity
during the exhalation phase of a voluntary cough. Various studies have shown that this
compression increases Cough Peak Flow (CPF) and Maximum Expiratory Pressure (MEP)
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compared to a voluntary cough [88, 89, 90], helping to release secretions trapped in the
airway. While a manually assisted cough is a safe and effective procedure for secretion
removal it needs to be provided by a trained caregiver. This has associated cost and resource
implications for the local health care provider [91, 92]. Additionally, the force used by the
caregiver to generate an effective cough is subjective. This makes it unlikely that the same
force is applied by different caregivers, or by the same caregiver in consecutive sessions,
resulting in a variability in the effectiveness of the technique.
2.3.2.2 Tracheal Suctioning
For many people with acute tetraplegia a tracheostomy, which is an incision in the trachea
to provide direct access to the airway, is applied. This allows a tube providing suction to
be inserted into the tracheostomy tube to remove secretions from the airway, a technique
known as tracheal suctioning. While tracheal suctioning can be used to successfully remove
secretions, it is uncomfortable for the patient and can induce gagging. Additionally,
tracheal suctioning often misses the left bronchus, which Sancho et al. [93] state is one
of the contributing factors to 80 percent of pneumonia occurring in the left lung of the
SCI population. Moreover, tracheal suctioning can lead to serious complications including
hypoxemia, bronchoconstriction and cardiac arrhythmias [93].
2.3.2.3 Mechanical Insuﬄation-Exsuﬄation
An alternative method to help clear secretions and improve respiration is Mechanical
Insuﬄation-Exsuﬄation (MI-E). MI-E involves applying alternating positive and negative
pressure to the user’s airway to simulate a cough. A number of studies have shown that
MI-E is more effective at removing secretions and reducing respiratory infections than
both manually assisted coughing and tracheal suctioning [92, 93, 94], with the advantage
over the latter that secretions are removed from both bronchi. MI-E has also been
shown to significantly reduce the length of stay in an intensive care unit and reduce the
rates of reintubation [95], with users finding MI-E to be more comfortable than tracheal
suctioning [93, 96].
All of the above outlined techniques can successfully be used to aid secretion removal in
the clinical setting, and hence reduce the risk of respiratory infection. However, all of these
techniques are passive and are used to replace the user’s own cough, leading to none of
the techniques directly improving respiratory function. An alternative solution, which uses
training of the respiratory muscles to provide an improvement in respiratory function, may
be beneficial to a patient’s long term respiratory health. This thesis will focus on the use of
electrical muscle stimulation to improve respiratory function.
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2.4 Methods to Improve Respiratory Function
During respiration the diaphragm is the main muscle used for inspiration, the intercostal
muscles are active during both inspiration and expiration and the abdominal muscles are
the main muscle group used during a forced exhalation, such as that taken during exercise
or cough. A number of methods have been developed to improve the respiratory function
of people with tetraplegia, with these methods designed to improve the function of one or
several of these major respiratory muscles. The methods that have been used include electrical
and magnetic stimulation and respiratory muscle training, with each of these methods being
discussed in detail in this section.
Electrical stimulation involves the application of a train of electrical pulses to a motor nerve,
causing the associated muscle to contract (see Section 1.5 for further explanation). An
improvement in respiratory function has been achieved by applying electrical stimulation to
either the diaphragm or the intercostal or abdominal muscles of tetraplegic patients.
Magnetic stimulation can be used to produce an electrical field in neural tissue. If this
electric field is large enough it can generate enough current to depolarise a nerve, creating
an action potential and resulting in a contraction of the associated muscle. Magnetic
stimulation has been used to improve respiratory function in tetraplegia in two ways: i) by
activating the phrenic nerve to cause a contraction of the diaphragm and ii) by activating
the thoracoabdominal nerve roots, causing the abdominal muscles to contract. While
magnetic stimulation to activate the diaphragm or abdominal muscles has the advantage
over transcutaneous electrical stimulation of being painless, as the cutaneous pain receptors
are not activated, it is associated with some problems of practicality. Firstly, magnetic
stimulation systems use a large stimulation coil that requires a large amount of power. This
requires these systems to be mains powered, making them non-portable and reducing their
practicality in a clinical setting. The amount of power that can be generated is also limited
by how fast the capacitors used to deliver the magnetic stimulation can be charged. Finally,
the magnetic coil used to deliver stimulation can generate a large amount of heat, creating
a potential risk of skin burns to the user. Despite these drawbacks, several studies have
demonstrated the use of magnetic stimulation to improve respiratory function.
Respiratory Muscle Training (RMT) uses flow resistive devices, pressure threshold devices
or abdominal weights to train either the inspiratory or expiratory muscles. RMT has been
used with the tetraplegic population to improve respiratory function by training both the
inspiratory (intercostal and diaphragm) and expiratory (abdominal) muscles.
Studies that have applied electrical or magnetic stimulation or respiratory muscle training to
the diaphragm, intercostal or abdominal muscles will be discussed in the remaining portion
of this chapter.
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2.4.1 Diaphragm
The phrenic nerve is used to send signals from the brain to the diaphragm, the main
respiratory muscle used during inhalation. This nerve originates from C3 to C5 of the spinal
cord. Therefore, anyone with an SCI with a neurological level of injury of C5 or above is
likely to have impaired diaphragm function, while an SCI with a neurological level of C2
or above is likely to result in complete paralysis of the diaphragm. For some people with a
complete SCI in the range C3 to C5 who have severely impaired diaphragm function, and
almost all people with a complete SCI at level C2 or above, respiratory support in the form
of mechanical ventilation is required. For these patients stimulation of the phrenic nerve can
be used to make the diaphragm contract, even when paralysed. This contraction causes the
diaphragm to descend, decreasing intrathoracic pressure and resulting in an inhalation. When
stimulation is stopped the diaphragm relaxes and returns to its original position, increasing
intrathoracic pressure and causing an exhalation. Repeated rhythmical stimulation of the
phrenic nerve can be used to create an artificial breathing pattern and reduce the need for
mechanical ventilation, a technique called diaphragm pacing. For diaphragm pacing to be
successful the phrenic nerve must be intact [34]. As the phrenic nerve originates from C3 to
C5 of the spinal cord, it is common that after a cervical SCI with a neurological level of C5
and above the patient will have sustained LMN damage to the phrenic nerve. This means
that the phrenic nerve cannot be stimulated [97].
Previous studies have used both electrical or magnetic stimulation of the phrenic nerve to
achieve diaphragm pacing with tetraplegic participants who did not have LMN damage.
2.4.1.1 Electrical Diaphragm Pacing
Electrical stimulation of the phrenic nerve for diaphragm pacing is currently achieved by either
phrenic nerve or intramuscular diaphragm pacing. It should also be noted that transcutaneous
electrical stimulation can be used to activate the phrenic nerve. While this can be useful for
identifying whether the phrenic nerve remains intact, necessary for a patient to be a suitable
candidate for diaphragm pacing (see Section 2.4.1.2 for more information on this technique),
due to co-activation of muscles in the neck transcutaneous electrical stimulation is not suitable
for long term electrical diaphragm pacing.
Phrenic Nerve Pacing Phrenic Nerve Pacing (PNP)1 is a technique where electrodes are
implanted around the phrenic nerves that control each hemidiaphragm. To trigger stimulation
a signal is sent from a transmitter, located outside the body, to an implanted radio frequency
receiver. The receiver then sends a signal to the electrodes that electrically stimulate the
phrenic nerves, causing the diaphragm to contract.
In 1968 Judson and Glenn [98] published a single participant case study where PNP was
1PNP is sometimes referred to in the literature as phrenic nerve stimulation
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successfully used to aid a patient with primary hypoventilation, preventing them from
requiring mechanical ventilation. In 1972 Glenn and colleagues [99] published the first use of
PNP to aid people with SCI. In this study PNP was used with a C1/2 tetraplegic patient to
replace the need for mechanical ventilation. This was followed in 1976 by the first large scale
documentation of the use of PNP to decrease reliance on mechanical ventilation for people
with SCI [64]. In the proceeding years, the use of PNP to replace mechanical ventilation for
people with SCI has grown, with the technique being applied to over 2, 400 patients worldwide
by 2013 [100].
PNP has some major advantages over mechanical ventilation. Successful diaphragm
pacing results in decreased dependance on mechanical ventilation, which reduces the
risk of developing respiratory infections associated with being connected to a mechanical
ventilator [74]. PNP users also have increased mobility as they are not attached to a
mechanical ventilator [34], and as such, no longer have the fear associated with being
disconnected from the ventilator [97]. Users are also less likely to suffer social stigma, have
improved speech, have reduced reliance on care giver support and have a greater level of
overall health compared to using mechanical ventilation [101, 102]. These factors all combine
to improve the user’s quality of life.
PNP is not a panacea and has some significant drawbacks. Firstly, the use of PNP cannot
achieve instant full time ventilatory support. For PNP candidates, it is likely that the
diaphragm will have suffered from disuse atrophy during the period after SCI. For PNP
to be successful, a reconditioning period, aimed at strengthening the diaphragm, must be
conducted. Glenn et al. [103] report that for four adults (age 15 to 26 years) the length
of this reconditioning period was three to four months. Furthermore, the implantation of
the PNP system is most commonly performed through an incision in the chest, known as a
thoracotomy. This is a major surgical procedure and is associated with a lengthy hospital stay
and high costs [34, 51]. As the technique for implanting the electrodes requires manipulation
of the phrenic nerve, this can also lead to additional phrenic nerve damage [64]. PNP
was also associated with a high infection and failure rate in early studies, although Sheﬄer
and Chae report that the infection and failure rates associated with PNP have significantly
improved [51]. Even with this improvement in failure rate, the risk of device failure means
that a ventilator is required to be on stand by while PNP is in use [81]. Therefore, while PNP
is an effective technique to support inspiration, with advantages over mechanical ventilation
such as reduced respiratory infection rates and improved quality of life, a less invasive and less
costly alternative would be beneficial for both the patient and the local health care provider.
Intramuscular Diaphragm Pacing Diaphragm pacing can also be achieved by electric-
ally stimulating the phrenic nerve at the location where it enters each hemidiaphragm, a
technique called intramuscular diaphragm pacing (DP). To stimulate the phrenic nerves,
electrodes are implanted onto the diaphragm at the motor points of the phrenic nerves, via a
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small incision in the abdomen, known as a laparoscopy [65]. The phrenic nerves can then be
stimulated rhythmically, causing the diaphragm to contract and achieving diaphragm pacing.
By 2012, 350 patients worldwide had been fitted with a DP system [66]. Tedde et al. [104]
reported that six months after implantation, 60 percent (3 of 5) of patients fitted with a DP
system were able to breathe independently of mechanical ventilation, relying solely on DP.
This correlates with the findings of Onders et al. [105] who report that greater than 70 percent
of people who were fitted with DP systems were able to permanently free themselves from
mechanical ventilation. As with PNP, this reduced dependence on mechanical ventilation
reduces the risk of respiratory infection associated with being connected to mechanical
ventilation.
The implantation of a DP system has an advantage over PNP in that a laparoscopy is
not a major surgical procedure, with a shorter hospital stay and lower overall cost than a
thoracotomy [106]. Although the risks of a laparoscopy are lower than that of a thoracotomy,
the procedure is not without risk. There is a small risk of the patient developing a
pneumothorax or subcutaneous emphysema caused by the placing of the electrodes [106].
The system developed by DiMarco et al. [65] also has wires exiting the skin to an external
power source. These wires pose a risk of infection or breakage, which would require another
laparoscopy to correct. While DP has been shown to be capable of generating a similar
Tidal Volume (VT ) to that achieved using PNP [106] it is not an instant solution, with users
required to undergo a reconditioning program to strengthen the diaphragm, avoid fatigue
and maintain adequate ventilation. Onders et al. [66] report that the reconditioning time
that allowed participants to achieve four hours of DP breathing was less than one week for
18 to 20 year olds who had been on a ventilator for less than one year. However, for two
participants over 65 years of age the reconditioning time required to achieve four hours of DP
breathing was 21 weeks. Despite these drawbacks DP is a viable alternative to mechanical
ventilation, with benefits over PNP of reduced cost and reduced length of hospital stay.
2.4.1.2 Magnetic Diaphragm Pacing
Man et al. [107] describe three methods of using magnetic stimulation of the phrenic nerve
to achieve diaphragm pacing. When a patient is sitting upright magnetic stimulation can be
applied to the back of the neck at level C7, a technique called cervical magnetic stimulation.
This technique achieves diaphragm pacing by stimulating the phrenic nerves roots, causing a
contraction of the diaphragm. Anterior pre-sternal magnetic stimulation involves placing the
patient in a supine position and applying stimulation over the sternum. This activates the
phrenic nerve at the point where it enters the diaphragm, again causing a contraction of the
diaphragm and achieving diaphragm pacing. Unilateral/bilateral anterolateral stimulation
can also be used to stimulate the phrenic nerve. In this case stimulation is applied on either
one (unilateral) or both sides of the neck (bilateral) to achieve phrenic nerve stimulation at
the nerve root.
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While the use of magnetic stimulation for diaphragm pacing has the advantage over electrical
diaphragm pacing (see Section 2.4.1.1) of being non-invasive, there are two significant
drawbacks when using the technique with people with tetraplegia. Firstly, for both cervical
and unilateral/bilateral anterolateral magnetic stimulation, stimulation is applied at the
cervical level and requires the users neck to be moved to allow placement of the stimulation
coil. Polkey et al. [108] state that this would make magnetic stimulation unsuitable for
anyone with an unstable SCI, common in the acute stage of injury. Secondly, while anterior
pre-sternal magnetic stimulation does not require neck movement, there is only limited data
supporting the use of this technique [107].
One potential use of magnetic stimulation of the phrenic nerve is to identify candidates
who have not suffered LMN and who would be suitable candidates for electrical diaphragm
pacing. To achieve this, magnetic stimulation is applied to the motor cortex, the area
of the brain responsible for motor function, and the results compared to those achieved
using cervical magnetic stimulation. If there is no response of the diaphragm to stimulation
of the cortex (indicating diaphragm paralysis) and the diaphragm contracts using cervical
magnetic stimulation (indicating that the phrenic nerve is intact) then the patient is likely
to be a suitable candidate for electrical diaphragm pacing [109]. It should be noted that
transcutaneous electrical stimulation can also be applied to the same areas to identify
candidates who have not suffered LMN. However, due to electrical stimulation activating
cutaneous pain receptors, this method is likely to be more painful for the user than magnetic
stimulation.
In summary, for people with tetraplegia whose diaphragm function renders them unable
to breathe spontaneously, PNP, DP and magnetic diaphragm stimulation can be used to
activate the diaphragm and create an artificial breathing pattern, termed diaphragm pacing.
Successful diaphragm pacing results in decreased dependance on mechanical ventilation and
reduced risk of respiratory infection. As the diaphragm is only active during inhalation (see
Section 1.4.1 for more information on respiratory muscle function) diaphragm pacing does not
improve expiratory function. The expiratory muscles are used to generate a cough, the body’s
main defence against respiratory infection. Therefore, a gain in expiratory muscle function
that leads to the generation of a more effective cough should decrease the risk of respiratory
infection and subsequent respiratory complications such as pneumonia and atelectasis.
2.4.2 Intercostal Muscles
The intercostal muscles are innervated by 24 separate nerves, termed the intercostal nerves,
which originate from the spinal cord at T1 to T11. Each of these nerves innervates muscles
that have both an inspiratory and expiratory function. The intercostal muscles play a
significant role in inhalation, being responsible for approximately 35 percent of a persons
VC [34]. They also play a role during forced exhalation, such as that taken during a cough.
Both electrical stimulation and RMT techniques have been applied to the intercostal muscles
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to try and improve respiratory function.
2.4.2.1 Intercostal Spinal Cord Stimulation
Spinal Cord Stimulation (SCS) is the electrical stimulation of spinal nerve roots via an
epidural electrode placed on the spinal cord. DiMarco et al. [110] used SCS of the intercostal
nerve roots (located at T1 to T4) to activate the intercostal muscles, denoted Intercostal
Spinal Cord Stimulation (iSCS), of five ventilator dependent tetraplegic patients. They
found that initially iSCS provided very small (less than 240 mL) inspired volumes. After
a reconditioning program participants were able to achieve inspired volumes of as large as
850 mL. However, due to co-activation this reconditioning program led to hypertrophy of
the upper trunk muscles, which is undesirable. DiMarco et al. [111] have also combined iSCS
with DP and found that it could be used to achieve extended periods (between 16 and 24
hours per day) of ventilator free breathing. Both these forms of electrical intercostal muscle
stimulation require a surgical technique to implant electrodes on the spinal cord.
Due to the intercostal muscles being innervated by nerves that have both an inspiratory and
expiratory function, transcutaneous electrical stimulation of the intercostal muscles would
cause contraction of muscles that had both an inspiratory and expiratory role. This makes
non-invasive transcutaneous electrical stimulation an unsuitable method to achieve intercostal
muscle stimulation. Due to a lack of data on the effectiveness of intercostal muscle stimulation,
and an inability to apply this technique non-invasively, it remains experimental [112].
2.4.2.2 Intercostal Muscle Training
Liaw et al. [113] used RMT to train the inspiratory muscles (primarily the diaphragm and
intercostal muscles) of 10 tetraplegic (C4 to C7) participants who were less than six months
post injury, comparing changes in respiratory function to 10 tetraplegic controls. Intervention
participants were asked to inhale against a resistive load for up to 20 minutes, twice per day,
seven days a week, for six weeks. They found a statistically significant increase in Forced Vital
Capacity (FVC), which is a measure of inspiratory muscle function (see Section 1.4.2), for
both groups. They also found a statistically significant increase in Forced Exhaled Volume in
one second (FEV1), Maximum Inspiratory Pressure (MIP) and MEP over the six week period
for both groups and a statistically significant increase in Peak Expiratory Flow (PEF) for the
intervention group. Notably the FVC, FEV1 and PEF of the treatment group increased by
67, 63 and 39 percent compared to a 27, 21 and 23 percent increase for the control group. It
should be noted that all measures of respiratory function were greater for the control group
both pre and post intervention. In summary, this study appears to show an improvement in
respiratory muscle function using inspiratory muscle training of the intercostal muscles.
Martin et al. [87] applied inspiratory muscle training, using a pressure threshold device,
to assist weaning from mechanical ventilation for 10 critically ill able bodied participants.
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Participants were required to generate an inspiratory pressure greater than a threshold to
open a valve and obtain a breath. They found an increase in MIP from 8 ± 3 cmH2O
to 18 ± 7 cmH2O. They also found that nine of the 10 (90%) participants weaned from
mechanical ventilation. No further respiratory measures were presented, making it difficult
to assess the effectiveness of RMT in this study.
Interestingly both Liaw et al. [113], who applied inspiratory muscle training, and Zupan et
al. [114], who applied expiratory muscle training (see Section 2.4.3.1), found a decrease in
dyspnea (shortness of breath) after RMT. Despite this, Houtte et al. [115] state that the
lack of controlled studies make it difficult to draw conclusions on the effectiveness of RMT
to improve the respiratory function of people with tetraplegia. They state that it is difficult
to differentiate between the effect of the intervention and natural recovery in many of these
studies, a problem inherent in many studies with the SCI population. This corroborates the
opinions of Stiller and Huff [116] who suggest that the lack of controlled RMT studies make
it difficult to exclude natural recovery to explain improvements in respiratory function. Due
to the lack of certainty regarding the effectiveness of the intervention, RMT is currently not
an established method for improving the respiratory function of the tetraplegic population.
2.4.3 Abdominal Muscles
The abdominal muscles are innervated by the thoracoabdominal nerves, which originate from
the spinal cord at T7 to T11. They are the major muscle used for forced exhalation, such as
that taking during coughing and exercise. An improvement in abdominal muscle function will
result in improved cough generation, which should lead to more effective secretion clearance
and decrease the risk of developing a respiratory infection. RMT, magnetic stimulation and
electrical stimulation have all been applied to the abdominal muscles to improve respiratory
function.
2.4.3.1 Abdominal Muscle Training
Zupan et al. [114] investigated the effect of inspiratory and expiratory muscle training on
the respiratory function of 13 people with tetraplegia (C4 to C7). Inspiratory muscle
training was performed using breathing exercises that recruit inspiratory muscles, principally
the diaphragm and intercostal muscles. Expiratory muscle training was performed using
breathing exercises that recruit the abdominal muscles and was coupled with AFES (see
Section 1.5.2 and 2.4.4). Each method was performed for up to 30 minutes, twice per day,
six days a week, over two four week periods. They found that when measuring the patient’s
unassisted effort, inspiratory muscle training caused a larger increase in respiratory function
than expiratory muscle training. Inspiratory muscle training was found to increase FVC
and FEV1 by 19 and 20.5 percent in the sitting position and 17.5 and 16 percent in the
supine position, while expiratory muscle training was found to cause no significant increase
in FVC and FEV1 in the sitting position and a 17 and 16 percent increase in the supine
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position. When measuring respiratory function with the support of AFES, FVC and FEV1
were greater than the participant’s unassisted efforts. These results should be treated with
caution as the addition of AFES during expiratory muscle training may effect the expiratory
muscle training results, as AFES training alone has been shown to lead to an improvement
in FVC and FEV1 (see Section 2.4.4).
2.4.3.2 Magnetic Abdominal Stimulation
Magnetic stimulation can also be used to activate the abdominal muscles by applying
a magnetic field close to the thoracic spinal cord. This magnetic field stimulates the
thoracoabdominal nerve roots (located at T7 to T11), causing the abdominal muscles to
contract. As the nerve roots below the level of SCI usually remain intact, this is a viable
method for improving the respiratory function of people with a cervical, or high thoracic,
SCI [69].
Lin et al. [69] used magnetic stimulation to activate the thoracoabdominal nerve roots of 13
tetraplegic patients (injury levels C4 to C7). They showed that the MEP generated using
magnetic stimulation was increased compared to voluntary efforts. They also found that the
respiratory flow rates of the tetraplegic participants, generated using magnetic stimulation,
were comparable to the voluntary respiratory flow rates generated by able bodied individuals.
The improvements in MEP and respiratory flow rates achieved using magnetic stimulation
were not found to be statistically significantly different to the results achieved during the
maximum spontaneous efforts of the participants. Polkey et al. [108] found that magnetic
stimulation could be used to generate large pressures in able bodied participants, although
no comparison of the pressure or respiratory flow rates that could be achieved with and
without stimulation were made. These results suggest that magnetic stimulation can be used
to improve cough generation.
Lin et al. [69] found that at high stimulation intensities respiratory function actually
decreased. This was believed to be caused by the recruitment of inspiratory antagonists,
attributed to the poor targeting of muscles with magnetic stimulation. Polkey et al. [108] also
found a high variability in the respiratory flow rate that could be generated using magnetic
stimulation, which they hypothesis to be due to glottal closure. DiMarco [34] alludes to these
drawbacks of magnetic stimulation. However, he is of the belief that with further development
of the equipment and identification of the correct users, magnetic stimulation could become
a practical tool to improve respiratory function.
2.4.3.3 Abdominal Spinal Cord Stimulation
Spinal Cord Stimulation (SCS) can also be used to activate the abdominal muscles, denoted
Abdominal Spinal Cord Stimulation (aSCS). In an aSCS system three electrodes are
implanted directly into the spinal cord, around the lower thoracoabdominal and upper lumbar
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nerve roots (T9, T11 and L1). These electrodes can be activated using the signal from an
external transmitter, controlled by the user or their caregiver.
The use of aSCS to improve respiratory function was first documented by DiMarco et al. [117].
In this preliminary study, aSCS was used with one tetraplegic patient (C5/6) who had
difficulty clearing secretions. This study found that the combined activation of the electrodes
implanted at T9 and L1, compared to activation of each electrode individually, improved PEF
(7.4 L/s v 6.4 and 5.0 L/s) and MEP (132 cmH2O v 90 and 82 cmH2O), although no baseline
measures of respiratory function were reported. In 2009 DiMarco et al. [67, 68] presented a
follow-up study where aSCS was used with a further nine tetraplegic patients to achieve a
mean CPF of 8.6 ± 1.8 L/s and a mean MEP of 137 ± 30 cmH2O, both of which approach
the predicted values for the able bodied population. Interestingly, as with the results reported
in [117], these values were achieved by stimulating the electrodes implanted at T9 and L1.
When the electrode at T11 was also activated, there was no additional increase in respiratory
function. As well as an acute increase in cough function DiMarco et al. [117] found that
continued use of aSCS reduced the participant’s reliance on a caregiver to provide an assisted
cough (see Section 2.3.2.1) from 8.57 to zero times per week. In the follow-up study, DiMarco
et al. [68] found the number of respiratory infections developed by each participant fell from
a mean of 2.0 events per year pre aSCS, to 0.7 events per year after implantation. They also
found that the use of aSCS led to fewer problems raising sputum, reduced need for suction,
an improvement in the user’s quality of life and an improvement in the control each user had
on their breathing. All of these factors led to the users of aSCS having improved respiratory
function.
The need for further surgery on the spinal cord to implant the aSCS electrodes, with an
associated hospital stay, may deter people from having the procedure. DiMarco et al. [68]
found that aSCS was associated with a large rise in blood pressure for three of the nine (33%)
users studied. They also found that due to co-activation, whereby the electrodes used for
aSCS activated any muscle controlled by nerves emerging from the stimulated nerve roots,
aSCS led to a significant contraction of the muscles in the back and leg. They also report
that a major drawback of aSCS is equipment failure rates of as high as 25 percent. These
findings led Butler et al. [118] to conclude that while aSCS can be used to improve cough, it
will only be implanted in a limited number of patients.
A summary of the pros and cons of the aforementioned techniques to improve the respiratory
function of the tetraplegic population is presented in Table 2.2.
2.4.4 Abdominal Functional Electrical Stimulation
Abdominal Functional Electrical Stimulation (AFES) is the non-invasive application of a
train of electrical pulses to the abdominal motor nerves, causing the abdominal muscles to
contract (see Section 1.5.2). A number of studies have used AFES to improve the cough and
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Table 2.2: A summary of the pros and cons of using Phrenic Nerve Pacing, Intramuscular
Diaphragm Pacing, Magnetic Diaphragm Pacing, Intercostal Spinal Cord Stimulation,
Intercostal and Abdominal Muscle Training, Magnetic Abdominal Stimulation and
Abdominal Spinal Cord Stimulation to improve the respiratory function of the tetraplegic
population.
Technique Pros Cons
Phrenic Nerve Alternative to mechanical Invasive. Extensive surgical
Pacing ventilation. procedure. Expensive.
Intramuscular Alternative to mechanical Wires exiting skin pose risk
Diaphragm Pacing ventilation. Less invasive of infection. Requires
surgery than Phrenic extensive training program.
Nerve Pacing.
Magnetic Non-invasive. Requires user to move neck.
Diaphragm Pacing
Intercostal Spinal Combined with Intramuscular Requires surgical procedure.
Cord Stimulation Diaphragm Pacing to achieve Small initial inspired volumes.
ventilator free breathing. After Hypertrophy of the
training can achieve adequate upper trunk muscles.
inspired volumes.
Intercostal & Non-invasive. Easy to apply. Lack of control studies.
Abdominal Muscle Decrease in dyspnea. Unclear whether intervention
Training effect or natural recovery.
Magnetic Abdominal Less painful than electrical Requires mains power.
Stimulation stimulation. Unportable. Risk of burns.
Abdominal Spinal Reduced caregiver reliance for Surgical procedure. Significant
Cord Stimulation assisted cough. Reduced contraction of the muscles in
respiratory infection rate. Less the back and leg. High rate
problems raising sputum. of equipment failure.
quiet breathing of the tetraplegic population, in both an acute and long term manner, with
these studies discussed in this section.
2.4.4.1 Acute Effect
The acute effect of AFES, or the immediate improvement in respiratory function that can
be achieved by applying stimulation, has been observed during both quiet breathing and
coughing.
Coughing In two almost simultaneous studies by Jaeger et al. [88] and Linder [89] AFES
was used to produce a more effective cough for people with tetraplegia. In the study by Jaeger
et al. AFES was applied to the rectus abdominis muscle, via electrodes situated on either
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side of the umbilicus (see Figure 2.1(a)), of 24 tetraplegic participants (C4 to C7). They
found that coughs produced with the assistance of AFES had a similar CPF as manually
assisted coughs (3.83 v 3.97 L/s) and a 13 percent greater CPF than voluntary coughs (3.83
v 3.38 L/s). In the study by Linder, AFES was applied during the cough of eight tetraplegic
participants, via electrodes situated on the abdominal wall. Linder showed an increase in
MEP from 27.3 to 60 cmH2O (120%) with the application of AFES, although this was lower
than the MEP of 80 cmH2O that could be achieved via a manually assisted cough.
Taylor et al. [119] applied AFES to the rectus abdominis muscles during coughing via two
pairs of electrodes, with one electrode positioned below the costal margin and the other
above the pubic symphysis on either side of the body (see Figure 2.1(g)). With a single
participant they found an increase in CPF of 55 percent. This increase is greater than that
found by Gollee et al. [72] who applied AFES to the rectus abdominis and external oblique
muscles. The electrodes used to stimulate the rectus abdominis muscles were located in a
similar position to that used by Taylor et al. and the electrodes used to stimulate the external
oblique muscles were situated between the costal margin and the iliac crest (top of hip bone)
(see Figure 2.1(f)). AFES was applied to four tetraplegic (C4 to C6) participants during
cough and was found to lead to a mean increase in CPF of 40 percent, along with an increase
in VT of 31.5 percent. Butler et al. [118] also stimulated the rectus abdominis and external
oblique muscle (see Figure 2.1(d)) to achieve an increase in CPF (36%), mean respiratory flow
(80%) and FEV1 (39%) during coughing. In this study one large pair of electrodes was used
to stimulate both the rectus abdominis and the external oblique muscles, with the position
used to stimulate the external oblique muscles more posterolateral (on the side and towards
the posterior) than that used by Gollee et al.
Quiet Breathing In a preliminary study involving nine able bodied and one tetraplegic
(C6/7) participant, Sorli et al. [120] applied AFES to the rectus abdominis muscles during
quiet breathing via one pair of electrodes, situated above and below the umbilicus on the
midline. They found that the VT of the able bodied participants increased from 667 mL to
1100 mL (65%) during stimulation, with an increase also observed in the participant with
tetraplegia. Stanic et al. [121] applied AFES to the rectus abdominis muscles of six able
bodied and five tetraplegic (C4 to C7) participants during quiet breathing, via electrodes
positioned in the same location as that used by Taylor et al. [119]. They found that the
application of AFES increased the VT of the able bodied participants by a mean of 34 percent
(1370 versus 1026 mL), a similar absolute increase to that observed by Sorli et al. They also
found that the tetraplegic participant’s VT increased by 35 percent (852 versus 629 mL)
during stimulation, a similar increase to that observed by Gollee et al. [72].
Langbein et al. [71] applied AFES to the rectus abdominis muscles via four pairs of electrodes,
positioned on either side of the umbilicus, with one pair located close to the costal margin
and one pair located close to the pubic symphysis (see Figure 2.1(e)). They found that for
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10 SCI (C5 to T7) participants, the application of AFES led to an increase in FVC (13%),
FEV1 (11%) and PEF (15%) compared to voluntary efforts. This increase in PEF is greater
than that observed by Lee et al. [122] who found that the use of AFES with a posterolateral
placement could increase the MEP (80%), PEF (10%), FVC (14%) and FEV1 (23%) of one
tetraplegic participant compared to their voluntary efforts. After a four week AFES training
protocol the application of AFES was found to lead to a larger acute improvement in MEP
(83%), PEF (32%), FVC (17%) and FEV1 (25%) than before training.
Ventilated Patients Kandare et al. [123] used AFES to support ventilation in three
tetraplegic (C0 to C2) participants who had complete diaphragm paralysis and were unable to
breathe independently of either mechanical ventilation or a PNP device (see Section 2.4.1.1).
AFES was applied to the rectus abdominis muscles via electrodes positioned in the same
location as used by Taylor et al. [119] and to the external oblique muscles via a pair of
electrodes placed parallel to those on the rectus abdominis muscle (see Figure 2.1(b)). The
participants were able to achieve up to three minutes of unsupported ventilation. VT was
25 percent less with AFES than with mechanical ventilation (0.83 versus 1.06 L), with the
stimulated VT being similar to that achieved by Stanic et al. [121]. This paper showed that
AFES could be used to support ventilation with ventilated patients, in addition to ventilator-
free patients, indicating an additional patient group who could benefit from AFES.
2.4.4.2 Long Term Effect
The long term effects of an AFES training program on cough and quiet breathing function
has also been investigated in a number of studies.
Coughing McBain et al. [73] used AFES to train the abdominal muscles of 15 SCI
participants (C4 to T5) by applying stimulation during five sets of 10 coughs per day, five
days per week, for six weeks. AFES was applied to the rectus abdominis and external oblique
muscles, using the same posterolateral electrode placement as Butler et al. [118]. They found
that the application of AFES achieved an acute improvement in PEF of 50 percent. After
the training period they found a statistically significant increase in stimulated PEF (16%)
and unstimulated VC (20%), FVC (12%), FEV1 (8%) and PEF (14%).
Quiet Breathing Cheng et al. [124] applied AFES to the pectoralis major and rectus
abdominis muscle, using the same electrode position as Taylor et al. [119], of 13 tetraplegic
participants in the acute stage of injury, for 30 minutes per day, five days per week, for
four weeks. Unlike Zupan et al. [114], who had earlier combined AFES with active RMT
exercises, Cheng et al. used a passive intervention protocol, with participants not required
to interact with the stimulation. The results were compared to 13 tetraplegic participants
who had received no intervention. They found that after a four week training period VC
(32%), FVC (32%), FEV1 (12%), PEF (33%), MIP (25%) and MEP (29%) had all increased,
with a further increase observed both three and six months post intervention. All of the
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respiratory measurements were statistically significantly greater for the intervention group
than the control group after the training period. These results agree with the findings of
McBain et al. who also found an increase in VC , FVC, FEV1 and PEF after an AFES
training program.
McLachlan et al. [70] used a three week AFES training program, during which AFES was
applied to the rectus abdominis and external oblique muscles of 12 tetraplegic participants
(C3 to C6) using the same electrode position as Gollee et al [72]. Stimulation was applied
five days per week for a duration of 20 minutes per day in week one, 40 minutes per day in
week two and 60 minutes per day in week three. Like Cheng et al. [124] this intervention
protocol was also passive, with participants not required to interact with the stimulation.
Like both Cheng et al. and McBain et al. [73], McLachlan et al. observed an increase
in FVC (0.36 L), FEV1 (0.18 L) and PEF (0.39 L/s)
2 after the AFES training program,
and like Cheng et al. they also observed an increase in MEP (2.6 cmH2O). Interestingly,
some of the respiratory measures (notably FVC and MEP) had not plateaued after the three
week training program, suggesting that a longer training intervention may be beneficial.
They also found no increase in respiratory function during a one week pre-treatment and
three week post-treatment control phase, suggesting that the intervention and not natural
recovery was responsible for the increases in respiratory function. This suggests that while an
AFES training program can be used to improve respiratory function, the optimum treatment
duration has yet to be established.
Ventilated Patients Lee et al. [122] applied an AFES training program to one 65 year old
tetraplegic (C4) who was eight months post injury and required non-invasive ventilation and
a tracheostomy due to repeated respiratory infections caused by an ineffective cough and poor
respiratory function. The AFES training program led to a 27 percent increase in unstimulated
PEF and a 29 percent increase in FVC. This improvement in respiratory function allowed the
patient to cough unaided after two weeks of AFES training and to have their tracheostomy
removed after three weeks of training. They did not have a further respiratory infection in
their 11 month hospital follow up. This suggests that AFES may be a suitable treatment
modality to improve the respiratory function of ventilator dependant tetraplegics and may
enable them to achieve faster weaning from mechanical ventilation.
Routsi et al. [125] applied FES to the leg muscles of acute ventilator dependant able patients
in an intensive care unit and found that these patients weaned from mechanical ventilation at
a statistically significantly faster rate than patients who did not receive FES. This suggests
that FES may be preventing muscle atrophy and thereby improving the health status of the
patient, enabling faster weaning from ventilation.
2Baseline, or percentage increases in, respiratory function were not published
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2.4.4.3 Electrode Placement
Another challenge in the use of AFES is to establish the optimum electrode placement. A
number of electrode placements have been used for AFES. These electrodes placements are
shown in Figure 2.1 and discussed in further detail in this section.
(a) Jaeger et al. [88]. (b) Kandare et al. [88]. (c) Lim et al. [126].
(d) [Lim et al., Lee et al. [122],
Butler et al. [118], McBain et
al. [73].
(e) Langbein et al. [71]. (f) Gollee et al. [72, 127],
McLachlan et al. [70].
(g) Taylor et al. [119].
Figure 2.1: Diagram of the different electrode placements used to apply AFES. The authors
who used each placement are shown in the caption for each subfigure.
In early studies AFES was only applied to the rectus abdominis muscles [88] (Figure 2.1(a)).
Kandare et al. [123] included the stimulation of the external oblique muscles (Figure 2.1(b)),
the most common electrode placement for studies involving AFES.
Lim et al. [126] used a gastroesophageal catheter to compare the gastric and esophageal
pressures generated using two alternative AFES electrode positions. Large electrodes were
used to stimulate both the rectus abdominis and external oblique muscles, with the external
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oblique muscles being stimulated in both an anterior (Figure 2.1(c)) and posterolateral
(Figure 2.1(d)) position. They found that at the highest intensity of stimulation, gastric
pressure generated using the posterolateral placement was two and a half times greater
than that generated using the anterior placement. No statistically significant difference in
esophageal pressure was observed for the two electrode positions. They also observed that
the application of magnetic stimulation (see Section 2.4.3.2) at T10 led to a statistically
significantly increase in both gastric and esophageal pressures, compared to AFES using
the anterior placement. There was no significant difference in the pressures produced using
magnetic stimulation or AFES using the posterolateral placement. They hypothesise that
the superior results achieved using the posterolateral position is due to the posterolateral
placement innervating the internal and external oblique, rectus abdominis, transverse
abdominis and some of the intercostal muscles, with a greater degree of muscle recruitment
than when using the anterior position.
Lee et al. [122] and Butler et al. [118] have both since used the posterolateral electrode
placement suggested by Lim et al. (Figure 2.1(d)). The acute gains in quiet breathing
function observed by Lee et al. were similar to those observed by Langbein et al. [71],
who only applied stimulation to the rectus abdominis muscles (Figure 2.1(e)). After Lee
et al. applied a four week AFES training program the acute improvements in respiratory
function from AFES were greater than those observed by Langbein et al. The increase
in CPF observed by Butler et al. was similar to that achieved by Gollee et al. [72] using
an anterior electrode placement (Figure 2.1(f)), and less than that observed by Taylor et
al. [119] who only stimulated the rectus abdominis muscles (Figure 2.1(g)). Therefore, the
results achieved using a posterolateral electrode placement are inconclusive as to whether
this position is superior to an anterior electrode placement.
The electrode placement that achieves the optimum muscle contraction when using AFES
remains to be established. Sheﬄer and Chae [51] state that, when using FES, the strongest
contraction of the target muscle is observed when stimulation is applied close to the muscle
motor point (see Section 1.3). Studies by Gobbo et al. [52] and Botter et al. [128] used
electrical stimulation to identify the position of the motor points of muscles in the leg, with
Botter et al. reporting the position, intrasubject variability and uniformity of the motor
points. A similar technique could be used to determine the position of the motor points of
the abdominal muscles, which should be the optimum AFES electrode location.
2.4.4.4 Automated AFES System
The suitability of AFES for use in a clinical setting could be improved by the development
of an automated AFES system. Such a system would allow AFES to be automatically
synchronised with the user’s respiratory activity, reducing operator dependence and allowing
AFES to be applied consistently over extended periods of time. Synchronisation of such
a system with a mechanical ventilator would also be useful for applying AFES with
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acute ventilator dependent tetraplegic patients. Such a system would also allow different
stimulation parameters to be applied for different breathing situations, such as quiet breathing
and coughing, improving the effectiveness of cough generation. Development of such a system
requires three main areas of focus, namely stimulation timing, classification of respiratory
activity and identification of a suitable sensor to allow this timing and classification to be
achieved.
Timing As the abdominal muscles are used for exhalation, AFES should only be applied
during exhalation to avoid interfering with inhalation. Previous studies have used a manual
input from the user [118, 119] or therapist [114] to apply stimulation at the correct point in
the breathing cycle. The use of manual triggering has two drawbacks. Firstly, if AFES is
being initiated by a therapist then they must be present at all times while AFES is being
used. This has a cost implication for the health care provider. Secondly, the application of
manual triggering is not as consistent as automatic triggering, especially over longer periods
of time.
The signal from a spirometer, regarded as the ‘gold standard’ device for respiratory function
measurement [129, 130], provides a direct measurement of respiratory flow and has been
widely used to measure the respiratory activity of people with tetraplegia [34, 72, 127]. Gollee
et al. [72], Sorli et al. [120] and Stanic et al. [121] have all developed AFES systems that are
able to automatically trigger stimulation at the start of exhalation using the signal from a
spirometer. All three studies reported an acute improvement in respiratory function when
using AFES, along with a consistent application of stimulation. A spirometer is typically
used with a full face mask, which is uncomfortable and intrusive, leaving the user unable to
eat, drink or verbally communicate while in use. This limits the long term use of a spirometer
within an AFES system, with a less invasive sensor being more suitable for this application.
Spivak et al. [90] developed a system that used an Electromyograph (EMG) signal from
the respiratory muscles to automatically apply AFES during exhalation to assist coughing.
They compared the PEF and FVC of 10 people with tetraplegia achieved using either EMG,
caregiver or patient activated stimulation. They found that patient activated AFES actually
resulted in a reduction in PEF and FVC, while caregiver and EMG activated stimulation
produced a PEF and FVC similar to unassisted efforts. While the result of this study did not
show any improvement in respiratory function with AFES, it did demonstrate the possibility
of using the signal from a non-intrusive sensor to automatically apply stimulation at the
correct point in the breathing cycle.
Classification To maximise the effectiveness of AFES, Gollee et al. [72] suggest that a
quiet breath and a cough should be stimulated at different points in the breathing cycle, using
different stimulation intensities. They suggest that during quiet breathing AFES should be
applied at, or shortly after, the start of exhalation, to effectively support exhalation, while
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during coughing stimulation should be applied at the end of inhalation to contribute to
pressure build-up during glottal closure. A higher level of stimulation for coughing than
for quiet breathing may also increase intrathoracic pressure, improving cough generation.
To enable the application of the correct stimulation parameters at the correct point in the
breathing cycle an automatic AFES algorithm must be capable of differentiating between a
quiet breath and cough.
Gollee et al. [72] designed a system that used respiratory flow measurements, recorded using
a spirometer, to identify a cough based on the inhalation flow rate and a quiet breath based
on a cross-correlation algorithm. This system required manual setting of threshold values
for the cross correlation and respiratory flow rate on a session by session basis. For clinical
use, it would be desirable to minimise manual intervention during setup, resulting in a fully
automated system.
Statistical classification, which is the principle of identifying the group an item belongs to
using statistical methods, may be suitable for classifying respiratory activity. By using
features within a signal statistical classification can be used to identify different groups.
McCaughey and Gollee [131] used the signal from a spirometer as the input to a statistical
classifier that made decisions based on a maximum likelihood algorithm. In this algorithm
the features used for classification were selected manually for each participant. This manual
selection of features is time consuming and not feasible in a clinical setting. A Support Vector
Machine (SVM) is a statistical learning technique for binary classification problems. An SVM
uses training data, marked as belonging to a certain group, to separate the data points in
higher dimensional space by as large a margin (also referred to as a gap) as possible. The
data points belonging to each group that are closest to this margin are called the support
vectors. By assigning new data points to the same space, they can be classified as belonging
to either group depending on their position relative to the support vectors.
When using an SVM data can either be separated linearly, using a linear kernel, or non-
linearly, using a Radial Basis Function (RBF) kernel. However, even when using the correct
kernel, data cannot always be separated cleanly. When this is the case the introduction of
a soft margin technique can be used to control the generalization ability of the classifier.
This soft margin technique splits data as cleanly as possible, allowing for misclassifications
to occur to maximise the size of the margin. This technique is particularly useful when noise
is present in a data set. In the case of a hard, or fixed margin, these noisy data points will
determine the location of the support vectors. When using a soft margin these noisy data
points are effectively ignored, allowing for a better and more stable separation of the data at
very little cost to the classification ability. Adjustment of the soft margin must be done with
care. If this boundary is too strict, or too loose, then some outliers will be assigned to the
wrong class, with an associated negative impact on classification performance.
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SVMs have a high generalization ability and good performance when compared to other
classifiers [132]. They use automatic feature selection giving them an advantage over
other classification techniques that require a greater degree of user input. Due to the
low level of user input and high classification performance, SVMs are widely used in a
clinical setting. Pradhapan et al. [133] used an SVM to successfully identify sleep apnea
(pauses in breathing during sleep) from photoplethysmography data while Tenev et al. [134]
used a combination of SVMs to use electroencephalography data to accurately identify
attention deficit hyperactivity disorder in the adult population. The accuracy of an SVM
was demonstrated by Qiu et al. [135] who used an SVM to predict the genotype of Hepatitis
C Virus with an accuracy of 99 percent.
The use of an SVM is a possible solution for the automatic classification of respiratory activity
within an AFES system. Such a system should allow a cough and a quiet breath to be
stimulated at different points in the breathing cycle, with different stimulation parameters,
increasing the effectiveness of an AFES system. The practicality of such a system could
be further increased by replacing an intrusive spirometer, the ‘gold standard’ sensor for
measuring respiratory function, with a non-intrusive sensor.
Non-Intrusive Sensors A number of non-intrusive sensors exist that could replace an
intrusive spirometer for the detection and classification of respiratory activity within an
automatic AFES system. Respiratory effort belts are made up of piezoelectric crystals which,
when placed under stress such as a displacement, produce a change in voltage. This is known
as the ‘piezoelectric effect’ (see Section 3.3.2 for further explanation of the piezoelectric effect).
Respiratory effort belts are a well established method of detecting apnea during sleep studies,
following oﬄine respiratory activity analysis [136, 137]. The results of a single participant
feasibility study by Gollee et al. [138] suggest that respiratory effort belts could be used
to detect respiratory activity in real-time. They also show that the respiratory effort belt
signal was not disturbed by the belt being placed on top of electrodes delivering AFES.
This suggests that a respiratory effort belt may be a suitable sensor for real-time detection
and classification of respiratory activity within an AFES system. A nasal thermocouple
is a non-intrusive sensor that measures air temperature. As an inhaled breath is cooler
than an exhaled breath, a nasal thermocouple is able to provide a qualitative measurement
of breathing activity [139]. Farre et al. [140] suggest that nasal thermocouples are only
semiquantative devices, which do not have the ability to accurately quantify respiratory
flow. This would suggest that while nasal thermocouples may have potential to be used to
detect the correct point for stimulation, they may be unsuitable for classifying respiratory
activity. Accelerometers have previously been used to record physical activity [141]. These
sensors, positioned on the abdomen or chest, may be suitable for monitoring respiratory
activity. Gollee and Chen [142] demonstrated that an Inertial Measurement Unit (IMU),
which integrates accelerometers and gyroscopes to give an estimate of its relative orientation,
could be used to detect respiratory activity. They also suggest that due to a difference in the
CHAPTER 2. LITERATURE REVIEW 50
magnitude of the sensor signal during quiet breathing and coughing, that these sensors may
be suitable for the classification of respiratory activity. While the small size of an IMU makes
them suitable for a clinical setting, they are considerably more expensive than accelerometers.
Additionally, the sensor used by Gollee and Chen was attached to an elastic belt, similar to
a respiratory effort belt. Therefore, there is no obvious practical advantage to using an IMU
when already using a cheaper respiratory effort belt. Therefore, this thesis will focus on the
use of respiratory effort belts, nasal thermistors and accelerometers for breathing pattern
detection and classification. The suitability of these sensors for real-time respiratory activity
detection and classification remains to be investigated.
2.5 Conclusions
In conclusion, AFES has been shown to be a suitable method to improve cough and quiet
breathing for the tetraplegic population. The non-invasive nature and easy application
of AFES make it a potentially suitable system for use in a clinical setting. Despite
these positive results AFES has yet to be adopted as a standard clinical treatment for
the tetraplegic population. To aid this clinical introduction it would be beneficial to
have an AFES system capable of automatically applying stimulation in synchrony with
the user’s respiratory activity, with stimulation effectiveness enhanced by applying it at
the abdominal muscle motor points. Additionally, case studies have indicated that AFES
may be suitable for improving respiratory function and assisting ventilator weaning for the
ventilator dependent tetraplegic population. A larger study that investigates the feasibility
and effectiveness of using AFES with the ventilator dependent tetraplegic population has
yet to be conducted. Finally, the optimum training protocol for use of AFES with the sub-
acute tetraplegic population and the combination of AFES with techniques currently used to
improve respiratory function remain to be investigated.
Therefore, this thesis will aim to develop a system capable of the automatic application of
AFES in a number of clinical settings. A simple technique capable of identifying the location
of the abdominal muscle motor points will also be investigated. Finally, the feasibility and
effectiveness of using AFES in a clinical setting with the ventilator dependent and sub-acute
tetraplegic population, along with the integration of AFES with MI-E, will also be evaluated.
This work should provide further evidence to support the clinical introduction of AFES for
improving the respiratory function of the tetraplegic population.
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Chapter 3
Experimental Methods
“Before anything else, preparation is the key to success.”
Alexander Graham Bell
CHAPTER 3. EXPERIMENTAL METHODS 52
3.1 Summary
This chapter introduces the methods used throughout this thesis to evaluate the feasibility
and effectiveness of using Abdominal Functional Electrical Stimulation (AFES) to improve
respiratory function. The methods used to measure the respiratory function of tetraplegic
participants are explained here. The methods used to record respiratory activity, which
allow AFES to be automatically synchronised with the user’s own respiratory activity, are
then outlined. The hardware, software and experimental set-up used to apply AFES with the
able bodied and tetraplegic population, including a description of how respiratory activity
was used to provide automatic stimulation, are then described. This chapter concludes by
providing a description of the statistical methods used to evaluate the effectiveness of AFES.
3.2 Measurement of Respiratory Function
In this thesis respiratory function was evaluated by measuring Tidal Volume (VT ), Vital
Capacity (VC), Forced Vital Capacity (FVC), Forced Exhaled Volume in one second (FEV1)
and Peak Expiratory Flow (PEF). All of these measures, except for VT , were calculated from
the output of a FVC or VC manoeuvre.
To conduct an FVC manoeuvre participants were instructed to inhale to maximum lung
capacity and exhale as fully and as forcibly as possible, with verbal encouragement provided.
To conduct a VC manoeuvre the same procedure was followed, however participants were
not asked, and not verbally encouraged, to exhale as forcibly as possible. The procedure for
conducting an FVC or VC manoeuvre is outlined in the American Thoracic Society (ATS)/
European Respiratory Society (ERS) standards for spirometry [129], with these standards
followed throughout this thesis. An FVC or VC manoeuvre was deemed to be successful if:
• Breaths were free from artefacts such as a cough, early termination, leakage or an
obstructed mouthpiece.
• Breaths had a satisfactory start i.e FEV1 was acceptable (FEV1 should be approxim-
ately 80 percent of FVC [43]).
• Breaths had a satisfactory exhalation i.e. participant was judged to have exhaled fully.
An example of features that would lead to an FVC or VC manoeuvre being classed as
unsuccessful are shown in Figure 3.1.
In the clinical study reported in Chapter 6 a VC manoeuvre was performed up to five times,
both with and without AFES, to form one run. A second run of VC manoeuvres was then
performed after VT had been recorded. This resulted in each assessment session providing
up to 10 stimulated and unstimulated VC manoeuvres. Whether stimulation was applied
during the first or second set of five VC manoeuvres within each run was randomised for
each participant at each session. In Chapter 7 an FVC manoeuvre was performed up to five
times, both with and without AFES, to form one run. A second run of FVC manoeuvres
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Figure 3.1: Example of a successful (blue) and unsuccessful (red) FVC manoeuvre. The
manoeuvre shown in red was deemed unsuccessful due to i) an unsatisfactory start (identified
from a low FEV1) ii) a leakage artefact (identified from a plateau in the volume) and iii) the
participant not exhaling fully (identified from early curtailment of the manoeuvre).
was then performed after a rest period of approximately two minutes. This resulted in each
assessment session providing up to 10 stimulated and unstimulated FVC manoeuvres. As
with Chapter 6, whether stimulation was applied during the first or second set of five FVC
manoeuvres within each run was randomised for each participant at each session.
The validity of each FVC or VC manoeuvre was checked oﬄine and any attempts that did
not meet the above criteria were rejected. FVC and VC is the largest exhaled volume, of at
least three successful FVC or VC manoeuvres, which is within 0.15 L of another attempt.
From the FVC or VC manoeuvres FEV1 and PEF were also calculated. FEV1 is the largest
volume recorded during the first second of an exhalation, of at least three successful FVC
or VC manoeuvres, which is within 0.15 L of another attempt. PEF is the largest exhaled
flow rate, from at least three successful FVC or VC manoeuvres, which is within 0.67 L/s of
another attempt.
VT was measured in Chapter 6 by asking participants to breathe normally for six minutes, or
until their oxygen saturation level (SaPO2) dropped below 92 percent. The participant’s VT
was the mean of the values recorded during this six minute period. VT was recorded both with
and without AFES, with the order of these measurements randomised for each participant at
each session. Stimulated and unstimulated measurement periods were separated by a break
of two minutes, or until the participant’s SaPO2 returned to baseline, with participants being
ventilated during this break if required.
To allow for effective group comparisons of respiratory function, the aforementioned measures
of respiratory function were normalised by weight for each participant. This provided weight
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corrected VC (VC/kg), VT (VT /kg), FVC (FVC/kg), PEF (PEF/kg) and FEV1 (FEV1/kg).
3.3 Respiratory Activity Sensors
Respiratory activity was recorded with a number of different sensors within this thesis,
including spirometers, respiratory effort belts, nasal/oral thermocouples, accelerometers and
pressure sensors. An example of the signals recorded using these sensors is presented in
Figure 3.2, with these sensor signals explained in further detail in this section.
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Figure 3.2: Example signals recorded using a spirometer, respiratory effort belt, nasal/oral
thermocouple and accelerometer. These signals were all recorded during the same quiet
breath from a human participant. Also shown is the signal recorded using a pressure sensor
during a quiet breath provided by a mechanical ventilator. For all of these sensors a negative
signal represents an inhalation and a positive signal represents an exhalation.
3.3.1 Spirometer
A spirometer (Microloop, Micromedical, UK), hereafter referred to as the Microloop
spirometer, was used to record respiratory activity in Chapters 4, 6 and 7. This device uses
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a turbine and light gate to measure respiratory activity. Every spin of the turbine, measured
using the light gate, represents a volume increment. Multiplying the total number of volume
increments within a specified sample time by the value of this volume increment provides the
respiratory volume during that sample time. Respiratory flow rate is the derivative of this
volume over the sample time. Whether this volume and flow rate was recorded during an
inhalation or exhalation can be established from the direction of the turbine.
This spirometer provides both a flow signal, in litres per second (L/s), and a volume signal,
in litres (L). The range and accuracy of this device is 0.1 to 8.0 L and 0.01 L when measuring
volume and 0.2 to 15.0 L/s and 0.03 L/s when measuring flow rate. This spirometer signal was
low pass filtered oﬄine to smooth the signal (eighth order simple moving average filter, cut off
frequency 2.7 Hz), necessary due to the use of volume increments to record respiratory volume,
with a filtered spirometer flow signal recorded during a quiet breath shown in Figure 3.2(a).
The spirometer was interfaced with a laptop computer using an RS232 interface.
To measure respiratory volume an interface is needed between the spirometer and the user.
In Chapter 4 the spirometer was attached to a full face mask (Hans Rudolph Inc., USA) and
in Chapters 6 and 7 the spirometer was attached to a mouthpiece, via a catheter mount tube.
When the mouthpiece was used a nasal clip was also used to prevent air leakage at the nose,
with participant’s also instructed to form a seal at the mouth to prevent air leakage there.
In Chapter 7 respiratory activity was measured during Mechanical-Insuﬄation Exsuﬄation
(MI-E) using a different spirometer, hereafter referred to as the ADInstruments spirometer.
The ADInstruments spirometer was used here as, unlike the Microloop spirometer, it could be
fitted in line with the MI-E device. In this system a spirometer pod (ML311, ADInstruments,
New Zealand), which is a differential pressure transducer, was connected to a respiratory flow
head (MLT1000L, ADInstruments, New Zealand), which contains a wire mesh at its centre.
Air flowing through this wire mesh creates a pressure difference on either side, with a larger
flow creating a greater pressure difference. This pressure difference, which is measured by
the spirometer pod, is directly related to the flow rate.
This spirometer was designed to be used with the manufacturer’s software (LabChart,
ADInstruments, New Zealand) and amplifier, the gain of which was unknown. As the
spirometer output was in Volts (V) it was necessary to calculate a calibration factor that
allowed the flow rate, and in turn volume, to be calculated from this voltage signal. To find
this calibration factor a 3 L syringe was used (3 Litre Calibration Syringe, Micromedical,
UK). The full volume of the syringe was passed through the ADInstruments spirometer 100
times, at manually varying flow rates. The signal, which corresponds to flow and is measured
in V, was integrated with respect to the sample time (0.02 s), with the maximum value of this
integrated signal corresponding to the respiratory volume. The mean of the 100 maximum
values was 0.0737 Volts seconds (Vs). By dividing the volume of the calibration syringe, which
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was known to be 3 L, by this mean value of 0.0737 Vs, it was found that a signal of 1 V
corresponded to a flow rate of 40.7 L/s. This corresponds with the manufacturers suggested
calibration factor of 40.1 L/s [143]. Therefore, the ADInstruments spirometer signal was
multiplied by a calibration factor of 40.7 L/s to provide a respiratory flow in L/s, a signal
which could be integrated to provide respiratory volume. The calibration syringe was also
used to verify that the Microloop spirometer was properly calibrated.
The ADInstruments spirometer is capable of measuring flow rates in the range of ± 16.7 L/s,
with a repeatability of 0.03 L/s. This spirometer had an in-built low pass filter (30 Hz) and
was interfaced with a laptop computer using a 16-bit data acquisition card (NI DAQCard
6036E, National Instruments, TX, USA). It was fitted in line with the tubing connecting the
participant and the MI-E device as shown in Figure 3.8.
3.3.2 Respiratory Effort Belts
Respiratory activity was also recorded using respiratory effort belts (Piezoelectric belts,
ProTech, USA). These belts make use of the ‘piezoelectric effect’, whereby certain solid
materials produce an electrical voltage when deformed. In an unstrained crystal, such as
that shown in Figure 3.3(a), the positively and negatively charged atoms are separated
symmetrically, causing the overall crystal structure to be charged balanced and no voltage to
be produced. When a force is applied to the crystal, such as that shown in Figure 3.3(b), the
symmetry of the charge separation is lost. This causes certain areas of the crystal to become
positively and negatively electrically charged, causing a voltage to be generated. This voltage
is proportional to the deformation of the material, hence respiratory effort belts positioned
around the body can be used to measure the deformation of these areas during respiration.
The signal from a respiratory effort belt is a measure of the stretch velocity of the belt and
is directly related to the respiratory flow recorded using a spirometer. This sensor provides
a signal in V, where a typical signal has a peak to peak amplitude of 600 µV and the sensor
has a sensitivity in the range of 2 to 30 µV/mm. The respiratory effort belts were connected
to a custom built amplifier that provided a gain of approximately 1000, a low pass filter
(cut off frequency 15 Hz), high input-impedance and a high common mode rejection ratio.
The respiratory effort belt signals were high pass filtered oﬄine to remove signal bias (1st
order butterworth, cut off frequency 0.04 Hz). In Chapter 4 these sensors were interfaced
with a laptop computer via a 16-bit data acquisition card (NI DAQCard 6036E, National
Instruments, TX, USA), while in all other chapters these sensors were interfaced via a 14-bit
USB data acquisition card (NI USB-6009, National Instruments, USA). Figure 3.2(b) shows
the amplified and filtered signal from a respiratory effort belt placed around the abdomen
recorded during a quiet breath.
In Chapter 4 two respiratory effort belts were used to measure respiratory activity; one
positioned around the participant’s abdomen, at the umbilicus, and the other positioned
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(a) Charge balanced piezoelectric crystal. (b) Charge unbalanced piezoelectric crystal.
(c) Respiratory effort belt.
Figure 3.3: Example of the piezoelectric effect. a) A charge balanced piezoelectric crystal,
with the symmetry of the crystal shown in purple and the walls of the crystal shown in grey.
b) The crystal is displaced by a compressive force, causing the upper surface of the crystal to
adopt a more positive charge and the lower surface of the crystal to adopt a more negative
charge. The new shape of the crystal is shown in green, with the previous, symmetrical,
shape shown in purple for comparison. c) The respiratory effort belt used in this thesis, with
the location of the piezoelectric crystal highlighted.
around the front of the chest, at the sternum. In Chapters 6 and 7 a respiratory effort belt
was positioned around the abdomen to measure respiratory activity. The optimum set-up
parameters for these respiratory effort belts were found in the study outlined below.
3.3.3 Respiratory Effort Belt Calibration
When using a respiratory effort belt to record respiratory activity a large signal magnitude is
desirable, as this will result in a large signal to noise ratio. This should allow for more accurate
measurement of respiratory activity. To establish the set-up parameters that provided the
largest signal magnitude a servo motor was used to accurately displace a respiratory effort
belt and the belt signal was recorded. The initial stretch, frequency of displacement and
displacement of the belt that provided the largest signal magnitude was investigated in the
experiment outlined below. When respiratory effort belts are used to measure respiratory
activity the initial stretch of the belt is the only one of these three variables that is directly
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under the operator’s control. Therefore, the initial stretch that provided the largest signal
magnitude was established first. This initial stretch was then applied to the belt when
investigating the frequency and magnitude of displacement that provided the largest signal
magnitude, both of which were deemed less within the operator’s control as they are more
dependant on the user’s respiratory activity.
3.3.3.1 Methods
Equipment and Pre-processing A respiratory effort belt (Piezoelectric belt, ProTech,
USA) was displaced by attaching it to a servo motor using a wire. The rotation of the servo
motor, and hence displacement of the belt, was controlled using a closed loop feedback system
implemented in the Simulink (Mathworks, USA) modeling environment. A diagram of the
experimental set up is shown in Figure 3.4.
Figure 3.4: Experimental set up used to measure the magnitude of a piezoelectric belt signal
under different conditions. Black arrows represent direction of data.
The belt signal was amplified using the custom amplifier described in Section 3.3.2. As the
belt signal is directly related to the velocity of the belt, the signal was integrated to provide
a signal relative to displacement, the variable being controlled by the feedback system. All
data was recorded in Simulink using custom-made blocks to enable real-time data acquisition
at a sample rate of 50 Hz.
The belt was tested under a number of different conditions, outlined below, to validate that
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the signal from a respiratory effort belt is suitable for measuring respiratory activity and to
establish the conditions under which the belt signal was largest.
Shape of Displacement The belt was displaced in a sinusoidal motion to provide a simple
representation of the movement of the chest, or abdomen, during respiration. However, this
movement is variable and can also be represented by a ramp. Therefore, the belt was also
displaced using two different ramps. The first ramp had a rise and fall time equal to 50
percent of the total displacement duration. The second ramp had a rise and fall time of 40
percent of the total displacement duration, with the belt held at its maximum displacement
for 20 percent of the total duration.
Initial Stretch An initial stretch of 0 cm was defined as the point where the belt was
under enough tension to remove all slack but where the addition of any further tension would
result in the belt being displaced from its initial position. To establish the initial stretch that
provided the largest signal magnitude the belt was displaced with an initial stretch that was
varied between 0 and 3 cm, in increments of 0.2 cm. This provided 16 measurement stretches.
The initial stretch was set by hand using a measuring tape. During each initial stretch the
belt was displaced by 2 cm for 60 s at a constant frequency of 0.2 Hz (chosen to correspond
to the human respiratory rate, which is approximately 12 breaths per minute [144]). This
movement provided 12 unique displacements, each of which had a unique maximum. The
value of the signal at each of these maximum points was used for analysis.
Each test was repeated a further twice. The first maximum of each test was ignored due
to potential noise, resulting in a total of 33 data points for each initial stretch value. The
mean value of each of these data points was assumed to be the maximum signal amplitude
for that displacement. After the initial stretch that provided the largest signal amplitude was
established, this value of initial stretch was used for all further tests.
Frequency The effect of the frequency of displacement on the signal magnitude was
analysed by displacing the belt at a frequency of between 0.1 and 0.5 Hz, in increments
of 0.1 Hz, resulting in five measurement frequencies. The initial stretch was optimised from
the information gathered from the previous test and the belt was displaced by 2 cm for 60 s.
This resulted in six, 12, 18, 24 and 30 data points for each frequency respectively. Each test
was repeated a further twice and the first maximum of each test was ignored. This resulted
in a total of 15, 33, 51, 69 and 87 data points for each frequency of displacement. The mean
value of the data points at each frequency was assumed to be the maximum signal amplitude
for that frequency.
Magnitude of Displacement To establish the displacement that provided the largest
signal magnitude the belt was displaced by between 0.2 and 5.0 cm, in increments of 0.2 cm,
resulting in 25 measurement displacements. The belt was displaced for 60 s at a constant
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frequency of 0.2 Hz and with a constant initial stretch, resulting in 12 measurement points.
Each test was repeated a further twice and the first maximum of each test was ignored. This
resulted in a total of 33 data points for each magnitude of displacement. The mean value of
the data points at each displacement was assumed to be the maximum signal amplitude for
that displacement.
3.3.3.2 Results
Shape of Displacement On all occasions the magnitude of the belt signal was greater
when displacing the belt using a sinusoidal motion, compared to both forms of ramp.
Initial Stretch Figure 3.5 shows the maximum amplitude of the belt signal for each initial
stretch, where each maximum is the mean of 33 maximums per displacement, taken from
three recordings. For all three shapes of displacement the data takes the form of a concave,
with an initial stretch of 0 cm having the largest signal magnitude, closely followed by an
initial stretch of 3 cm. From an initial stretch of 2 cm the gradient starts to increase, with
this trend continuing to the largest tested value of 3 cm.
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Figure 3.5: Maximum belt signal magnitude (mean ± standard deviation) for varying initial
stretch values. Belt was displaced by 2 cm at a frequency of 0.2 Hz using a sine wave (black),
a ramp with a rise time corresponding to 50% of total displacement duration (blue) and a
ramp with a rise and fall time corresponding to 40% of total displacement duration (red).
Frequency Figure 3.6 shows the maximum magnitude of the belt signal recorded when the
belt was displaced at five different frequencies. Each maximum is the mean of 15, 33, 51, 69
and 87 maximums for each of the respective frequencies. The maximum magnitude of the
signal was found to decrease with increasing frequency of displacement, with the maximum
signal amplitude observed when the belt was displaced at a frequency of 0.1 Hz.
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Figure 3.6: Maximum belt signal magnitude (mean ± standard deviation) for varying
frequency of displacement. Belt was displaced by 2 cm, with an initial stretch of 3 cm, using a
sine wave (black), a ramp with a rise time corresponding to 50% of total displacement duration
(blue) and a ramp with a rise and fall time corresponding to 40% of total displacement
duration (red).
Displacement The maximum magnitude of the belt signal recorded when the belt was
stretched to 25 different displacements is shown in Figure 3.7. Each maximum is the mean
of 33 maximums recorded for each displacement. The maximum magnitude of the signal
exhibits a linearly increasing response to increasing displacement. The largest maximum
magnitude of the belt signal was observed at 5 cm for all three shapes of displacement.
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Figure 3.7: Maximum belt signal magnitude (mean ± standard deviation) for varying
displacement. Belt was displaced by 2 cm at a frequency of 0.2 Hz using a sine wave (black),
a ramp with a rise time corresponding to 50% of total displacement duration (blue) and a
ramp with a rise and fall time corresponding to 40% of total displacement duration (red).
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3.3.3.3 Discussion and Conclusion
The largest magnitude of belt signal was observed when the belt was displaced from an
initial stretch of 0 cm. However, an initial stretch of 0 cm is not practical for use with a
human subject as any negative displacement from this point, such as would occur during an
exhalation, would result in a ‘negative stretch’. During this time the belt signal would not
change, rendering the belt unsuitable for measuring respiratory activity at these ‘negative
stretch’ values. An initial stretch of 3 cm provided the largest signal magnitude away from
the 0 cm point. The magnitude of the belt signal increased as the initial stretch was increased
between 2 and 3 cm. This increase in magnitude may continue for initial stretches of greater
than 3 cm. However, due to the tension that the initial stretch generates in the belt it was
difficult to apply an initial stretch of greater than 3 cm using the servo motor. It was decided
that 3 cm was the most suitable initial stretch value when using respiratory effort belts to
measure respiratory activity.
The largest magnitude of the belt signal occurred when the belt was displaced at a frequency
of 0.1 Hz, with only a small decrease in the magnitude of the signal when the belt was
displaced at 0.2 Hz. The average human breathing rate is approximately 0.2 Hz, with the
belt signal having a large signal amplitude when displaced at this frequency. This would
provide a suitable signal to noise ratio at this frequency, hence respiratory effort belts were
deemed suitable for measuring respiratory activity at these frequencies.
The magnitude of the belt signal increased linearly as the belt was displaced by an increasing
amount. Therefore, larger displacements have a larger signal to noise ratio. As the magnitude
of the movement of the chest, or abdomen, during respiration will vary between participants,
the belt should always be placed in the position with the largest displacement. The magnitude
of the signal was larger when the belt was displaced in a sinusoidal motion compared to a
ramp. The shape of respiratory activity is outside of the operators control. However, having
the user relax into a cyclic breathing pattern, which best represents a sinusoidal wave, will
result in the largest signal magnitude.
One problem encountered when using piezoelectric crystals, such as those found within these
piezoelectric respiratory effort belts, for measurements is ‘leakage’. Leakage causes the signal
to slowly drifts back towards the baseline value during periods with no displacement, or
displacement at a low frequency. During this experiment no evidence of leakage was observed,
even when the belt was displaced at a frequency of 0.1 Hz.
It can be concluded that the set-up parameters outlined in this study should make respiratory
effort belts suitable for measuring respiratory activity. Therefore, an initial stretch of 3 cm
was applied to the respiratory effort belt for all use in this thesis. To allow for the greatest
magnitude of displacement to be recorded the belt was positioned to detect the greatest
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movement of the chest or abdomen. As the average human respiratory rate is approximately
12 breaths per minute [144], it was felt that respiration at this frequency would provide a
signal magnitude that would provide a suitable signal to noise ratio.
3.3.4 Nasal/Oral Thermocouple and Tri-Axial Accelerometers
In Chapter 4 respiratory activity was also recorded using a nasal/oral thermocouple (ProTech,
USA), placed on the participant’s top lip. A nasal/oral thermocouple measures the
temperature of air around prongs situated at the nose and mouth. As inhaled air has a lower
temperature than exhaled air direction of respiratory flow can be calculated. This sensor
provides a signal in V, where a typical signal has a peak to peak amplitude of 400 µV and
the sensor has a sensitivity in the range of 2 to 30 µV/mm. The nasal/oral thermocouple
was connected to an amplifier with similar characteristics to that used for the respiratory
effort belts (see Section 3.3.2). In this thesis the amplified nasal/oral thermocouple signal
was differentiated to allow comparison with the spirometer respiratory flow rate.
Two tri-axial accelerometers (ADXL 335, Analog Devices, USA), positioned on top of the
respiratory effort belts located on the abdomen and chest, were also used in Chapter 4 to
record respiratory activity. The accelerometers were used to measure acceleration with a
range of ± 3.6 g and a sensitivity of 300 mV/g. They provide an output in V, with a signal
of 1 V equal to an acceleration of 0.7 g. They were connected to a custom built electronic
subtractor, which was used to remove the gravitational offset from each of the accelerometer
signals. Each accelerometer provides three separate acceleration signals in cartesian x, y and
z coordinates. These signals were combined oﬄine using a custom MATLAB (Mathworks,
USA) script to provide one signal, in spherical coordinates, for each accelerometer. For all
analysis within this thesis this acceleration signal was integrated, resulting in a velocity signal,
which could be directly compared with the spirometer signal.
Both the nasal/oral thermocouple and accelerometer signals were high pass filtered oﬄine
to remove signal bias (first order butterworth, cut off frequency 0.04 Hz). In Chapter 4
these sensors were interfaced with a laptop computer using a 16-bit data acquisition card
(NI DAQCard 6036E, National Instruments, TX, USA), while in all other chapters these
sensors were interfaced using a 14-bit USB data acquisition card (NI USB-6009, National
Instruments, USA). Figure 3.2(c) shows an amplified and filtered nasal/oral thermocouple
signal recorded during a quiet breath, while Figure 3.2(d) shows the combined and filtered
signal from an accelerometer placed on the abdomen recorded during the same quiet breath.
3.3.5 Pressure Sensor
In Chapter 6 a pressure sensor (HDIM050GBZ8H5, First Sensor AG, Germany) was
connected to the filter located on the exhalation limb of a mechanical ventilator (Evita
XL, Draeger, Germany) to provide a measure of the ventilatory flow. This pressure sensor
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measures gauge pressure (pressure relative to the atmosphere) of gas (in this case air), with
a range of ± 50 mbar and an accuracy of 0.75 mbar. It provides an output in V, with 1 V
corresponding to 25 mbar. The pressure sensor signal was high pass filtered oﬄine to remove
signal bias (first order butterworth, cut off frequency 0.04 Hz) and interfaced with a laptop
computer using a 14-bit USB data acquisition card (NI USB-6009, National Instruments,
USA). A filtered pressure sensor signal recorded from a mechanical ventilator is shown in
Figure 3.2(e).
This pressure sensor was also used in Chapter 7 to measure the flow from a MI-E device.
To achieve this the pressure sensor was connected to a filter, fitted in line with the tubing
between the participant and the MI-E device as standard clinical practice, to measure when
insuﬄation and exsuﬄation were applied. This setup is shown in Figure 3.8.
Figure 3.8: Spirometer interface used during Mechanical Insuﬄation-Exsuﬄation (MI-E).
This shows the MI-E device, the respiratory flow head connected to the spirometer pod,
filters to prevent secretions reaching the spirometer pod and a pressure sensor used to record
respiratory activity. The filter on the right hand side of the image is the same filter as
highlighted in Figure 7.2.
3.3.6 Software
All data was recorded in the Simulink modeling environment (Mathworks, USA) using
custom-made blocks to enable real-time data acquisition at a sample rate of 50 Hz. A
custom LabVIEW (National Instruments, USA) Graphical User Interface (GUI) was created
and interfaced with the Simulink model using the LabVIEW simulation interface toolkit
connection manager. This GUI displayed the sensor signals in real-time.
All of the MATLAB, Simulink and LabVIEW software used for data acquisition in this thesis,
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and all of the MATLAB software used for data analysis, was created by the author.
3.4 Methods For AFES
AFES was applied and triggered in this thesis using a number of different methods,
descriptions of which are provided below.
3.4.1 Stimulation System
A neuromuscular stimulator (RehaStim v1, Hasomed, Germany) was used to stimulate the
abdominal muscles, bilaterally, using four stimulation channels. Bi-phasic current controlled
stimulation pulses were applied at a frequency of 30 Hz and the pulsewidth varied between
100 and 500 µs. Current was adjusted on a channel by channel basis until a visible muscle
contraction was observed.
Stimulation was controlled using a custom built Simulink model. Once the criteria to trigger
stimulation had been met (see Section 3.4.3) the model sent a signal to the stimulator, via
a USB interface, initiating stimulation. The Simulink model was interfaced with a custom
LabVIEW model, using the LabVIEW simulation interface toolkit connection manager. This
LabVIEW model provided a GUI that allowed adjustment of the stimulation current, duration
and trigger threshold in real-time and also displayed the stimulation pulsewidth. Stimulation
pulsewidth was adjusted in real-time by the operator using a variable resistor shown in
Figure 3.9.
Figure 3.9: Stimulation pulsewidth could be adjusted by the operator using a variable resistor.
Two switches were also used to control stimulation, one which acted as a safety switch to
stop stimulation being applied (shown in red) and one which allowed stimulation to manually
be applied by the operator (shown in black).
This switch was interfaced with a laptop computer using a 16-bit data acquisition card in
Chapter 4 and a 14-bit USB data acquisition card in all other chapters. Two switches, also
shown in Figure 3.9, were interfaced in a similar manner. The first of these acted as a
safety switch which, when pressed, prevented stimulation being applied while the program
was running, even if the criteria to start stimulation was met. The second of these switches
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allowed stimulation to be manually triggered by the operator. Both of these switch inputs
were controlled within the Simulink model. The model also prevented stimulation from being
triggered within one second of the previous stimulation burst ending.
3.4.2 Electrode Placement
During the studies outlined in Chapters 4, 6 and 7 stimulation was applied via four pairs of
transcutaneous electrodes (33 mm x 53 mm rectangular, PALS, Axelgaard, USA) placed
on the abdomen over the rectus abdominis and external oblique muscles on both sides
of the body, as shown in Figure 1.10. In Chapter 4 the electrodes used to stimulate the
external oblique muscles were placed horizontally, just below the bottom rib with a spacing
of approximately 3 cm between the electrodes. The electrodes used to stimulate the rectus
abdominis muscles were placed horizontally, approximately 2 cm horizontally and vertically
from the umbilicus, with a spacing of approximately 3 cm between the electrodes. In the
two clinical studies presented in Chapters 6 and 7 the electrodes were positioned horizontally
around the motor point of the muscles, determined using the motor point location method
described in Chapter 5, with a spacing of approximately 3 cm between the electrodes.
3.4.3 Automatic Stimulation
A number of the methods used to measure respiratory activity (see Section 3.3) were also
used to automatically synchronise stimulation with the participant’s respiratory activity. In
all cases stimulation was applied at the start of exhalation for a period of 1 to 2 s (set
manually using the LabVIEW GUI), with the exact duration dependant on the length of
each participant’s average exhalation.
In Chapters 4, 6 and 7 the signal from a spirometer was used to apply stimulation in
synchrony with the participant’s respiratory activity. Stimulation was applied at the start of
exhalation, which was defined as a positive sample that proceeded a negative sample when the
previous zero crossing was an inhalation (detected using the opposite logic). The signal from
a respiratory effort belt was also used to apply stimulation in synchrony with the participant’s
respiratory activity. In this case the start of exhalation was defined as two consecutive positive
samples, preceded by three non positive samples, where the previous zero crossing was an
inhalation (detected using the opposite logic). If a participant was dependant on mechanical
ventilation stimulation was automatically synchronised with the mechanical ventilator using
the signal from a pressure sensor. The start of exhalation was defined as two samples with
a value of greater than 0.05 V1 (corresponding to a pressure of 1.25 mbar, used to avoid
noise around 0 V) which preceded three samples with a value of less than 0.05 V, with the
previous zero crossing being an inhalation (detected using the opposite logic). A graphical
representation of these automatic triggering methods is shown in Figure 3.10. These three
methods for triggering stimulation, along with the switch that could be used by the operator
1The stimulation threshold could be adjusted by the operator in real-time using the LabVIEW GUI
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to apply stimulation (see Section 3.4.1), are shown in Figure 3.11.
In Chapter 7 stimulation was automatically synchronised with MI-E using the signal from a
pressure sensor. The criteria to start stimulation was the same as outlined for the pressure
sensor above, with stimulation being applied for the whole exsuﬄation period of 3 s.
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Figure 3.10: A graphical representation of the stimulation triggering algorithm for the
spirometer, respiratory effort belts and pressure sensor. Figure 3.10(a) shows the stimulation
triggering algorithm for the spirometer. When using the signal from the spirometer
stimulation is automatically applied after detection of a negative sample (individual samples
are shown by black ∗) directly followed by a positive sample when the previous zero
crossing was an inhalation (detected using the opposite logic). Figure 3.10(b) shows the
stimulation triggering algorithm for the respiratory effort belts. When using the signal from
the respiratory effort belts, in this example the respiratory effort belt positioned around
the abdomen, stimulation is automatically applied after the detection of three negative
samples proceeded by two positive samples, when the previous zero crossing was an inhalation
(detected using the opposite logic). Figure 3.10(c) shows the stimulation triggering algorithm
for the pressure sensor. When using the signal from the pressure sensor stimulation is
automatically applied after the detection of three samples less than 0.05 V proceeded by two
samples greater than 0.05 V, when the previous zero crossing was an inhalation (detected
using the opposite logic). In all figures the point where stimulation is applied is shown by a
green line.
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(a) Pressure sensor used when participant was
connected to mechanical ventilation.
(b) Spirometer used during assessment sessions.
(c) Respiratory effort belt used during training
sessions.
(d) Manual switch which could be used to apply
stimulation at all times.
Figure 3.11: Experimental set up showing the four sensors used to trigger stimulation in
synchrony with the user’s respiratory activity. Black arrows indicate direction of data.
3.5 Statistical Analysis
A number of statistical tests were used in this thesis. They were employed to test for
normality of data, linear dependance, statistical significance and to measure the effect size
of an intervention. All of these statistical calculations were performed using the MATLAB
statistics toolbox (version 7.3).
3.5.1 Normality
The normality of a data set affects the test employed to test for statistical significance. In
this thesis normality was tested using the Shapiro-Wilk test of normality, which tests the null
hypothesis that a sample originates from a normally distributed population. If the p-value is
found to be smaller than the chosen significance, or alpha level (in this thesis set at 0.05 for
all statistical tests), then the null hypothesis is rejected and it can be assumed that the data
does not come for a normally distributed population. This test was chosen as it has been
shown to be the most powerful normality test [145].
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3.5.2 Linear Dependance
A Pearson product-moment Correlation Coefficient (PCC) was used to test for linear
correlation, or dependance, between two data sets. The PCC, calculated as the covariance of
two data sets divided by their standard deviation, is a value between one and minus one. A
value of one indicates a total positive correlation (i.e all data points lying on a linear line and
as one data set increases so does the other), minus one indicates a total negative correlation
(i.e all data points lying on a linear line and as one data set increases the other decreases)
and a value of zero shows that there is no correlation between the data sets. If the data
could not be represented by a linear line a PCC of greater than 0.8 was regarded as a strong
positive correlation.
3.5.3 Significance Testing
Three different statistical tests were used in this thesis to test for statistical significance, with
the choice of test depending on whether the data was normally distributed or not. For all
significance testing the significance level, or p-value, was set as 0.05, with a p-value of less
than 0.05 deemed statistically significant.
3.5.3.1 Parametric Test
For data that was found to be normally distributed, or parametric, when using a Shapiro-Wilk
test, an analysis of variance (ANOVA) was used to test for a statistically significant difference
between data sets. This test, which allows a significance test to be performed on more than
one group of data, provides an indication of whether the means of the groups are equal. This
is found by calculating the within and between group variances, both of which should be equal
if the means of the two data seats are equal, or different if the means differ. In the case where
a statistically significant difference between means was found, post hoc multiple comparison
testing was performed using the Tukey-Kramer honest significant difference test. This test
compares the mean of every group with the mean of every other group to identify differences
between pairs of means that are greater than the expected standard error, calculated using
the ANOVA test. When analysing individual participant’s data a one-way ANOVA was
performed and when analysing grouped data, where the data was collected from the same
group of participants at different time points, a two-way repeated measures ANOVA was
performed.
An independent Student’s t-test is used to test the null hypothesis that the difference between
two independent data sets comes from a normal distribution that has a mean of zero. An
independent Student’s t-test was used in this thesis to test for a statistically significant
difference between the means of two different groups, where the data within each group was
found to be normally distributed. A one-way ANOVA is an extension of the Student’s t-test
for comparing the means of at least three groups.
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3.5.3.2 Non-parametric Test
For data that was found to not be normally distributed, or non-parametric, when using
a Shapiro-Wilk test, a Kruskal-Wallis test was used to test for a statistically significant
difference between groups of data sets. This test, which is the non-parametric equivalent of a
one-way ANOVA, allows a significance test to be performed on more than one group of data
and provides an indication of whether the groups originate from the same distribution. This
is found by summing the ranks of both groups and calculating the test statistic. In the case
where a statistically significant difference was found, post hoc multiple comparison testing
was performed using the Tukey-Kramer honest significant difference test, with the expected
standard error calculated using the Kruskal-Wallis test.
When comparing two groups of data that were found to not be normally distributed when
using a Shapiro-Wilk test, and found to be linearly correlated, using a PCC test, a Wilcoxon
signed-rank test was used to test for statistical significance. This test provides an indication of
whether the medians of two groups are statistically significantly different by firstly comparing
the pre and post treatment values, then ranking them and applying a sign to the rank (i.e.
negative if the post treatment value was less than the pre treatment value and vice-versa).
The positive and negative ranks are then summed and the lowest value of the negative and
positive summed values provides the test statistic. If this test statistic is greater than the
critical value for the test criteria, computed from standard statistical tables, then the null
hypothesis (that the data comes from a distribution with the same median) cannot be rejected.
3.5.4 Effect Size
While significance testing provides an indication of whether the mean, or median, of two
different groups is statistically significantly different, it does not provide an indication of the
size of this difference. In intervention studies with a large enough sample size, any differences,
or effect, will be found to be statistically significantly different, even when this difference has
no practical importance or is not clinically relevant. Likewise, a study with a small sample
size can show a large effect, which is clinically relevant, even when no statistically significant
difference is shown. Effect size is a way of quantifying the size of an intervention effect. In this
thesis the effect size of an intervention is quantified using Cohen’s d [146], which expresses the
difference between two means in standard deviation units i.e. a Cohen’s d of one implies that
the means are different by one standard deviation. An effect size less than 0.2 is regarded
as small, 0.5 medium and greater than 0.8 large [146]. It should be noted that a large effect
size between two means can be detected even when the difference between these two means
is not statistically significant. Cohen’s d, d, is calculated using Equation 3.1, where x¯ is the
mean of the value being analysed before (1) and after (2) an intervention has been applied.
d =
x¯1 − x¯2
s
(3.1)
The pooled variance, s, is calculated using Equation 3.2, where n is the number of sample
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points and s is the standard deviation of the data before (1) and after (2) an intervention
has been applied.
s =
√
(n1 − 1)s1 2 + (n2 − 1)s2 2
n1 + n2 − 2 (3.2)
The margin for error within an effect size estimate can be analysed using confidence intervals.
If these confidence intervals show that the lower confidence is greater than zero then it can
be concluded that there is almost certainly a positive effect from the intervention. The
confidence interval, c, of the effect size was calculated in this thesis using Equation 3.3.
c =
√
n1 + n2
n1n2
+
d2
2(n1n2)
(3.3)
It should be noted that when using an ANOVA to test the effect of an intervention Eta-squared
η2 can be used to estimate the amount of the variance between the pre and post intervention
results that can be explained by the intervention (i.e the effect size). η2 is a ratio between the
sum of the squares of the treatment (SSTreatment) and the total sum of the squares (SSTotal)
and can be calculated using Equation 3.4.
η2 =
SSTreatment
SSTotal
(3.4)
This calculation tends to seriously over estimate the size of the effect, especially when using
a small sample size, as it is a sample based estimate [147]. Therefore, due to the low sample
sizes in the studies reported in this thesis, Cohen’s d was used to quantify the effect size,
even when using an ANOVA.
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Chapter 4
Real-time Detection and
Classification of Respiratory
Activity For Automatic Abdominal
Functional Electrical Stimulation
“In every branch of knowledge the progress is proportional to the amount of facts on which
to build, and therefore to the facility of obtaining data.”
James Maxwell
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4.1 Summary
The effectiveness of Abdominal Functional Electrical Stimulation (AFES) can be enhanced
by using different stimulation parameters, optimised for quiet breathing and coughing.
Previously, respiratory flow, measured using a spirometer coupled with an intrusive facemask,
has been used to detect and differentiate between these two breath types allowing the correct
stimulation parameters to be applied. In this chapter five non-intrusive sensors were evaluated
for their suitability to detect respiratory activity in real-time. The signals from two of these
sensors, respiratory effort belts positioned around the chest and the abdomen, were then
used for real-time breathing pattern classification. In this work, which has been published
in Medical Engineering and Physics [148], a Support Vector Machine (SVM) algorithm was
trained on a participant by participant basis to classify respiratory activity as either quiet
breathing or coughing. By using the signal from the respiratory effort belt positioned around
the chest the SVM could be used to achieve an acceptable classification performance compared
to that achieved using the signal from a spirometer. The signal from the belt positioned
around the abdomen and a combination of both belt signals resulted in a lower classification
performance. This novel SVM algorithm could be incorporated into an automatic AFES
device, designed to improve the respiratory function of people with tetraplegia.
4.2 Background
AFES has been shown to improve the respiratory function of people with tetraplegia (see
Section 2.4.4). Gollee et al. [72] show that the effectiveness of AFES could be improved
by using different stimulation parameters for quiet breathing and coughing. They suggest
that quiet breaths should be stimulated at the start of exhalation, to support exhalation and
avoid interfering with an inhalation, while coughs should be stimulated during glottal closure
(between the end of inhalation and the start of a cough exhalation) with a higher level of
stimulation than a quiet breath. This would increase intrathoracic pressure and aid cough
generation.
A number of AFES systems have been developed which i) detect respiratory activity to
allow AFES to be applied at the correct point in the breathing cycle and ii) differentiate
between quiet breathing and coughing, enabling different stimulation parameters to be applied
for each breath type (see Section 2.4.4.4) . Many of these systems use the signal from a
spirometer. A spirometer is typically coupled with a full face mask which is uncomfortable
and intrusive, leaving the user unable to eat, drink or verbally communicate while in use.
Using a non-intrusive sensor, such as those described in Section 2.4.4.4, would make these
systems considerably more practical. Additionally, the systems previously used to classify
respiratory activity require operator intervention to optimise classification performance. This
is time consuming and unsuitable in a clinical setting. The use of a statistical classifier based
on an SVM (see Section 2.4.4.4) could decrease the need for operator intervention, making
CHAPTER 4. CLASSIFICATION OF RESPIRATORY ACTIVITY 75
such an AFES system more suitable for a clinical setting.
The two aims of this study were i) to identify a non-intrusive sensor capable of detecting
respiratory activity in real-time, and ii) to develop a classification algorithm capable of using
the signal from this non-intrusive sensor to classify respiratory activity in real-time, with
minimal operator intervention.
4.3 Methods
Ten able bodied participants (six males, four females, age 27.6 ± 5.2 years (mean ± standard
deviation) [range 24 : 40 years]) were recruited for this study and asked to attend two sessions,
described below. The study was approved by the Faculty of Biomedical and Life Sciences
ethics committee at the University of Glasgow (Local Code: FBLS 1034). All procedures
conformed to the declaration of Helsinki and all participants gave written informed consent.
4.3.1 Equipment
The participant’s respiratory activity was recorded using a spirometer, two respiratory effort
belts, a nasal/oral thermocouple and two tri-axial accelerometers, as described in Section 3.2.
A diagram of this experimental set up is shown in Figure 4.1.
All data was recorded on a laptop computer in the Simulink modeling environment
(Mathworks, USA) at a sample rate of 50 Hz. The spirometer was connected to the laptop
computer using an RS232 interface and the respiratory effort belts, nasal/oral thermistor
and accelerometers were connected using a 16-bit data acquisition card (NI DAQCard 6036E,
National Instruments, TX, USA). The respiratory effort belt, nasal/oral thermocouple and
accelerometer signals were high pass filtered oﬄine to remove signal bias while the spirometer
signal was low pass filtered to smooth the signal. This pre-processing is described in further
detail in Section 3.3.
4.3.1.1 Stimulation System
Stimulation was applied using the system described in Section 3.4.1. Stimulation current was
adjusted on a channel by channel basis for each participant (with a pulsewidth of 100 µs)
until a visible contraction was observed (range 10 to 60 mA for all participants), with this
current remaining fixed for the remainder of both sessions. Stimulation pulsewidth was varied
between 100 and 150 µs within each session to account for muscle fatigue. Stimulation was
automatically applied for 1.5 seconds for a quiet breath and one second for a cough at the
start of exhalation, in synchrony with the participant’s respiratory activity, using the signal
from the spirometer. This automatic application of stimulation is described in further detail
is Section 3.4.3.
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Figure 4.1: Experimental set up showing methods used to record respiratory activity;
namely a spirometer, two respiratory effort belts, a nasal/oral thermocouple and two tri-
axial accelerometers. Also shown is a stimulator and electrodes used to apply AFES, a
laptop computer used to record data, a RS323 interface used to connect the spirometer
to the laptop, an amplifier used to amplify the signals of the respiratory effort belts and
the thermocouple, an electronic subtractor used to remove the gravitational offset from
the accelerometer signals and a DAQ card used to connect the respiratory effort belts,
accelerometers and the thermocouple to the laptop. Bold arrows represent direction of data.
Thin arrows indicate items.
4.3.2 Data Collection Protocol
The data collection protocol is summarised in Figure 4.2. Experimental sessions included
runs consisting of approximately six to ten coughs and one minute of quiet breathing, with
and without the support of AFES. The order of each of these four breath types within each
run was randomised, with each breath type following directly one after the other. Each
run was repeated three times per session, separated by a rest period of approximately two
minutes. The session was repeated after a period of approximately seven days.
The data recorded during the two sessions was combined for each participant. Data sets
containing all of the cough data or all of the quiet breathing data were then created for each
sensor, for each participant.
4.3.3 Analysis
The suitability of the non-intrusive sensor signals for real-time detection of respiratory activity
was evaluated by analysing the time shift of these signals relative to the respiratory flow
measured by the spirometer. In a second step, the signals found to be suitable for real-time
respiratory activity detection were used to construct SVMs, and the ability of these SVMs
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Figure 4.2: Protocol showing two sessions, split into three runs, with each run containing a
period of AFES assisted and unassisted quiet breathing and coughing.
to accurately classify respiratory activity as quiet breathing or coughing was evaluated.
4.3.3.1 Time Shift
To determine the suitability of the non-intrusive sensors for real-time detection of respiratory
activity, the time shift between the start of exhalation detected by each of the non-intrusive
sensor signals and the spirometer signal was calculated for all breaths recorded from each
participant (approximately 100 coughs and 200 quiet breaths). The spirometer signal provides
a direct measurement of respiratory flow, with positive values corresponding to exhalation
and negative values representing inhalation. A positive zero crossing of the spirometer signal
(i.e. from a negative to a positive value as marked on Figure 4.3) was taken to represent
the start of exhalation. For the non-intrusive sensors, the start of exhalation was defined as
two consecutive positive samples, preceded by three non positive samples, where the previous
zero crossing was an inhalation (detected using the opposite logic). Due to the high signal
to noise ratio achieved using the filtering techniques described in Section 3.3 these methods
were found to be robust enough to minimise false positive detection.
A mean time shift for a sensor across all participants of ± 0.1 s (2% of the length of a breath
assuming a breathing rate of 12 breaths per minute [144]) was considered acceptable for real-
time respiratory activity detection. Zero crossings that occurred outside 0.4 s of the start
of exhalation, as detected by the spirometer, were deemed incorrect and ignored to avoid
incorrect detections caused by noise.
Figure 4.3(a) shows a typical example of the sensor signals recorded during a full breath.
Details of the respiratory effort belt and spirometer signals around the zero-crossing are
depicted in Figure 4.3(b), which shows the time shift between the signals. In this example,
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the abdominal belt signal precedes (a signal that precedes the spirometer signal will be
denoted by a negative value of time shift) the spirometer signal by T1 = 0.08 s and the chest
belt signal lags the spirometer signal by T2 = 0.02 s.
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Figure 4.3: Example of sensor signals and the time shift between these signals and the
spirometer. (a) shows an example of all of the sensor signals and their respective zero crossings
during one full breath. (b) shows the time shift between the respiratory effort belt signals
and the spirometer signal, where T1 is the time shift between the spirometer (black) and the
abdominal (blue) belt signal and T2 is the time shift between the spirometer and the chest
(red) belt signal.
4.3.4 Support Vector Machine
From pre-processed data (see Section 4.3.1) inhalations were detected, based on when
the zero-crossings occurred (see previous section), and from each inhalation features were
extracted (see below). The features from a subset of approximately 50 cough and 100 quiet
breath inhalations, together with information indicating whether the data represented a quiet
breath or a cough, were used to train an SVM on a participant by participant basis. After
training, the SVM was used to classify all of the breaths recorded from that participant, and
not used to train the SVM, as either a quiet breath or a cough, again using features extracted
from each inhalation. The classification structure is shown in Figure 4.4 and explained in
further detail in this section.
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Figure 4.4: Classification structure. The classification algorithm firstly pre-processes all data
and then extracts the inhalations and features from all data sets. The algorithm can then be
used to either train the Support Vector Machine (SVM), or can use a trained SVM to classify
respiratory activity.
4.3.4.1 Feature Extraction
Twenty one features (listed below), extracted from both the time and frequency domain, were
calculated for each inhalation.
1. Length
2. Sum
3. Minimum value
4. Maximum value1
5. Number of peaks
6. Mean
7. Mean magnitude (power spectral density) of Fast Fourier Transform (FFT)
8. Sum of magnitude (power spectral density) of FFT
9. Maximum magnitude (power spectral density) of FFT
10. Minimum magnitude (power spectral density) of FFT
11. Sum of magnitude (power spectral density) of FFT, divided by signal length
12. Index of minimum value
13. Mean gradient (Equation (4.1))
14. Minimum gradient (Equation (4.1))
15. Maximum gradient (Equation (4.1))
16. Sum of gradient (Equation (4.1))
17. Cross correlation with a quiet breath (Equation (4.2))
1If using continuous sampling the maximum value of inhalation would be zero. Due to the discrete sampling
technique employed, this was not the case. As quiet breaths have a smaller inhalation amplitude than coughs,
the maximum sampled value of a quiet breath is likely to be closer to zero than the maximum sampled value
of a cough
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18. Cross correlation with a cough (Equation (4.2))
19. Mean of autocorrelation (Equation (4.3))
20. Maximum value of autocorrelation (Equation (4.3))
21. Minimum value of autocorrelation (Equation (4.3))
The gradient, ∆s, was calculated using Equation (4.1).
∆s = s(i)− s(i− 1) (4.1)
∆ s is the difference between the value of the current data point, s(i), and the previous data
point, s(i− 1).
Cross correlation, c(t), between the measured signal, y(k), and a reference breath, x(k),
was calculated using the equation used by Gollee et al. [72], shown in Equation (4.2). The
reference breath, x(k), was the mean of either all of the quiet breaths or all of the coughs
collected from all participants during session one.
c(t) =
∑N
i=1 x(i)y(t−N + i)√∑N
i=1 x
2(i)
∑N
i=1 y
2(t−N + i)
(4.2)
c(t) is defined as the similarity between the measured signal, y(k), and the reference signal,
x(k), where the measured signal has a length of N sample points. The reference signal
has a length of t sample points and i denotes the sample point being compared. If c(t) is
one, both samples are identical. If c(t) is minus one both samples are identical, but have
a phase difference of 180 degrees. A value of zero indicates that the signals are not correlated.
Autocorrelation, a(t), was calculated using Equation (4.3).
a(t) =
N∑
k=1
N∑
i=1
x(i)x(k + i− 1) (4.3)
a(t) is a comparison of a signal, x, of length N , at time point (i), with the same signal at
every other time point (k + i− 1).
Examples of some of the quiet breath and cough features extracted from the time domain of
the chest belt signal are shown in Figure 4.5.
To evaluate whether combining the signals from more than one sensor provided a better
classification performance, the features from the respiratory effort belts positioned around
the chest and the abdomen were combined, providing a total of 42 feature values.
4.3.4.2 Classification
Peak Expiratory Flow Peak Expiratory Flow (PEF), the maximum flow rate during
exhalation (recorded with the spirometer), is greater for a cough than for a quiet breath.
Therefore, PEF was used oﬄine to label each inhalation as a quiet breath or a cough. The
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Figure 4.5: Respiratory flow signal recorded using a respiratory effort belt positioned around
the chest. An example of the signal recorded during a cough and a quiet breath, in addition
to example features extracted from these two breath types, is shown.
threshold for a breath to be deemed a cough was a PEF of 0.1 L/s greater than the maximum
expiratory flow recorded during any of the quiet breaths recorded from that participant. This
threshold was set on a participant by participant basis and provided a sensitivity of 100
percent. The labelled data was used to train the SVM and to allow the performance of the
SVM to be assessed. Note that a real-time classification must be made at the end of each
inhalation. For this reason PEF data, which is based on exhalation, would not be available
for online classification in real-time.
Support Vector Machine The signals from the respiratory effort belts positioned around
the abdomen and the chest, as well as a combination of these signals, were used to construct
SVMs for each participant. The signal from the spirometer was used to create a baseline SVM
with which the classification performance using the different non-intrusive sensor signals could
be compared. To test the robustness of the SVMs a simple cross validation method was used.
The SVMs were trained on a participant by participant basis using the data collected from
session one (Train 1 ), session two (Train 2 ) and the first 50 percent of the data recorded
from each session (Mix ). This training data contained approximately 50 coughs and 100
quiet breaths.
The feature values, and a label denoting whether each breath was a quiet breath or a cough,
were used to train the SVM model. Training was performed using a model developed from
the MATLAB Bioinformatics Toolbox (Version 3.5), which was used to find the combination
of features that separated the data in higher dimensional space by as large a margin, also
known as a gap, as possible (see Section 2.4.4.4 for further explanation). When using an
SVM data can be separated linearly, using a linear kernel, or non-linearly using a Radial
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Basis Function (RBF) kernel. Therefore, an SVM was created using both kernel types. The
strength of the soft margin (see Section 2.4.4.4 for further explanation) is controlled within
this SVM model using a variable called ‘boxconstraint’. For both kernel types boxconstraint
was varied oﬄine between 1x10−5 and 1x105, in steps of 1x101, and the value of boxconstraint
that achieved the highest combination of quiet breath and cough sensitivity was evaluated
on a participant by participant basis for both kernel types.
4.3.4.3 Classification Performance
To evaluate the performance of the SVMs the data collected during the sessions that was not
used to train the SVMs was classified as either a quiet breath or a cough, using the previously
trained SVMs. For each breath type the classification sensitivity, Se, was calculated. Se is
defined as the percentage of the number of breaths that were correctly classified as that
breath type, N iy, over the total number of breaths that should have been classified as that
breath type, N it , where i denotes the breath type (c=cough, q=quiet breath).
Sei =
N iy
N it
× 100 (4.4)
Sensitivity of one breath type alone is not a suitable parameter to evaluate a classifier: for
example, if every breath was classified as a cough this would lead to 100 percent cough
classification sensitivity, even though all quiet breaths had been incorrectly classified as
coughs, as false positives are not accounted for [149]. In the general case, specificity can be
used to include the effect of false positive detection. In this case where only two classes are to
be distinguished, the cough classification sensitivity is equal to the quiet breath classification
specificity and vice versa.
As previously stated, it is believed that a greater stimulation intensity is required to generate
an effective cough compared to a quiet breath [72]. Therefore, incorrect classification of a
quiet breath as a cough would lead to a higher stimulation intensity than necessary being
applied, with the breath said to be over stimulated. While this is not dangerous, as this higher
stimulation intensity is safely being used to stimulate a cough, it may be less comfortable
for the user as the greater stimulation intensity may lead to the recruitment of more pain
receptors. It was agreed with clinical colleagues that in the context of an AFES system a
high quiet breath sensitivity, which would lead to less quiet breaths being incorrectly over
stimulated as coughs, was more important than a high cough sensitivity, which would lead
to less coughs being incorrectly under stimulated as quiet breaths. It was agreed that a quiet
breath sensitivity of greater than 95 percent was clinically suitable, as this would result in
only one out of 20 quiet breaths being incorrectly stimulated as a cough, or approximately one
quiet breath per 100 seconds of use (assuming a breathing rate of 12 breaths per minute [144]).
A cough sensitivity of greater than 90 percent, which would lead to one in every 10 coughs
being under stimulated, was also deemed to be clinically acceptable.
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4.3.5 Statistical Analysis
A Shapiro-Wilk test was performed to test for normality of the feature values during
both quiet breathing and coughing. A Pearson product-moment Correlation Coefficient
(PCC) was calculated to ascertain whether quiet breaths and coughs and stimulated and
unstimulated breaths were linearly correlated. A Wilcoxon signed-rank test was used to test
for a statistically significant difference (p-value less than 0.05) between: quiet breath and
cough feature values for each participant; the stimulated and unstimulated feature values
for each participant; the classification performance between each of the non-intrusive sensors
and the spirometer and the classification performance when classifying only stimulated or
unstimulated breaths.
4.4 Results
The signals from the accelerometers and nasal/oral thermocouple could not be used for
analysis. This was mainly attributed to poor data collection protocol and is discussed in
further detail in Section 4.5. Therefore, this results section will only include data collected
from the respiratory effort belts and spirometer.
4.4.1 Statistical Testing
The results of a Shapiro-Wilk test showed that for the spirometer all of the 210 (100%)
quiet breath feature values and 174 (82.9%) of the cough feature values were not normally
distributed (21 features for each of the 10 participants). This confirmed the use of a non-
parametric test for significance testing. The PCC between quiet breathing and coughing was
found to be 0.79, and the PCC between stimulated and unstimulated breaths was found to
be 0.98, indicating a strong linear correlation between both sets of variables. Non-parametric
distribution and high linear dependance between variables advocated the use of a Wilcoxon
signed-rank test for significance testing.
4.4.2 Time Shift
Table 4.1 shows the mean time shift between the respiratory effort belt and spirometer signals
at the start of exhalation (positive zero crossing). This value is calculated for each participant
from all (approximately 300) breaths recorded from that participant, and then averaged over
all participants.
The signal from the belt positioned around the abdomen was used to detect the start of
exhalation 0.01 s before the spirometer, while the signal from the belt positioned around the
chest was used to detect the start of exhalation 0.04 s after the spirometer. The signal from
both of the belts could be used to detect the start of exhalation within 0.1 s of the spirometer
signal.
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Table 4.1: Time shift (mean ± standard deviation) between the respiratory effort belt and
spirometer signals at the start of exhalation for 10 participants. The time shift for each
participant is calculated from approximately 300 breaths.
Sensor Time Shift (s)
Chest Belt 0.04 ± 0.12
Abdominal Belt −0.01 ± 0.12
4.4.3 Feature Selection
Of the 21 features (see Section 4.3.4.1) extracted from the various sensor signals, the number
of features that had a statistically significantly different median for a quiet breath and cough
for all 10 participants is shown in Table 4.2. The median of the feature values for each
participant was calculated from the features of around 100 coughs and 200 quiet breaths.
Table 4.2: Number of features extracted from the spirometer, chest belt and abdominal belt
signals that had a statistically significantly different median for quiet breathing and coughing
for all 10 participants.
Sensor Number of features
Spirometer 21
Chest Belt 18
Abdominal Belt 13
The median of all 21 features extracted from the spirometer signal was found to be statistically
significantly different for a quiet breath and cough for all 10 participants. This advocated
the use of these features within an SVM. For both the chest and abdominal belt over half
of the features had a median that was statistically significantly different for a cough and
a quiet breath. A list of the features that were found to have a statistically significantly
different median for quiet breathing and coughing for each sensor can be found in Appendix A,
Table A.1.
To find the effect of stimulation on the feature values, the number of features that had
statistically significantly different medians for stimulated and unstimulated breaths, for all
10 participants, is shown in Table 4.3. Again the median was calculated from around 100
coughs and 200 quiet breaths for each participant.
It was found that the signals from the respiratory effort belts had a very low number of
features that had a statistically significantly different median for stimulated and unstimulated
breaths. A list of the features that were found to have a statistically significantly different
median for stimulated and unstimulated breaths for each sensor can be found in Appendix A,
Table A.2.
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Table 4.3: Number of features extracted from the spirometer, chest belt and abdominal belt
signals that had a statistically significantly different median for stimulated and unstimulated
breaths for all 10 participants.
Sensor Total no. of features
Spirometer 9
Chest Belt 1
Abdominal Belt 3
4.4.4 Classification
Boxplots showing the quiet breath and cough classification sensitivities achieved with the 10
participants when using the different sensors and training methods outlined in Section 4.3.4.2
are shown in Figure 4.6. The SVMs were trained on a participant by participant basis and
evaluated using the data, collected over the two sessions, which was not used to train the
classifier (approximately 50 coughs and 100 quiet breaths). Training was performed using a
linear kernel and a boxconstraint value of 0.1.
The classification sensitivities achieved when training the SVM with data collected at both
session one and two (Mix ) provided the best combination of high cough and quiet breath
classification sensitivities for all sensors. The cough classification sensitivity achieved using
the signal from the abdominal belt and training with the data collected at session one (Train
1), was the only non-intrusive sensor that provided a cough classification sensitivity that was
statistically significantly inferior to that achieved using the signal from the spirometer. The
signal from the spirometer provided the highest quiet breath sensitivity, with this sensitivity
found to be statistically significantly greater than that achieved using all bar one of the non-
intrusive sensor and training data combinations (chest belt and Train 2). The inter-quartile
range of the quiet breathing sensitivity using the spirometer signal was consistently small,
whereas the inter-quartile range was larger when using the signal from the non-intrusive
sensors. The inter-quartile range of the cough sensitivity was generally larger than for quiet
breathing, with minimal sensitivity as low as 50 percent. It should also be noted that when
performing quiet breath classification using the chest belt and Train1 there was one outlier,
which had a classification sensitivity of 57 percent. This is believed to be due to non optimal
training methods, detailed further in the discussion.
The classification performance that could be achieved using either a linear or RBF kernel was
investigated, with a boxconstraint value of 0.1 and 1 found to provide the highest classification
performance for these two kernel types respectively. The classification performance obtained
when optimising the boxconstraint value on a participant by participant basis was also
evaluated. The mean classification sensitivity achieved when training the SVM with the first
50 percent of the data recorded from session one and session two (Mix ) (found to provide
the best combination of high cough and quiet breath classification sensitivity as shown in
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Figure 4.6) on a participant by participant basis and classifying the data not used to train
the classifier (approximately 50 coughs and 100 quiet breaths) is presented in Table 4.4. The
classification sensitivity achieved using Train1 and Train2 is presented in Appendix A.
Table 4.4: Mean percentage quiet breath (q) and cough (c) sensitivity (Se) (± standard
deviation) achieved using the signals from the respiratory effort belts placed around the
abdomen (abdo) and the chest, a combination of respiratory effort belt signals and the signal
from a spirometer (spiro). The SVM was trained for each participant using a mix of the
first 50% of the data recorded from session one and session two (Mix ). Classification was
performed on the data not used to train the SVM using: a linear kernel with a boxconstraint
value of 0.1, a linear kernel with an optimised (opti) box constraint value for each participant,
an RBF kernel with a boxconstraint value of one and an an RBF kernel with an optimised
boxconstraint value for each participant. ∗ indicates statistically significantly different from
spirometer when using the same training data and † indicates statistically significantly
different from results achieved using a linear kernel and box constraint of 0.1.
Sensor Linear & 0.1 Linear & opti RBF & 1 RBF & opti
Sec (%) Seq (%) Sec (%) Seq (%) Sec (%) Seq (%) Sec (%) Seq (%)
Spiro 90.7 98.9 93.0 98.9 92.2 91.8† 96.2† 90.9†
±7.6 ±1.6 ±5.7 ±1.6 ±9.6 ±5.3 ±3.9 ±6.4
Chest 92.9 96.1∗ 93.4 96.8∗ 91.6† 86.7 90.6† 90.0
Belt ±4.9 ±4.2 ±5.3 ±3.7 ±11.8 ±3.8 ±11.7 ±2.4
Both 92.0 91.5∗ 92.1 91.6∗ - - - -
Belts ±6.0 ±7.9 ±6.0 ±7.8 - - - -
Abdo 83.1 89.4∗ 84.5 91.5∗ 62.9∗† 92.0 82.3∗† 83.6†
Belt ±14.6 ±5.3 ±12.9 ±4.6 ±27.7 ±5.3 ±11.1 ±11.2
Due to problems believed to be associated with over classification, the combined belt signals
could not be evaluated with an RBF kernel. This issue is discussed in further detail in
Section 4.5. The use of a linear kernel with a boxconstraint value optimised for each
participant resulted in a slight (generally less than two percent) increase in the cough and
quiet breath classification sensitivity. For the spirometer and chest belt the use of an RBF
kernel led to a large (statistically significant in the case of the spirometer) decrease in quiet
breath sensitivity, whether the value of boxconstraint was optimised or not, compared to
when using a linear kernel. Similar trends were observed when using Train1 and Train2.
To assess the impact of AFES on classification performance, the classification sensitivity
achieved when training with the same three training methods and classifying only stimulated
or unstimulated breaths was investigated. The mean sensitivity achieved when training with
the first 50 percent of the data recorded from session one and session two (Mix ) and when
classifying only stimulated or unstimulated breaths that were not used to train the SVM
is shown in Table 4.5. The classification sensitivity achieved using Train1 and Train2 is
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presented in Appendix A.
Table 4.5: Mean percentage cough (c) and quiet breath (q) sensitivity (Se) (± standard
deviation) of stimulated (stim) and unstimulated (unstim) breaths using the signals from
respiratory effort belts placed around the abdomen and the chest, a combination of these
signals, and the signal from a spirometer. The SVM was trained for each participant using a
mix of the first 50% of the data recorded from session one and session two (Mix ). Classification
was performed on the second 50% of the data recorded from session one and session two using
a linear kernel and a boxconstraint value of 0.1.
Sensor Stim Unstim Stim Unstim
Sec (%) Sec (%) Seq (%) Seq (%)
Spirometer 91.7 89.7 98.9 98.7
±7.6 ±7.3 ±2.0 ±1.9
Chest Belt 93.0 93.3 95.9 96.0
±6.3 ±6.0 ±4.9 ±4.0
Both Belts 90.1 90.7 89.9 91.4
±7.8 ±9.3 ±8.5 ±8.6
Abdominal Belt 81.7 84.8 88.2 91.2
±17.1 ±14.1 ±7.2 ±6.6
It was found that the classification performance was not statistically significantly different
when classifying only stimulated or unstimulated breaths for any of the sensors. Similar
trends were observed when using Train1 and Train2.
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Figure 4.6: Boxplots showing the classification sensitivities for different sensors and training
data sets. Each box shows the median together with the inter-quartile range, with outliers
marked by a black dot. (a) shows the median quiet breath sensitivity and inter-quartile range
for the spirometer and respiratory effort belts when trained for each participant using: 1) all
the data collected from that participant during session one (black), 2) all the data collected
from that participant during session two (blue), Mix the first 50% of the data recorded from
session one and session two (red). A linear kernel and a boxconstraint value of 0.1 were
used to train the SVM, with classification performed on the data collected at the two sessions
which was not used to train the classifier. (b) shows the cough sensitivity for the same sensors
using the same training data. ∗ indicates statistically significantly different from spirometer
when using the same training data.
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4.5 Discussion
In this chapter the signals from non-intrusive sensors were used to automatically detect
and classify respiratory activity with minimal user intervention. The results show that a
non-intrusive respiratory effort belt positioned around the chest can be used for the real-
time detection and classification of respiratory activity, with an acceptable classification
performance compared to that achieved using the signal from an intrusive spirometer. This
suggests that a respiratory effort belt positioned around the chest, together with an SVM
classification algorithm, can be used to detect and classify respiratory activity in the context
of an automatic AFES system.
4.5.1 Timing
The abdominal muscles are active only during exhalation. Therefore, it is desirable to only
apply AFES during this time, while avoiding the early application of stimulation which may
curtail an inhalation. The signal from a spirometer, which is usually coupled with an intrusive
facemask, has previously been used to detect respiratory activity, allowing AFES to be applied
at the correct point in the respiratory cycle [72, 120, 121]. For a non-intrusive sensor to be
suitable to detect respiratory activity in real-time it must have as small a time shift compared
to the spirometer signal as possible, allowing accurate detection of the start of exhalation.
The signal from a non-intrusive respiratory effort belt, positioned around the chest or the
abdomen, was found to have a time shift of less than 0.05 s (1% of the length of a breath
assuming a breathing rate of 12 breaths per minute [144]) compared to the signal from a
spirometer. To perform the time shift analysis breaths that had a time shift of greater than
0.4 s were ignored in case of noise. It was found that for the chest belt signal, which had a
larger time shift than the abdominal belt, the mean time shift plus three standard deviations
was exactly 0.4 s, justifying this 0.4 s window. These results indicate that respiratory effort
belts positioned around the chest or abdomen are suitable for the real-time detection of
respiratory activity.
4.5.2 Classification Performance
To create a stand alone AFES device capable of differentiating between quiet breathing and
coughing the signal from the input sensor must have features that differ for the two breath
types. In this study 21 features were identified from the time and frequency domain of an
inhalation, with the signal from the spirometer found to have a statistically significantly
different median for a quiet breath and cough for all 21 features. This validated the use of
these features for the classification of respiratory activity. It was also found that the use of
AFES did not have a statistically significant impact on the feature values of the respiratory
effort belts positioned around the chest and the abdomen, with one and three features having
statistically significant medians for stimulated and unstimulated breaths for all 10 participants
respectively. This allowed all breaths of the same type, stimulated or not, to be combined
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into one data set for training purposes.
McCaughey and Gollee [131] used the signal from an intrusive spirometer as the input to
a maximum likelihood classification algorithm, which was capable of differentiating between
quiet breathing and coughing. This algorithm required a high degree of manual intervention,
with the operator selecting the optimum features for classification based on each participant’s
training data. Here, the manual assignment of features was replaced with automatic feature
selection and classification using an SVM. It was found that for all sensors the highest
combination of quiet breath and cough classification sensitivities was achieved when training
the SVM with a mixture of data collected at session one and two (Mix ). Using this training
method a non-intrusive respiratory effort belt positioned around the chest was used to provide
a cough classification sensitivity (92.9%), which was similar to that achieved using the signal
from an intrusive spirometer (90.7%). Although the quiet breathing sensitivity of 96.1
percent, achieved using the signal from the chest belt and training with Mix, was found
to be statistically significantly lower than that achieved using the signal from the spirometer
(98.9%), it would result in only one breath every two minutes (assuming a breathing rate
of 12 breaths per minute [144]) being classified incorrectly. This quiet breath classification
performance was greater than the minimum clinically relevant quiet breath classification
performance of 95 percent that was agreed with clinical colleagues (see Section 4.3.4.3).
The classification performance achieved using the signal from the belt positioned around the
abdomen, and a combination of the chest and abdominal belt signals, provided an inferior
classification performance compared to that achieved using the spirometer, which was not
deemed to be clinically suitable. As the stimulation intensity applied during a quiet breath is
lower than that applied during a cough, it is more desirable to incorrectly stimulate coughs as
quiet breaths, where a breath will be under stimulated, than quiet breaths as coughs, where a
breath will be overstimulated. The cough sensitivity achieved with the chest belt and training
the SVM with a mixture of the data collected at session one and two (Mix ) of 92.9 percent
was lower than the quiet breath sensitivity of 96.1 percent achieved using the same sensor
and training methods. However, this sensitivity, which would result in approximately 1 in
every 12 coughs being incorrectly under stimulated, was greater than the clinically relevant
minimum cough classification performance of 90 percent that was deemed acceptable in the
context of an AFES system. Therefore, these results suggest that a respiratory effort belt
positioned around the chest, together with the SVM classification algorithm, can be used to
classify breathing patterns in the context of an automatic AFES system.
To test the robustness of the classifier, the impact of training the classifier with data recorded
on different days was investigated. While training with a mix of data recorded at two
different sessions (Mix ) provided the best combination of high quiet breath and high cough
classification sensitivities (see Figure 4.6), for the spirometer and chest belt these classification
sensitivities were not statistically significantly different to those achieved when training the
SVM with the data collected at session one (Train 1 ). This suggests that, with further
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refinement of the training protocol, only one training session per user may be required to
train the SVM. The lack of impact of stimulation on classification performance was also
demonstrated by the classification sensitivity not being statistically significantly different
when classifying only stimulated or unstimulated breaths. This would allow the user to
receive a mixture of stimulated and unstimulated breaths during the training/familiarisation
session. Practically, this would give the user the opportunity to experience the sensation of
stimulation while the classifier was being trained, saving valuable time in the clinical setting
where patient contact time can be limited.
The classification sensitivities that could be achieved by training the SVM with a non-linear
RBF kernel, as opposed to a linear kernel, was investigated. However, the use of an RBF
kernel instead of a linear kernel led to a large, statistically significant, decrease in quiet
breath sensitivity when using the spirometer or chest belt. In addition, an RBF kernel
is computationally more expensive than a linear kernel [150]. Therefore, a linear kernel
was deemed preferential for this system. The boxconstraint value controls the strength of
the soft margin (i.e how many misclassifications are allowed in the training data). The
effect of optimising the boxconstraint value oﬄine, on a participant by participant basis, to
provide the best combination of high quiet breath and cough classification sensitivity, was
also investigated. While this led to small, non statistically significant, improvements in cough
and quiet breath sensitivity, this optimisation on a participant by participant basis requires
a high degree of operator input, making it unsuitable for a clinical setting. Therefore, a
boxconstraint value of 0.1 and a linear kernel is suggested for all further developments of the
SVM.
4.5.3 Limitations
An RBF kernel could not be used to classify the combined belt signals, although the use
of this kernel with the individual signal from both belts did provide a suitable classification
performance. With the combined signals it was observed that every breath that was in the
training data was classified correctly, while every breath that was not in the training data
was classified as a quiet breath. When using the combined signals the classifier was provided
with 42 features, compared to just 21 for the single signals. If the number of features was
reduced, classification performance improved. This indicated that when using the 42 features
there was a problem with over fitting. Over fitting occurs when classification is memorised
rather than learned and the model has poor generalisation, a problem commonly encountered
when using an RBF kernel and a large number of input features [151]. When using the linear
kernel the classification performance achieved using both belt signals was not found to be
greater than that achieved using the chest belt signal alone, leading to the belief that this
problem of over fitting when using both belt signals did not justify further exploration.
The signals from the accelerometers and nasal/oral thermocouple were not suitable for
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analysis due to a large amount of signal noise, attributed to poor data collection protocols.
The amplitude of both signals was small leading to a poor signal to noise ratio. Data was
sampled at 50 Hz, rendering the removal of mains artefact (also at 50 Hz) very difficult
from both signals. For the accelerometers, the magnitude of acceleration achieved by body
movement was much greater than that achieved during respiration. As the participants
were not instructed to remain still during each session, this body movement artefact added
a large degree of noise to the signal. As people with tetraplegia are likely to have some
form of paralysis below the level of injury, body movement may be less of an issue with this
group, making the accelerometers a potentially suitable sensor for measuring their respiratory
activity. While the inability to use the nasal/oral thermocouples was disappointing, Farre
et al. suggest that they are only semiquantative and cannot be used to accurately measure
respiratory flow [140], which would have made them unsuitable for classifying respiratory
activity. The sampling of data at 50 Hz, along with participants being free to move, should
be avoided if using these sensors in future studies.
4.5.4 Future Work
While the current classification performance achieved using the signal from the spirometer and
chest belt was deemed acceptable, the range of classification sensitivities observed across the
participants may be improved by optimising the selection of training data. This may provide
a better representation of a quiet breath and cough on which to base the classification. This
optimisation could take the form of selecting more and/or better features or further refinement
of the classification algorithm. This may allow the generation of a ‘universal’ training data set
that provides a high classification performance for all users, negating the need for a training
session. The classifier presented here is only capable of assigning breaths into one of two
classes, a quiet breath or a cough. The system developed by Gollee et al. [72] was able to
mute stimulation for periods of unexpected activity, such as speaking. Development of the
classification algorithm to utilise a hierarchy of SVMs, where one level decides whether a
breath is valid for classification, and another classifies a valid breath as a quiet breath or a
cough, would enable the introduction of a ‘zero class’ for all breaths that were not suitable
for classification. This would allow stimulation to be muted in all unusual situations, further
improving the usefulness of the system.
In future work, the classification algorithm should be tested with tetraplegic participants. As
people with tetraplegia have a reduced PEF, the difference in the feature values between a
quiet breath and cough may not be as distinct as with the able bodied population. This may
cause a reduction in classification performance for this patient group. Additionally, people
with tetraplegia often exhibit paradoxical breathing, where the chest and abdomen move
in opposing motions to that expected [152, 153, 154]. It is not anticipated that paradoxical
breathing will lead to a reduction in classification performance, as breath features, and hence a
distinction between breath types, should remain (with a phase shift of 180 degrees). However,
further tests with tetraplegic patients who exhibit paradoxical breathing would be required
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to establish the suitability of the system for this patient group.
4.6 Conclusion
The signal from a non-intrusive respiratory effort belt positioned around the chest can be
used to achieve real-time classification of respiratory activity, with an acceptable performance
compared to that achieved using the signal from an intrusive spirometer.
94
Chapter 5
Detection of the Motor Points of
the Abdominal Muscles
“Everything should be made as simple as possible, but not one bit simpler.”
Albert Einstein
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5.1 Summary
It is widely known that the optimum muscle response to electrical stimulation occurs when
stimulation is applied in close proximity to the muscle motor point. Despite this, Abdominal
Functional Electrical Stimulation (AFES) studies continue to use a range of empirically
derived electrode locations, with no consensus as to the optimum electrode location. In this
study the feasibility of using Neuromuscular Electrical Stimulation (NMES) to locate the
motor points of the Rectus Abdominis (RA) and External Oblique (EO) muscles, along with
the repeatability and uniformity of these motor point positions, was investigated with 10 able
bodied and five tetraplegic participants. The motor points of the RA and EO muscles were
successfully located for all 15 participants. The position of these motor points was found to
change little over time, but was posture dependent and found to vary between participants.
It was also shown that NMES could be used to detect these motor point positions with
an adequate repeatability. Implementation of this motor point detection technique should
indicate the optimum electrode placement for AFES. Application of AFES at these motor
points should help achieve the optimum muscle contraction, which should lead to the greatest
improvement in respiratory function and allow for easier comparison of AFES studies.
5.2 Background
When using electrical stimulation the optimum muscle contraction is observed when
stimulation is applied close to the motor point, the location where the motor branch of a
nerve enters a muscle [51]. Studies have shown that placing the stimulating electrodes at
the motor point maximises force output and minimises discomfort [52, 53]. Despite this,
studies investigating the effectiveness of AFES to improve respiratory function continue to
use a range of empirically derived electrode locations (outlined in Section 2.4.4.3). This lack
of consistency in electrode placement, and hence muscle contraction, makes a comparison of
AFES studies difficult.
While anatomical charts showing the location of the motor points for the limbs have long
been available [155], less information is available about the motor points of the muscles of
the abdominal wall. Bell et al. [156] studied the underlying anatomical structures at the
sites where AFES is usually applied and found that there were significant differences in these
structures between participants. Botter et al. [128] used NMES to identify the position of
the motor points of muscles in the leg and showed that these motor point positions varied
between participants. The location of the motor points of the abdominal muscles, how they
vary between participants and whether they are time and posture dependent has not been
investigated in detail. This information would be useful for optimising the electrode placement
used for AFES.
The aims of this study were i) to assess the feasibility of using NMES to detect the position of
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the motor points of the RA and EO muscles and to assess the repeatability of this technique,
ii) to evaluate the intersubject uniformity of these motor point positions, and iii) to evaluate
how the motor point locations depend on posture and whether they vary over time.
5.3 Methods
5.3.1 Participants
Ten able bodied (five males, five females, age 29.5 ± 7.9 years (mean ± standard deviation)
[range 24 : 40 years]) and five tetraplegic participants (demographics shown in Table 5.1) were
recruited. The tetraplegic participants, who were inpatients at the Queen Elizabeth National
Spinal Injuries Unit, Southern General Hospital, Glasgow, were able to breathe independently,
but had no useful abdominal movement and associated reduced respiratory function. Ethical
approval to conduct the study with the able bodied participants was granted by the University
of Glasgow College of Science and Engineering ethics committee (Local Code: CSE00965),
while for the tetraplegic participants approval was granted by the National Health Service
West of Scotland Research Ethics Committee (Local Code: 13/WS/0002). All procedures
conformed to the Declaration of Helsinki and all participants gave written informed consent.
Table 5.1: Tetraplegic participant demographics showing sex, age, injury level, American
Spinal Injuries Association Impairment Scale (AIS) level (see Section 1.2.3.2) and time post
injury at recruitment.
Participant Sex Age Injury AIS Time post
(years) level level injury (days)
1 M 77 C3/4 C 31
2 M 24 C5/6 A 52
3 M 32 C5 B 46
4 M 20 C5 C 29
5 M 24 C5/6 C 19
5.3.2 Motor Point Detection
A virtual line was taken superiorly from the highest point of the iliac crest (top of the hip
bone) until reaching the costal margin, as shown in Figure 5.1, with this distance used as
the reference measurement in the superior direction (yn). The lateral distance between the
umbilicus and this virtual line was taken as the reference measure in the lateral direction
(xn). Both measurements, performed on the right hand side of the body, were recorded
using a measuring tape and assumed to remain fixed throughout each assessment. They were
used to normalise motor point positions in the corresponding direction to allow intersubject
comparison.
To locate the position of the motor points, a bar electrode (MLADDF30, ADInstruments, New
Zealand), with 9 mm diameter electrode contacts and 3 cm spacing between the contacts,
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Figure 5.1: Diagram of reference and motor point position measurements. A virtual line was
taken superiorly from the highest point of the iliac crest until reaching the costal margin. The
superior length of this line (yn) and its lateral distance from the umbilicus (xn) were used
as reference measurements for motor point positions. Motor point positions were normalised
with respect to these distances. The white arrows illustrate the definition of the superior (y)
and lateral (x) position of a motor point (represented by the white circle). Position of the
iliac crest, costal margin and umbilicus is indicated by blue arrow.
was used. Electrolytic gel was applied to the electrode to enable the effective transfer of
current from the electrode to the skin. To locate the position of the motor points of the EO
muscles the bar electrode was positioned horizontally, slightly below the costal margin. The
stimulation system outlined in Section 3.4.1 was used to apply single biphasic stimulation
pulses, at a frequency of 0.5 Hz and a pulsewidth of 100 µs, to initiate a twitch contraction.
Stimulation current was adjusted on a participant by participant basis (20 to 60 mA for
all participants) until a visible contraction of the muscle was achieved. The bar electrode
was moved horizontally until the strongest muscle contraction was observed. This point of
maximum contraction, determined both visually and from participant feedback, was recorded
as the position of the motor point of the EO muscle. To locate the position of the motor point
of the RA muscle the electrode was positioned vertically, approximately 3 cm horizontal of
the umbilicus, and moved vertically and horizontally until the strongest muscle contraction
was observed. This procedure was performed on both sides of the body, with the order in
which each motor point was identified randomised for each participant. The position of each
motor point was measured superiorly from the highest point of the iliac crest (y) and laterally
from the umbilicus (x), as illustrated in Figure 5.1. This procedure took approximately two
to five minutes. To reduce inter-operator variability the author of this thesis recorded the
motor point positions for all participants. To further reduce experimental variability the
same measuring tape, which had a resolution of approximately 0.25 cm, was used to measure
all motor point positions.
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Able bodied participants were asked to attend one assessment session (A1). Each participant
was asked to sit in an upright position and the landmark measurements and motor point
positions were recorded. Motor point position measurements were repeated after a rest period
of approximately 30 minutes, during which time participants were free to move or walk about
the room. The total duration of A1, summarised in Figure 5.2(a), was approximately one
hour.
(a) Able bodied.
(b) Tetraplegic.
Figure 5.2: Experimental protocol showing periods of anatomical measurements, motor point
recording and rest.
The same motor point detection procedure was used for the tetraplegic participants, but this
was conducted at the participant’s bedside, with participants in a supine position due to
the acute stage of their Spinal Cord Injury (SCI). For these participants the procedure was
repeated after three days, as shown in Figure 5.2(b), due to constraints on participant’s time.
Both measurements are referred to as assessment T1.
Five of the able bodied participants (three males, two females, age 28.8 ± 7.4 years (mean ±
standard deviation) [range 25 to 42 years]) were recalled after an 18 month period and
the same motor point detection procedure performed, with the motor points being detected
twice in both an upright seated (A2) and supine (A3) position. This 18 month period was
chosen due to the realisation at this time of the need for the follow-up experiment, with
only five participants recalled due to participant availability. The assessment procedures are
summarised in Table 5.2.
Table 5.2: Summary of motor point detection assessment procedures for the able bodied and
tetraplegic participants.
Assessment Participant Posture Repeat Time of assessment
A1 Able bodied Seated 30 minutes Baseline
A2 Able bodied Seated 30 minutes 18 months after A1
A3 Able bodied Supine 30 minutes 18 months after A1
T1 Tetraplegic Supine 3 days Baseline
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5.3.3 Analysis and Outcome Measures
Motor point positions were analysed in the x direction as follows, equivalent calculations
apply to motor point positions in the y direction. The absolute motor point position within
an assessment session, measured in centimeters (cm), was calculated as the mean (x¯i) of the
two measurements recorded at each assessment session from each (i) participant (xi1, x
i
2). The
absolute motor point position was also normalised by the corresponding landmark distance
xni (see Section 5.3.2), providing the mean normalised motor point position, x¯in, measured
as a percentage of the corresponding landmark distance.
x¯i =
xi1 + x
i
2
2
(5.1)
x¯in =
x¯i
xni
(5.2)
The standard deviation of the absolute difference between the two measurements within each
assessment session for each participant was also calculated.
sx =
√√√√ 1
N
N∑
i=1
(xi1 − xi2)2 (5.3)
(Note: 1/N is used to calculate sx as real difference between these measurements is assumed
to be zero).
The mean (X¯) and standard deviation (sX) of the motor point positions recorded at each
assessment session for the N participants was calculated. This measurement is reported in
absolute, measured in cm, and normalised (denoted by subscript n), measured as a percentage
of the corresponding landmark distance, terms. A Student’s independent t-test was used to
test for a statistically significant difference (p-value less than 0.05) in the group motor point
positions recorded at A1 and T1.
X¯ =
1
N
N∑
i=1
x¯i (5.4)
X¯n =
1
N
N∑
i=1
x¯in (5.5)
sX =
√√√√ 1
N − 1
N∑
i=1
(x¯i − X¯)2 (5.6)
sXn =
√√√√ 1
N − 1
N∑
i=1
(x¯in − X¯n)2 (5.7)
The standard deviation of the normalised measurements, sXn , represents the intersubject
uniformity of the motor point positions.
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Assuming the real difference between a repeated measurement, taken from the same
participant, is zero, the coefficient of repeatability (CoR) provides a range within which
95 percent of test-retest measurements will lie [157]. CoR was calculated to assess the
repeatability of the two measurements recorded within the same assessment session (A) and
is measured in cm.
CoR(A) = 1.96×sx (5.8)
CoR was also calculated to compare the motor point positions recorded at two different
assessment sessions.
CoR(A1, A2) = 1.96×
√√√√ 1
N
N∑
i=1
(x¯iA1 − x¯iA2)2 [cm] (5.9)
To assess the repeatability of using NMES to detect motor point position, the mean of the
CoR calculated for the two motor point positions recorded from each participant at A1, A2,
A3 and T1, using Equation 5.8, was used.
CoR =
1
4
(CoR(A1) + CoR(A2) + CoR(A3) + CoR(T1)) (5.10)
To evaluate the time and posture dependence of the motor point positions, Equation 5.9 was
used to calculate the CoR for the motor point positions recorded at sessions (A1,A2) and
(A2,A3).
5.4 Results
The mean of the reference measurements, yn and xn, recorded at the various assessment
sessions are shown in Table 5.3.
The normalised locations of the motor points of the RA and EO muscles recorded at A1 and
T1 are shown in Figure 5.3. Figure 5.3(a) depicts the motor points for each participant (taken
as the mean of the two repeat measurements within each assessment session). Figure 5.3(b)
shows the normalised motor point positions for each muscle, grouped by assessment session.
While the median motor point positions of the EO muscles are in approximately the same
normalised position for both the able bodied and tetraplegic participants, the range of the
positions when measured superiorly from the iliac crest line was relatively large. For the RA
muscles, the motor point positions for the two participant groups are different in both the
lateral and superior directions. Also shown are the normalised locations of the umbilicus in
the superior direction, which indicates that these also differ between both groups.
The mean (± standard deviation) motor point positions recorded at A1 and T1 are shown in
Table 5.4 as both absolute and normalised measurements. It can be seen that the absolute
motor point positions recorded at T1 were all statistically significantly different to the motor
point positions recorded at A1 when measured from the iliac crest (Y¯ ). However, when these
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Table 5.3: Mean (± standard deviation) and range of reference measurements recorded in
the vertical yn and horizontal direction xn for the 10 able bodied participants who took part
in A1 and the five tetraplegic participants who took part in T1. Also shown is the mean (±
standard deviation) of the reference measurements of the five able bodied participants who
were recalled for a second assessment session, recorded at A1 and A2/3.
Assessment Number of Measurement Mean±std Range
Participants (cm) (cm)
A1 10 yn 11.1 ± 2.3 9− 16.5
xn 18.0 ± 2.2 14− 20
T1 5 yn 14.6 ± 4.7 12− 23
xn 17.1 ± 2.3 13.5− 20
A1 5 yn 10.6 ± 0.5 10− 11
xn 18.2 ± 2.4 14− 20
A2/3 5 yn 10.4 ± 0.5 10− 11
xn 17.7 ± 2.4 13.5− 19
measurements were normalised to allow for more effective comparison between groups, Y¯n,
only the motor points of the RA muscles were in a statistically significantly different position
at T1 compared to A1. These motor points were found to be statistically significantly closer
to the costal margin. The uniformity of these motor point positions, the standard deviation
of the normalised positions, was found to range from 2.8 to 8.8 percent.
Table 5.4: Mean position and standard deviation (intersubject uniformity) of the position
of the Rectus Abdominis (RA) and External Oblique (EO) motor points for assessment A1
(10 able bodied participants) and T1 (five tetraplegic participants). Results are expressed
as absolute distances measured superiorly from the iliac crest (Y¯ ) and laterally from
the umbilicus (X¯), and corresponding normalised distances with respect to the reference
measurements (Y¯n and X¯n), ± standard deviations s. ∗ indicates mean of T1 is statistically
significantly different to mean of A1.
Ass. Muscle Y¯ ± sY X¯ ± sX Y¯n ± sYn X¯n ± sXn
[cm] [cm] [%] [%]
A1 RA–Right 6.2 ± 1.1 4.3 ± 0.7 55.8 ± 6.1 24.1 ± 4.0
RA–Left 6.2 ± 1.3 4.0 ± 0.7 55.8 ± 4.4 22.3 ± 2.8
EO–Right 9.2 ± 1.4 15.6 ± 2.1 83.9 ± 8.8 86.9 ± 7.8
EO–Left 9.1 ± 1.7 15.6 ± 2.3 82.3 ± 7.3 86.7 ± 6.3
T1 RA–Right 9.9 ± 4.3∗ 4.8 ± 0.5 66.0 ± 5.8∗ 28.0 ± 2.5
RA–Left 9.8 ± 4.5∗ 4.8 ± 0.6 65.4 ± 7.1∗ 28.1 ± 4.1∗
EO–Right 12.6 ± 4.3∗ 14.7 ± 1.3 85.7 ± 4.0 86.2 ± 5.8
EO–Left 13.0 ± 5.0∗ 14.8 ± 1.6 87.7 ± 6.3 86.9 ± 3.9
The mean (± standard deviation) motor point positions recorded from the five participants
who took part in A1, A2 and A3 are shown in Table 5.4 as both absolute and normalised
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(a) Normalised individual motor point positions recorded at A1 (black ×) and T1 (blue o). Also shown
are the landmarks for the reference measurements (top of the iliac crest (purple ∗), corresponding point
on the costal margin (purple +)).
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(b) Group motor point positions (median and inter-quartile ranges), recorded at A1 (black) and T1
(blue), normalised with respect to the vertical distance from the Iliac Crest (IC) to the Costal Margin
(CM) and the horizontal distance from the Umbilicus (UM) to the Iliac Crest.
Figure 5.3: Individual and group motor point position of the external oblique (outer left
and right) and rectus abdominis (inner left and right) muscles of 10 able bodied (assessment
A1, black symbols) and five tetraplegic (assessment T1, blue symbols) participants, with the
position of the umbilicus shown on the midline. Motor point positions are normalised to the
reference measurements shown in Figure 5.1.
measurements. It can be seen that the motor point positions recorded 18 months apart at A1
and A2 were very similar, with only the normalised position of the right EO muscle, when
measured from the umbilicus (X¯n), being found to be statistically significantly different.
However, when comparing the motor point position in an upright (A2) and supine position
(A3) the absolute position of the motor points of the RA muscle on both sides of the body,
and the EO muscle on the left side of the body, when measured from the iliac crest (Y¯ )
were found to be statistically significantly different. Although the normalised motor point
CHAPTER 5. MOTOR POINT DETECTION 103
positions of the RA were closer to the costal margin at A3 compared to A2 (i.e. a larger value
of Y¯n) none of the normalised motor point positions were found to be statistically significantly
different.
Table 5.5: Mean position and standard deviation of the position of the Rectus Abdominis
(RA) and External Oblique (EO) motor points for assessment A1 (five able bodied
participants) and A2 (18 months later) and A3 (supine). Results are expressed as absolute
distances measured superiorly from the iliac crest (Y¯ ) and laterally from the umbilicus (X¯),
and corresponding normalised distances with respect to the reference measurements (Y¯n and
X¯n), ± standard deviations s. ∗ indicates mean of A2 is statistically significantly different to
mean of A1, † indicates mean of A3 is statistically significantly different to mean of A2.
Ass. Muscle Y¯ ± sY X¯ ± sX Y¯n ± sYn X¯n ± sXn
[cm] [cm] [%] [%]
A1 RA–Right 6.0 ± 0.8 4.0 ± 0.7 56.1 ± 6.8 22.6 ± 5.1
RA–Left 5.7 ± 0.4 4.1 ± 0.8 54.0 ± 2.2 22.4 ± 3.2
EO–Right 9.1 ± 0.9 15.0 ± 2.2 85.6 ± 8.4 82.2 ± 4.8
EO–Left 9.0 ± 0.9 15.4 ± 2.5 84.3 ± 5.9 84.5 ± 6.5
A2 RA–Right 6.1 ± 0.7 3.8 ± 0.4 58.2 ± 6.8 21.7 ± 3.1
RA–Left 5.8 ± 0.5 3.9 ± 0.6 55.3 ± 3.9 21.9 ± 2.8
EO–Right 8.8 ± 0.6 15.6 ± 2.0 84.4 ± 8.2 88.2 ± 1.3∗
EO–Left 8.6 ± 0.3 15.6 ± 1.8 82.4 ± 4.8 88.2 ± 5.3
A3 RA–Right 7.1 ± 0.7† 4.3 ± 0.7 61.4 ± 7.1 24.8 ± 3.0
RA–Left 6.9 ± 0.6† 3.7 ± 0.5 59.4 ± 7.3 21.7 ± 3.1
EO–Right 9.0 ± 0.3 15.4 ± 1.8 77.4 ± 4.6 89.3 ± 1.5
EO–Left 9.0 ± 0.2† 15.1 ± 1.8 77.9 ± 4.7 87.6 ± 1.5
Table 5.6 shows the mean CoR between the two measurements of motor point position
recorded at all assessments (A1, T1, A2 and A3, CoR) which provides a measure of
the repeatability of the measurement technique. The repeatability of the motor point
position over time was assessed by comparing motor point positions at assessments A1
and A2 (CoR(A1, A2)), which were performed 18 months apart, while the coefficient of
repeatability between assessment A2 (seated) and A3 (supine) shows the influence of posture
(CoR(A2, A3)) on motor point position. From CoR it can be concluded that 95% of test-retest
measurement differences would be less than 1.7 cm, with a similar CoR even after an 18 month
period (CoR(A1, A2)). The CoR is greater if tests are performed with different postures
(CoR(A2, A3)), indicating a dependence of motor point position on posture in particular for
the RA muscle when measured in the superior direction (y).
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Table 5.6: Mean coefficient of repeatability (CoR) of the position of the motor points
of the Rectus Abdominis (RA) and External Oblique (EO) muscles recorded 30 minutes
apart for: 10 able bodied participants in seated position (A1); five able bodied participants
after 18 months in seated position (A2); five able bodied participants after 18 months in
supine position (A3) and three days apart for five tetraplegic participants in supine position
(T1). Also shown is the mean CoR of the motor point positions recorded 18 months apart
(CoR(A1, A2)) and in a seated and supine position (CoR(A2, A3)). Results are expressed
as absolute distances measured superiorly from the iliac crest (y) and laterally from the
umbilicus (x).
CoR CoR(A1, A2) CoR(A2, A3)
Muscle y x y x y x
[cm] [cm] [cm] [cm] [cm] [cm]
RA–Right 1.2 0.9 0.9 1.3 3.1 1.5
RA–Left 0.9 0.8 0.7 0.9 2.3 1.1
EO–Right 1.0 1.6 1.3 1.5 1.5 1.4
EO–Left 1.3 1.6 1.5 1.6 1.0 1.9
5.5 Discussion
In this chapter the feasibility of using NMES to detect the position of the motor points of
the RA and EO muscles was demonstrated for the first time. Using a simple and quick
procedure, these motor points were detected successfully in all 10 able bodied and five
tetraplegic participants. A range of intersubject uniformities and an adequate intrasubject
repeatability was demonstrated for these motor point positions when recorded at the same
assessment session and after 18 months. Variations in posture resulted in a change of the
position of the motor points of the RA muscle.
The results of this study suggest that the use of NMES can be easily adopted to reliably detect
the position of the motor points of the abdominal muscles. As the abdominal muscles are
often not included in standard motor point charts [155], and due to the adequate repeatability
found here, it is suggested that this technique should be adopted as standard procedure for
all future AFES studies.
5.5.1 Motor Point Position
When analysing the position of the motor points of muscles in the leg Botter et al. [128]
developed criteria that allowed values of uniformity to be classed as ‘good’, ‘fair’ or ‘bad’.
It was found that when classifying the intersubject uniformity of the motor point position
measurements recorded at assessments A1 and T1 (see sXn and sYn in Table 5.4), three were
‘good’, six were ‘fair’ and seven were ‘bad’. However, it should be noted that uniformity
depends on how normalisation is performed. Botter et al. based their uniformity calculations
on normalising the muscles by their estimated lengths, while in this study the locations are
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normalised by anatomical reference measurements. Additionally, Botter et al. had a sample
size of 53 participants, compared to the two groups of five tetraplegic and 10 able bodied
participants in this study. This lower sample size inherently leads to a greater standard
deviation and poorer uniformity. Nevertheless, the range of intersubject uniformity observed
here suggests that the use of standard motor point locations may not be suitable for detecting
the exact location of the motor points of the abdominal muscles, agreeing with the finding
of Botter et al. for the muscles of the leg.
Bland and Altman [157] suggest the CoR as a technique to assess the test-retest repeatability
of a method with a 95 percent confidence. In this study the largest CoR between the motor
point positions recorded at A1, A2, A3 and T1 was 1.6 cm for the EO muscles and 1.2 cm
for the RA muscles. This indicates that if the motor points of these muscles were to be
detected twice, on 95 percent of occasions the difference between these measurements would
be 1.6 cm or less. During the two measurements no restrictions were placed on participant
movement, indicating that NMES can be used to detect the position of the motor points with
good repeatability, even after time and activity.
When the positions of the motor points were detected 18 months apart the largest CoR was
also 1.6 cm, indicating that the positions of the motor points remain relative constant over
time. The electrodes typically used for AFES studies are approximately 5 cm long with a
space of approximately 3 cm between the electrodes [71, 72]. This means that the CoR would
fall within this electrode area and suggests that use of the motor point detection technique
outlined here to locate the position of the motor points once for each individual, at the start
of a course of AFES, would be adequate.
Placement of the stimulating electrodes at the motor points appeared to lead to a more
effective muscle contraction compared to when using empirically derived electrode locations.
The effect of this should be twofold. Firstly, this should lead to a greater benefit from
using AFES which may, in turn, lead to a greater improvement in the respiratory function
of the user and improve their quality of life. Secondly, it should ensure a consistent muscle
contraction across AFES studies, making a comparison of such studies easier.
The motor points of the tetraplegic participants were detected in a supine position due to
the acute stage of their SCI. For these participants the motor points of the RA muscle, when
measured vertically from the iliac crest, were statistically significantly closer to the costal
margin than for the able bodied participants (see Y¯n for RA in Table 5.4). This posture
dependance of motor point position was further highlighted when the motor points of five
of the able bodied participants were detected in both an upright and supine position. In
these tests the absolute position of the motor points of the RA muscle were found to be
statistically significantly (greater than 1 cm) closer to the costal margin in a supine position.
Additionally, while the normalised positions were not statistically significantly different, they
CHAPTER 5. MOTOR POINT DETECTION 106
were again closer to the costal margin in a supine position. The CoR between motor point
positions detected in an upright and supine position was also found to be as large as 3.1 cm.
This suggests that motor point positions are posture dependant and should be re-identified
if posture changes occur.
5.5.2 Impact of Findings
The detection of the motor points of the abdominal muscles may be useful in the development
of an AFES garment, which houses electrodes at a fixed location for a particular user. This
garment could take the form of a belt with an array of buttons or velcro, with electrodes
attached to the garment at the appropriate location to stimulate the motor points, detected
using the technique outlined here. Such a garment would ensure that stimulation was
applied at the same location at different training sessions, reducing intersession variability.
The incorporation of a garment into an automatic AFES device, such as that discussed in
Section 8.5, would further increase the usefulness of an AFES system.
Dyskinesia, a movement disorder causing involuntary muscle movements, has been reported
to affect the abdominal muscles [158, 159, 160]. The application of Botulinum toxin A
(BoTN-A) to a nerve to prevent it from functioning, known as nerve blocking, has been
used to treat dyskinesia [161]. For effective nerve blocking BoTN-A should be applied at
the motor point [162]. The detection of the motor points of the abdominal muscles using
the methods outlined here may aid in the application of BoTN-A for treating dyskinesia
and other movement disorders that cause spasm of the abdominal wall. Studies have shown
that the use of NMES to train the abdominal muscles of able bodied participants can lead to
improved muscle strength, endurance and appearance [163, 164]. This method of motor point
detection may be beneficial to select the optimum electrode placement when using NMES for
this use.
Anatomical investigations of the abdominal muscles [156] suggest that the RA and EO muscles
have more than one motor point. In this study, the focus was to detect the location where the
strongest contraction was observed. For two of the able bodied participants there appeared
to be a second motor point of the RA muscle, located just below the costal margin. This
motor point was not present in all participants, or could not be as easily detected as the
other motor point positions reported here. One reason for this difficulty of detection may
be that this motor point is located deeper than the other motor points. It is also possible
that this motor point belonged to another muscle group, situated in close proximity to the
RA muscle. While Langbein et al. [71] used an electrode position that may have stimulated
this ‘second’ motor point of the RA muscle (see Figure 2.1(e)), the difficulty of detection
found here suggests that the application of AFES at this point would not achieve an effective
muscle contraction. The position of the motor points of the EO muscle reported here were
the only motor points of this muscle detected.
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5.5.3 Limitations
A potential limitation of this study was the accuracy with which the motor point positions
could be measured. By using a traditional measuring tape the resolution was approximately
0.25 cm. This resolution may account for some of the CoR and uniformity values that were
observed. One solution to this problem would be to use position markers in combination with
an accurate position measurement system to measure the motor point positions. However,
these devices tend to be large, making them impractical in an acute care setting. Additionally,
the author measured all motor point positions to reduce inter-operator variability. To evaluate
this inter-operator variability a second operator could have been used to detect all motor point
positions. Finally, previous motor point detection studies have used a pen electrode to apply
stimulation [52, 128]. In this study a bar electrode, which spreads stimulation over a larger
surface area, was used to minimise user discomfort. This larger electrode size may have led
to it being more difficult to accurately locate the position of a motor point. The low CoR
observed in this study suggests that neither of these measurement inaccuracies had a major
influence on accurately locating the position of the motor points.
5.6 Conclusion
This study has demonstrated for the first time the feasibility of using NMES to reliably
detect the position of the motor points of the abdominal muscles in both the able bodied and
tetraplegic population. While the position of the motor points of the RA and EO muscles
change little over time, they were found to be posture dependent, and variations were observed
between participants. The motor point detection procedure described in this study should
enable the optimum AFES electrode location for each user to be identified, which if adopted
as a standard technique for all AFES studies, would allow easier comparison of studies.
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Chapter 6
Abdominal FES to Assist
Ventilator Weaning in Tetraplegia
“Money does not represent such a value as men have placed upon it. All my money has been
invested into experiments with which I have made new discoveries enabling mankind to have
a little easier life.”
Nikola Tesla
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6.1 Summary
Paralysis of the respiratory muscles, resulting from tetraplegia, leads to reduced respiratory
function. This reduction in respiratory function causes many people with tetraplegia to
require mechanical ventilation in the acute stage of injury. In a single participant case
study documented in this chapter, the use of an Abdominal Functional Electrical Stimulation
(AFES) training program was found to be a feasible technique to assist ventilator weaning
with one chronic ventilator dependent tetraplegic participant. This study was the motivation
for investigating the use of an AFES training program to assist ventilator weaning for the
acute tetraplegic population in a larger clinical study. In this study the feasibility of using an
AFES training program to improve respiratory function and assist weaning from mechanical
ventilation was investigated with 10 acute ventilator dependant tetraplegics. Each participant
was matched with a retrospective ventilator dependent control, based on injury level, age
and sex, who had received no intervention. AFES was applied five times per week, on
four alternate weeks, for between 20 and 40 minutes per day. Vital Capacity (VC) and
Tidal Volume (VT ) were measured at weekly assessment sessions, with weaning progress
also recorded and compared to the retrospective controls. The application of AFES was
associated with an acute increase in VT and VC . VT and VC increased throughout the study.
Participants who received AFES training were found to wean from mechanical ventilation on
average 11 days faster than their matched controls. The results of this study indicate that
AFES is a feasible technique for improving the respiratory function of ventilator dependent
acute tetraplegics, and that this technique may enable faster weaning from mechanical
ventilation.
6.2 Introductory Case Study
A Spinal Cord Injury (SCI) can be classified by three distinct phases of recovery from
injury, namely the acute, sub-acute and chronic phase. Acute SCI generally refers to the
immediate post-injury period when there is continuing tissue damage and the patient is in
spinal shock. This phase generally lasts for up to four weeks [19]. While the spinal cord
undergoes a reparative process and there is continuing neurological recovery an SCI can be
classified as sub-acute, with this phase typically beginning around four weeks after injury
and continuing for three months. When neurological recovery has reached a plateau an
SCI can be classified as chronic, which typically occurs approximately three months after
injury [20]. Respiratory failure leads to some patients with tetraplegia requiring mechanical
ventilation in the acute stage of injury. This respiratory failure is commonly caused by
paralysis or severe impairment of the respiratory muscles, the neurological level of SCI
ascending one or two levels because of bleeding or swelling in the area of the trauma (reducing
function of respiratory muscles not originally affected by the SCI) and subsequent respiratory
complications [47]. This use of mechanical ventilation reduces the patient’s quality of life and
costs the health care provider approximately an additional £1000 per ventilated day [27, 46].
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While most of these patients will wean from mechanical ventilation within a number of weeks
people with chronic tetraplegia who retain some diaphragm function can fail to wean from
mechanical ventilation for a number of reasons, most notably as a result of frequent respiratory
infections and complications [47, 122]. These patients continue to suffer a decrease in quality
of life and an increased susceptibility to respiratory infections while reliant on mechanical
ventilation [27, 84]. Therefore, a reduction in time spent dependent on mechanical ventilation
will have benefits for both the patient and the health care provider.
A study by Lee et al. [122] demonstrated that an AFES training program could be used to
assist ventilator weaning, the process of removing a patient from mechanical ventilation, for a
ventilator dependent chronic tetraplegic patient who retained some diaphragm function (see
Section 2.4.4.2). However, no larger studies investigating the effectiveness of AFES to assist
ventilator weaning for patients who retain some diaphragm function have been conducted1.
Before conducting a larger study investigating the effectiveness of AFES to assist ventilator
weaning at the Queen Elizabeth National Spinal Injuries Unit (QENSIU), the feasibility of
conducting such a study with the tetraplegic population had to be determined.
In Chapter 4 the use of a respiratory effort belt positioned around the chest to automatically
detect and classify respiratory activity was demonstrated. Clinically, this technology would
allow AFES to be applied in synchrony with the user’s respiratory activity, reducing reliance
on a trained operator. In Chapter 5 the use of Neuromuscular Electrical Stimulation (NMES)
to detect the abdominal muscle motor points of able bodied and tetraplegic patients was also
demonstrated. By placing AFES at the motor points found using this technique the optimum
muscle contraction should be achieved. It is hypothesised that this will lead to the greatest
improvement in respiratory function. However, the suitability of these two methods for
use with the ventilator dependent tetraplegic population required to be tested before being
implemented in any larger study.
The three aims of this case study were to assess the feasibility of using i) an AFES training
program to assist ventilator weaning for the tetraplegic population, ii) a respiratory effort belt
to automatically apply stimulation in synchrony with the respiratory activity of tetraplegic
patients and iii) NMES to detect the motor points of the abdominal muscles of ventilator
dependent tetraplegic patients.
6.2.1 Methods
One chronic tetraplegic participant (female, age 76 years, C5, AIS A, 13 weeks post injury),
who was an inpatient at the QENSIU and had difficulty weaning from mechanical ventilation,
despite retaining some diaphragm function, was recruited for this study. Due to the need
for mechanical ventilation the participant had a tracheostomy, which was present throughout
1Patients who do not retain diaphragm function will not be able to breathe independently of mechanical
ventilation or diaphragm pacing
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the study duration.
Five times weekly training sessions, used to strengthen the abdominal muscles, were
performed for 20 minutes per day for three weeks. AFES was applied using the system
described in Section 3.4.1. During training sessions stimulation was applied in synchrony
with the participant’s respiratory activity using the signal from the respiratory effort belt
positioned around the abdomen (automatic stimulation methods are explained in more detail
in Section 3.4.3). The rectus abdominis and external oblique muscles were stimulated using
electrodes positioned at the motor points of these muscles, found using the protocol outlined in
Chapter 5. A stimulation current of 100 mA was used to achieve a visible muscle contraction
at all training sessions. Stimulation pulsewidth was varied between 100 and 500 µs within
each session to account for muscle fatigue. Where possible, training sessions were performed
while the participant was disconnected from mechanical ventilation, with the participant
reconnected to mechanical ventilation during the session if their oxygen saturation level
decreased below 92 percent. If the participant could not be disconnected from mechanical
ventilation, as was the case at the first three sessions and at the fourth and fifth training
sessions in week two, training was performed while the participant remained connected to
mechanical ventilation throughout.
The participant’s VC was measured at the first and final training session by disconnecting
the participant from mechanical ventilation and asking them to inhale as deeply as possible
and exhale fully. No verbal encouragement was provided during the exhalation. The
maximum value of three successful attempts, judged to be such using the protocol described
in Section 3.2, which lay within 0.15 L/s of another attempt was taken to be the participant’s
VC . This measurement was made using a standard medical spirometer (Wright Respirometer,
Ferraris Development and Engineering Company Limited, London, United Kingdom) which
was attached to the participant’s tracheostomy tube. While this is a rudimental way
of recording VC , only the feasibility of measuring the respiratory function of ventilator
dependent tetraplegic patients, rather than the effect of this technique on respiratory function,
was assessed within this study.
The daily time spent breathing without the support of mechanical ventilation was used to
give a primitive indication as to the effectiveness of the intervention.
6.2.2 Results
The training session on day four of week two of AFES training was missed due to the patient
being unwell, resulting in a compliance rate to training sessions of 93 percent. The participant
had spent 14 weeks without being able to breathe independently of mechanical ventilation
before AFES training commenced. Figure 6.1 shows the daily time spent breathing without
mechanical ventilation during the AFES training period.
After three days of AFES training the participant was able to breathe independently of
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Figure 6.1: Time spent per day breathing without mechanical ventilation for one chronic
tetraplegic participant during a three week AFES training program. Solid black line along
bottom of plot indicates AFES training period.
mechanical ventilation for the first time. The participant being unwell during the middle
part of week two of participation (15 weeks after ventilation) resulted in them not spending
any time breathing without the assistance of mechanical ventilation for three days. Despite
this, the time spent breathing independently of mechanical ventilation increased from zero
hours per day to one a half hours per day during the AFES training period. Importantly, on
the final day of the second week of the study this one and a half hours was achieved in three
separate 30 minute sessions, while in the final week of the study this one and a half hours was
achieved in one session. The participant’s VC was 60 mL before the AFES training period
and 160 mL after, indicating that AFES training may be improving respiratory function.
6.2.3 Discussion
People with chronic tetraplegia who retain some diaphragm function can fail to wean from
mechanical ventilation for a number of reasons, most notably as a result of frequent respiratory
infections and complications [47, 122]. The aim of this case study was to evaluate the
feasibility and effectiveness of using an AFES training program to assist ventilator weaning
for the chronic tetraplegic population who retain some diaphragm function. The feasibility
of this intervention was demonstrated by the adequate muscle contraction observed in this
case study and the 93 percent compliance to the training sessions achieved. The results show
that time spent breathing independently of ventilation and VC increased during the AFES
training period. This suggests that AFES training can be used to assist chronic tetraplegic
patients to wean from mechanical ventilation, agreeing with the findings of Lee et al. [122].
While the participant was only able to achieve 90 minutes of ventilator free breathing during
the study duration, this had some significant effects on the participant’s quality of life.
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Firstly, the ability to breathe independently of mechanical ventilation removed some of
the participant’s fear of disconnection from mechanical ventilation, a common problem for
ventilator dependant tetraplegics [97]. Breathing independently of ventilation also improved
the participant’s feeling of wellbeing and made their transfer from a supine position to
a wheelchair easier. All of these factors combined to give the participant a perceived
improvement in quality of life.
This case study also provided the opportunity to test some of the technology developed in the
previous two chapters of this thesis in a clinical setting. In Chapter 4 the use of a respiratory
effort belt positioned around the chest was shown to be suitable for detecting and classifying
respiratory activity. In this case study no classification of respiratory activity was made as it
was assumed the participant would only be taking quiet breaths and not coughing. However,
it was initially assumed that the signal from a respiratory effort belt positioned around the
chest would allow AFES to be applied in synchrony with the respiratory activity of the
participant. By conducting this study it was found that the respiratory effort belt used
to measure respiratory activity had to be placed around the abdomen. This was because
many tetraplegics require a halo or back brace to stabilise their SCI, limiting access to their
chest. It was established that the signal from a respiratory effort belt positioned around the
abdomen could be used to apply AFES in synchrony with the patient’s respiratory activity. In
Chapter 5 the use of NMES to detect the abdominal muscle motor points was demonstrated
with 10 able bodied and five tetraplegic participants. In this case study the use of NMES to
detect the motor points of ventilator dependent tetraplegic participants was also shown to
be feasible.
To confirm the effectiveness of AFES to improve respiratory function and assist ventilator
weaning for chronic tetraplegic participants who retain some diaphragm function a random-
ised clinical study is required, with the weaning progress of the intervention group compared
to that of a control group who did not receive AFES training. However, due to the small
number of chronic tetraplegic participants who retain diaphragm function but have difficulty
weaning from mechanical ventilation at the QENSIU (one or two per year) it was not possible
to conduct such a study within this thesis. A multicentre study may enable the recruitment
of a sufficient number of participants to evaluate the effectiveness of this intervention.
However, this case study does demonstrate that AFES can feasibly be used to assist ventilator
weaning for the ventilator dependent tetraplegic population.
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Clinical Study
6.3 Background
Poor respiratory function often leads to people with tetraplegia requiring mechanical
ventilation during the acute stage of injury (see Section 2.3.1). Reliance on mechanical
ventilation reduces a patient’s quality of life, leaves them more susceptible to respiratory
infection and places a cost burden on the local health care provider [27, 46]. An improvement
in respiratory function that leads to a reduction in time spent dependant on mechanical
ventilation will have significant benefits.
The use of AFES has been shown to improve the respiratory function of people with chronic
(greater than three months post injury) and sub-acute (between four weeks and three
months post injury) tetraplegia. The acute effect of AFES, the immediate improvement
in respiratory function achieved by applying stimulation, has been observed in a number of
studies (see Section 2.4.4.1). Langbein et al. [71] found that the application of AFES led
to a mean 13 percent increase in the Forced Vital Capacity (FVC) of 10 spinal cord injured
participants. This increase in FVC was slightly less than the 17 percent increase observed
by Lee et al. [122] with one chronic tetraplegic participant. Gollee et al. [72] found that
the application of AFES led to an increase in Tidal Volume (VT ) of between nine and 71
percent for four chronic tetraplegic participants. Kandare et al. [123] used AFES to support
ventilation in three chronic tetraplegic participants who had no respiratory drive and were
unable to breathe independently. However, they found that the VT generated with AFES was
approximately 25 percent less than that generated with the support of mechanical ventilation.
Additionally, the repeated application of AFES, known as AFES training, has been shown
to lead to a longitudinal increase in respiratory function. McBain et al. [73] found a mean
longitudinal increase in VC of 20 percent after a six week AFES training program with 15
chronic tetraplegic participants, while McLachlan et al. [70] found FVC to increase by a
mean of 0.36 L after a three week AFES training program with 12 sub-acute and chronic
tetraplegic participants. Therefore, these studies indicate that AFES can be used to improve
the respiratory function of chronic and sub-acute tetraplegic participants.
A study by Lee et al. [122] demonstrated that an AFES training program could be used
to improve respiratory function and assist ventilator weaning for a ventilator dependent
chronic tetraplegic patient who retained some diaphragm function (see Section 2.4.4.2). The
feasibility of conducting a clinical study using this method at the QENSIU was demonstrated
by the case study outlined above. For tetraplegic patients who require mechanical ventilation
in the acute stage of injury, the need for mechanical ventilation reduces quality of life and
has a cost implication for the health care provider. Additionally, both the acute stage of
tetraplegia and the need for mechanical ventilation are associated with a high susceptibility
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to respiratory complications (see Section2.4), largely attributed to poor respiratory function.
Therefore, an early intervention that improves respiratory function would not only reduce
this patient groups susceptibility to respiratory complications, it would also improve quality
of life and reduce the cost to the health care provider. Routsi et al. [125] applied FES
to the leg muscles of acute ventilator dependant patients, hypothesising that FES could
beneficially improve muscle functional status. They found that in addition to improving
muscle function, FES training led to these patients weaning from mechanical ventilation
statistically significantly faster than patients who did not receive FES. In this chapter the
use of AFES to improve respiratory function and assist ventilator weaning for the acute (less
than four weeks post injury) ventilator dependent tetraplegic population is investigated.
To evaluate the effectiveness of this intervention it is necessary to estimate when weaning
has occurred and the time to wean if the intervention had not been applied. Current
understanding is that injury level, age and sex are the best indicators of weaning time for
this patient group, with weaning being deemed to be successful after a period of 24 hours or
seven days of ventilator free breathing (see Section 2.3.1).
The aim of this study was to evaluate the feasibility and effectiveness of using an AFES
training program to improve respiratory function and assist ventilator weaning in acute
tetraplegia.
6.4 Methods
Ten tetraplegic participants, who were inpatients on the high dependency ward of the
QENSIU, were recruited for this study. The study was approved by the National Health
Service Scotland A research ethics committee (Local Code: 11/SS/0098). Patients were
unable to give written informed consent due to high levels of sedation needed in the
early stages of mechanical ventilation. Written informed consent was obtained from each
participant’s welfare guardian. Consent was later sought from the participant if they were
deemed to have regained capacity within the study duration. All experimental procedures
conformed to the Declaration of Helsinki.
Participants were recruited according to the following inclusion and exclusion criteria.
Inclusion criteria:
1. Men or women over 16 years of age;
2. Acute tetraplegia (patients less than four weeks post injury);
3. Reduced respiratory function requiring mechanical ventilation;
4. Good visual response to surface electrical stimulation of the abdominal muscles,
suggesting that lower motor neurons are intact.
Exclusion criteria:
1. Under 16 years of age;
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2. Female participants who are pregnant;
3. Significant history of autonomic dysreflexia;
4. No visual response to surface electrical stimulation of the abdominal muscles, suggesting
that lower motor neurons are not intact;
5. Unstable chest or abdominal injury;
6. Bulbar dysfunction.
Participants were recruited for this study by consultants at the QENSIU, based on the
inclusion and exclusion criteria provided above. However, the ultimate decision for inclusion
was based on the clinical judgement of the consultant.
All participants in this study had a tracheostomy tube fitted to allow mechanical ventilation
to be applied via the trachea. This tracheostomy tube was removed within one week of
weaning from mechanical ventilation for all participants.
Each participant was matched with a retrospective control participant, obtained from records
of previous patients at the QENSIU, based on injury level, age (within five years) and sex.
Each of these control participants required mechanical ventilation in the acute stage of injury.
All matching of intervention and control participants was performed by a consultant at the
QENSIU, based on the criteria outlined above. However, due to the relatively small number
of retrospective controls available at the QENSIU, a limited number of suitable controls were
available to the consultants. Therefore, matching was based on the clinical judgement of the
consultant, with the author not made aware of the detailed process.
The daily time that each of these participants spent breathing without the support of
mechanical ventilation, along with the point at which they weaned from mechanical
ventilation, was retrieved from their patient notes by a consultant at the QENSIU.
This allowed a comparison of the time to wean from mechanical ventilation between the
intervention and control participants. The demographics of both the intervention and control
participants are shown in Table 6.1. It should be noted that Participant 5 was a non-responder
to electrical stimulation, whereby the applications of AFES achieved no muscle contraction.
Therefore this participant did not complete the study and as such no control participant was
sought for Participant 5.
6.4.1 Protocol
Each participant took part in AFES training sessions five times per week, on four alternate
weeks, with the total duration of participation eight weeks. The participant’s progress was
monitored at weekly assessment sessions. An effort was made to perform all procedures at
the same time of day and all procedures were performed at the participant’s bedside with
the participant in a supine position.
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Table 6.1: Intervention and control participant (part’) demographics showing sex, age, injury
level, American Spinal Injuries Association Impairment Scale (AIS) level (see Section 1.2.3.2),
weight and time post injury at recruitment.
Intervention Control
Part’ Sex Age Injury AIS Weight Time Post Sex Age Injury AIS
level level injury level level
(years) (kg) (days) (years)
1 F 42 C4 A 50 20 M 34 C5 A
2 M 63 C3/4 A 70 39 M 63 C3 C
3 M 38 C4 C 78 24 M 35 C5 A
4 M 53 C4 B 81 29 F 58 C4 A
5 M 44 C0/5 A 90 24 - - - -
6 M 77 C3/4 C 76 10 M 78 C4 A
7 M 74 C6/7 C 82 43 M 73 C6 A
8 M 24 C5/6 A 80 11 M 25 C5 B
9 M 32 C5 B 95 11 M 32 C5 A
10 F 35 C7 A 75 11 M 32 C5 A
6.4.1.1 Training Session
Five weekly training sessions, used to strengthen the abdominal muscles, were performed for
20 minutes per day in week one, 30 minutes per day in week three and 40 per day minutes in
weeks five and seven as shown in Figure 6.2. The cycle of one week with AFES training and
one week without was used to provide an indication of the effectiveness of the intervention
for improving respiratory function in the short term.
Figure 6.2: Study timeline showing weeks with and without AFES training, training duration
and assessment sessions (A.).
Based on previous research [86, 165, 166] participants were expected to go through four
distinct phases before successfully weaning from mechanical ventilation. These phases are
summarised in Table 6.2. This table shows that participants were initially fully ventilator
dependent and unable to breathe without the support of mechanical ventilation. However,
it should be noted that during this time participants could be disconnected from mechanical
ventilation for short periods of time, during which they would show some respiratory
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activity. As the study progressed these participants were disconnected from the ventilator
and encouraged to breathe independently from mechanical ventilation for increasing periods
of time, a process refereed to as ventilator weaning.
Table 6.2: Expected phases of weaning, adapted from [86, 165, 166]
Phase 1. Participants unable to breathe
independently of mechanical ventilation
Participants are not be able to breathe
independently of mechanical ventilation.
Levels of ventilatory support are reduced
throughout this period.
Phase 2. Participants disconnected from
mechanical ventilation and Spontaneous
Breathing Trials (SBTs) begin
Participants are only able to undertake
SBTs (see Section 2.3.1) for a short period
of time before oxygen saturation level
(SaPO2) falls below 92 percent. During
this time participants struggle to actively
participate or follow instructions. All
breaths at Vital Capacity (VC).
Phase 3. Participants become accustomed
to breathing without ventilator support
Duration of each SBT can be increased
before SaPO2 falls below 92 percent.
All breaths continue to be at VC until
respiratory function begins to improve.
Phase 4. Participants can actively parti-
cipate while disconnected from mechanical
ventilation
Duration of SBTs increases beyond one
hour. Respiratory function improves to
a level where Tidal Volume (VT ) of a
normal breath is below VC . Participants
are able to actively take deeper breaths
to VC when requested. Duration of SBTs
continues to increase until participant is
freed from mechanical ventilation.
While participants were not able to breathe independently of mechanical ventilation,
represented by Phase 1 in Table 6.2, AFES was applied while the participants remained
connected to mechanical ventilation. As weaning progressed through the stages outlined in
Phases 2 to 4 of Table 6.2, Spontaneous Breathing Trials (SBTs) (see Section 2.3.1) began,
during which participants were encouraged to breathe independently of mechanical ventilation
for increasing periods of time. During this time AFES was applied while participants were
disconnected from mechanical ventilation. However, during SBTs the participant’s oxygen
saturation level (SaPO2) was monitored and recorded every minute. If SaPO2 decreased below
92 percent participants were immediately reconnected to mechanical ventilation until SaPO2
returned to baseline, at which point they were once again disconnected from mechanical
ventilation. AFES was applied throughout this process. AFES training sessions continued
throughout the eight weeks even if the participant successfully weaned from mechanical
ventilation within the study duration as it was believed that, even if the participant
had weaned from mechanical ventilation, AFES training would continue to improve their
respiratory function.
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6.4.1.2 Assessment Session
Before the study commenced, and at the end of each week, an assessment session was
conducted as shown in Figure 6.2. Before the first assessment session commenced the
stimulation current required to achieve a visible contraction of the rectus abdominis and
external oblique muscles was established. During each assessment session VT and VC were
measured, with and without AFES, using the protocol described in Section 3.2. To record VC
participants were asked to inhale to maximum lung capacity and exhale as fully as possible.
This manoeuver was repeated up to five times, both with and without AFES, to form one
run. VT was then recorded by measuring six minutes of normal relaxed breathing, both with
and without the support of AFES, separated by a rest period of approximately two minutes.
This provided approximately 75 stimulated and unstimulated breaths, the mean of which was
denoted as the VT . A second run of VC manoeuvres was then performed after a rest period
of approximately two minutes. This resulted in each assessment session providing up to 10
stimulated and unstimulated VC manoeuvres. The maximum of these manoeuvres, which
was within 0.15 L of another breath, was taken as the VC . Whether stimulation was applied
during the first or second set of five VC manoeuvres within each run was randomised for each
participant at each session. During all measurements of VC participants were asked to inhale
and exhale as deeply as possible. However, no verbal encouragement was provided during the
exhalation. It should be noted that VC was recorded rather than FVC as, at early assessment
sessions, participants could not always exhale as ‘forcibly as possible’ due to sedation levels
and poor respiratory muscle coordination. However, as explained in Section 1.4.2, there is
very little difference between the values of VC and FVC. A plot demonstrating a VT and VC
measurement, recorded using a spirometer with Participant 10 at the final assessment session
(A8), is shown in Figure 6.3.
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Figure 6.3: A respiratory volume trace recorded from Participant 10 using a spirometer at
the final assessment session. A positive gradient represents an inhalation and a negative
gradient represents an exhalation. The participant was asked to undertake a Vital Capacity
(VC) manoeuvre (shown in red), preceded and proceeded by a regular breath (shown in blue).
VC was calculated from the total volume during the exhalation phase of the VC manoeuvre,
found to be approximately 1.3 L. Tidal Volume (VT ) was calculated from the total volume
during the exhalation phase of the normal breaths, found to be approximately 0.6 L.
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In cases where participants were unable to actively participate, most commonly due to high
levels of sedation in the early stages of the study, their VT , which was assumed to also
be their VC at this acute stage of injury, was recorded from the output of the mechanical
ventilator. During the first (A0) and second (A1) assessment with Participant 1, and the first
(A0) assessment with Participant 6, VT was calculated as the mean of six breaths recorded
from the ventilator, while VC was calculated as the maximum of these breaths. All other
participants were able to actively participate at all assessment sessions.
In cases where the participant was unable to sustain respiration without the support of
mechanical ventilation for extended periods of time their SaPO2 was monitored and recorded
during every minute of the assessment session. If SaPO2 decreased below 92 percent
participants were immediately reconnected to mechanical ventilation until SaPO2 returned to
baseline, at which point they were once again disconnected from mechanical ventilation and
the assessment session resumed. If SaPO2 fell below 92 percent during a period where VT
was measured only breaths measured before the participant was reconnected to mechanical
ventilation were used for analysis. This only occurred at the first assessment session (A0) for
Participant 10, where 20 stimulated and unstimulated quiet breaths were used to calculate
VT .
6.4.1.3 Time to Wean
Each participant’s weaning progress was monitored on a daily basis throughout the course
of the study. Two measures were used to determine whether weaning had been successful:
i) Short term weaned - Participant able to breathe independently of mechanical ventilation for
24 hours and ii) Long term weaned - Participant able to breathe independently of mechanical
ventilation for seven days.
The duration of SBTs conducted within the QENSIU is recorded in the patient’s notes.
This allowed a comparison of the time spent breathing without mechanical ventilation
to be made between the intervention and control participants. The time for the control
participants to wean from mechanical ventilation was retrospectively assessed over the first
100 days of ventilation, used as an approximate comparison with the maximum possible
participation in the intervention arm of this study (assuming intervention participant is
recruited approximately four weeks after initial ventilation and takes part in the full eight
week AFES training program).
6.4.2 Equipment
During training sessions the participant’s respiratory activity was detected using a respiratory
effort belt positioned around the abdomen, while during assessment sessions respiratory
activity was recorded using a spirometer, with both of these methods described in Section 3.3.
The reliability of a respiratory effort belt to detect respiratory activity was shown in Chapter 4
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(Note no classification of different kinds of respiratory activity was performed in this study as
all breaths were assumed to be quiet breaths). In initial assessment sessions the spirometer
was connected to the participant’s tracheostomy tube. If the tracheostomy cuff, a balloon
which directs all air out of the tracheostomy tube, was removed during the study duration the
spirometer was connected to a mouthpiece. The participant was asked to breathe through this
mouthpiece while their tracheostomy tube (if still present) was capped to avoid air leakage. If
the participant was unable to breath without the support of mechanical ventilation a pressure
sensor was connected in line with the expiratory limb of the ventilator and used to measure
the ventilator’s, and in turn the participant’s, respiratory activity. Data was collected and
pre-processed using the methods described in Section 3.3.
6.4.2.1 Stimulation System
AFES was applied using the stimulation system described in Section 3.4.1. During training
sessions stimulation was applied in synchrony with the participant’s respiratory activity using
the signal from the respiratory effort belt positioned around the abdomen. During assessment
sessions stimulation was applied in synchrony with the participant’s respiratory activity using
the signal from the spirometer. If the participant was unable to breath without the support
of mechanical ventilation stimulation was applied in synchrony with the ventilator using the
signal from the pressure sensor (automatic stimulation methods are explained in more detail
in Section 3.4.3). The rectus abdominis and external oblique muscles were stimulated using
electrodes positioned at the motor points of these muscles, found using the protocol outlined
in Chapter 5. The stimulation currents required to achieve a visible muscle contraction of
these muscles at the pre-study assessment (with a pulsewidth of 100 µs), was used at all
subsequent sessions, and is shown for each participant in Table 6.3. The same stimulation
current was used throughout the eight weeks of participation, with the response to stimulation
not appearing to change over this period. Stimulation pulsewidth was varied between 100
and 500 µs within each session to account for muscle fatigue. It should be noted that
as Participant 5 was a non-responder to AFES, no stimulation currents could achieve a
contraction with this participant.
6.4.3 Analysis and Outcome Measures
The primary outcomes measures of this study are the time to wean from mechanical
ventilation and respiratory function. Respiratory function was quantified by VT and VC .
Individual results recorded from each participant are presented as VT and VC measured in
litres (L). Group results are normalised by weight and are presented as weight corrected tidal
volume (VT /kg) and weight corrected vital capacity (VC/kg) [39, 38, 42]. VT /kg and VC/kg
are measured in milliliters per kilogram (mL/kg).
The variability of time to wean from mechanical ventilation in the tetraplegic population,
coupled with the fact that the quantitative effectiveness of the intervention was largely
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Table 6.3: Stimulation currents, in mA, used to achieve a visible contraction of the External
Oblique (EO) and Rectus Abdominis (RA) muscle groups for each participant.
Participant Right EO Left EO Right RA Left RA
mA mA mA mA
1 70 70 50 50
2 30 50 40 40
3 50 50 30 30
4 60 60 50 60
5 N/A N/A N/A N/A
6 50 50 50 50
7 100 105 100 105
8 60 50 50 50
9 75 70 55 75
10 75 75 75 65
unknown in this patient group, made it difficult to reliably estimate the required sample
size for this study. The target number of participants was determined by an estimate of the
available patient population at the QENSIU who would be eligible for this study.
Participant 7 did not complete the final assessment session (A8) due to poor health.
Therefore, their results recorded during the previous assessment session were used for
group analysis. The eight assessment sessions conducted with Participant 7, and the nine
assessment sessions conducted with the eight other participants, provided 80 individual
assessment sessions. These 80 assessment sessions, conducted with nine participants, allowed
71 longitudinal comparisons (i.e. A0 compared to A1).
The stimulated and unstimulated VT /kg data recorded during the nine assessment sessions
with each of the nine participants were grouped into two data sets and tested for normality
using the Shapiro-Wilk test. The same process was performed on the VC/kg data. Based
on the results of these tests a Kruskal-Wallis test was used to test for statistically significant
longitudinal changes in stimulated and unstimulated VT /kg and VC/kg and for a statistically
significant difference in the stimulated and unstimulated VT , VT /kg and VC/kg recorded at
each assessment session. In the case of significance (p-value of less than 0.05), post hoc
multiple comparisons were performed using the Tukey-Kramer honest significant difference
test to identify statistically significantly different pairs. As VC is the maximum value recorded
at an assessment session, it was not possible to test for a statistically significant difference
between the stimulated and unstimulated VC recorded at any individual assessment session,
or for longitudinal changes in stimulated and unstimulated VC for each participant. On the
advice of clinical colleagues, it was agreed that an increase in VC of 200 mL was regarded as
clinically significant.
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The mean time for the intervention and control participants to achieve 24 hours (short term
weaned) and seven days (long term weaned) of ventilator free breathing, from the date of
initial ventilation, was compared for statistical significance using an independent Student’s
t-test.
6.5 Results
At the initial assessment session (A0) conducted with Participant 5 it was observed that this
participant did not respond to AFES. Despite this AFES was applied daily for three further
days with varying electrode positions and stimulation intensities. AFES was then applied on
a weekly basis throughout the eight weeks of participation, however no response to AFES
was observed at any of these sessions. As described in Section 6.6.2, it was later discovered
that this participant had suffered Lower Motor Neuron (LMN) damage. Due to this lack of
response to AFES Participant 5’s data was not included in the analysis.
A Shapiro-Wilk test showed that both the stimulated and unstimulated VT /kg data sets,
which contained approximately 3000 breaths each, and the stimulated and unstimulated
VC/kg data sets, which contained 81 breaths each, were not normally distributed, validating
the use of a non-parametric test for significance testing.
In the remainder of this section improvements in respiratory function, assessed by measuring
VT and VC , and time to achieve ventilator weaning, will be presented.
6.5.1 Tidal Volume
Figure 6.4 shows example signals recorded using the spirometer and the respiratory effort
belt positioned around the abdomen during a quiet breath, both with and without AFES. As
can be seen in Figure 6.4(b), a stimulation artefact can be observed in the respiratory effort
belt signal at the onset of stimulation. However, this stimulation artefact is only present for
approximately the first 0.5 seconds of stimulation, after which the respiratory effort belt signal
matches the spirometer signal. The short duration of this stimulation artefact means that it
does not affect the respiratory effort belt signal during either the preceding, or proceeding,
inhalation.
The stimulated and unstimulated VT recorded from Participant 1 at each of the nine
assessment sessions is shown in Figure 6.5. The stimulated and unstimulated VT of the
other eight participants who completed the study are shown in Appendix B.
Participant 1’s stimulated VT was found to be statistically significantly greater than
unstimulated VT at five of the nine (55.6%) assessment sessions. Their stimulated and
unstimulated VT was found to statistically significantly increase during three (37.5%) of
the eight weeks of participation, with a statistically significant decrease observed during one
of the eight (12.5%) weeks.
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Figure 6.4: Signals recorded during quiet breaths taken by Participant 8 at assessment session
A7, using a spirometer, shown in blue, and a respiratory effort belt positioned around the
abdomen, shown in red. Figure 6.4(a) shows a quiet breath where stimulation is not applied.
Figure 6.4(b) shows a quiet breath where stimulation is applied for one second at the onset of
exhalation, shown in green. A stimulation artefact, which can be detected in the respiratory
effort belt signal at the onset of stimulation, is also highlighted.
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Figure 6.5: Tidal Volume (VT ) ± standard deviation of Participant 1, recorded at nine weekly
assessment sessions, where a blue line represents stimulated, and a red line unstimulated,
breaths. Solid black line along the bottom of plot represents one week of AFES training,
solid grey line along bottom of the plot represents one week of no training, due to patient
developing pneumonia (P), and no line indicates week with no training. Black x indicates
stimulated VT was statistically significantly different to unstimulated VT , blue ∗ indicates
that stimulated VT was statistically significantly different to stimulated VT recorded at
previous assessment and red ∗ indicates that unstimulated VT was statistically significantly
different to unstimulated VT recorded at previous assessment.
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Across all participants stimulated VT was found to be statistically significantly greater than
unstimulated VT at 42 of the 80 (52.5%) assessment sessions and statistically significantly
smaller at three of the 80 (3.8%) assessment sessions. Stimulated VT was found to statistically
significantly increase during 20 of the 71 (28.2%) combined weeks of participation and
statistically significantly decrease between 12 (16.9%) of the weeks of participation. Fourteen
(70.0%) of the increases occurred during weeks where AFES was applied, while three (25.0%)
of the decreases occurred during weeks when AFES was applied. Unstimulated VT was
found to statistically significantly increase during 21 of the 71 (29.6%) combined weeks
of participation and statistically significantly decrease during 12 (16.9%) of the weeks of
participation. Of these increases 14 (66.7%) occurred during weeks where AFES was applied,
while four (33.3%) of the decreases occurred during weeks when AFES was applied.
The mean VT /kg of all nine participants at each of the nine assessment sessions is shown
in Figure 6.6. There was no statistically significant difference between stimulated and
unstimulated VT /kg at any assessment session, or stimulated or unstimulated VT /kg over the
study duration. Stimulated VT /kg increased in all weeks where AFES training was applied,
but only increased in the final week when AFES training was not applied. The change in
unstimulated VT /kg was found to be similar during weeks with and without stimulation.
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Figure 6.6: Mean weight corrected tidal volume (VT /kg) ± standard deviation for all
nine participants, recorded at nine weekly assessment sessions, where a blue line represents
stimulated, and a red line unstimulated, breaths. Solid black lines along the bottom of plot
represent one week of AFES training and no line indicates one week with no training.
Figure 6.7 shows each participant’s unstimulated VT /kg at each of the nine assessment
sessions. Participant 7 had the lowest unstimulated VT /kg, with a mean of around 3 mL/kg
across the study duration. Participant 7 was the only participant who received AFES training
and did not wean from mechanical ventilation within the eight week study duration.
The group cumulative change in stimulated and unstimulated VT /kg during weeks with and
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Figure 6.7: Unstimulated weight corrected tidal volume (VT /kg) of all participants, recorded
at nine weekly assessment sessions. Participant 7 is represented by a red line. A VT /kg of
5 mL/kg is also marked, which is the point at which participants were expected to wean from
mechanical ventilation.
without AFES training is shown in Figure 6.8. It can be seen that stimulated VT /kg decreased
in weeks without training over the study duration, while changes in unstimulated VT /kg are
similar throughout the study.
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Figure 6.8: Group cumulative change in stimulated and unstimulated Weight Corrected (WC)
Tidal Volume (VT /kg) ± standard deviation for all nine participants, recorded at nine weekly
assessment sessions, where a blue line represents weeks with AFES training and a red line
represents weeks without AFES training. Black ∗ indicates change recorded after a week with
AFES training was statistically significantly different to change recorded after the following
week with no AFES training.
6.5.2 Vital Capacity
Stimulated and unstimulated VC recorded from Participant 1 at each of the nine assessment
sessions is shown in Figure 6.9. Also shown is the daily time spent breathing without
ventilator support. The stimulated and unstimulated VC of the other eight participants who
completed the study, along with the daily time spent breathing without ventilator support,
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are shown in Appendix B.
Assessment
Vi
ta
l C
ap
ac
ity
 (L
)
 
 
A0 A1 A2 A3 P A4 A5 A6 A7 A8
0.25
0.5
0.75
1.0
1.25
5
10
15
20
25
Tim
e off vent (hours/day)
Stimulated
Unstimulated
Weaning times
Figure 6.9: Vital Capacity (VC) of Participant 1, recorded at nine weekly assessment sessions,
where a blue line represents stimulated, and a red line unstimulated, breaths. Solid black
line along the bottom of plot represents one week of AFES training, the solid grey line
along the bottom of the plot represents one week of no training, due to patient developing
pneumonia (P), and no line indicates one week with no training. Green line represents time
spent breathing without ventilator support per day, while broken black line represent a VC
of 500 mL, the VC at which participants were expected to wean based on clinical experience.
The dashed magenta line represents the time point at which the participant achieved 24 hours
of ventilator free breathing, while the dashed cyan line represents the time point at which
the participant achieved seven days of ventilator free breathing.
Participant 1’s VC appeared to show a strong positive correlation to time spent breathing
without ventilator support. It can also be observed that while the development of pneumonia
in week four of the study delayed weaning, it did not appear to affect VC , which increased
slightly during the two weeks where Participant 1 received no AFES training.
Across all participants stimulated VC was found to be clinically significantly greater than
unstimulated VC at nine of the 80 (11.3%) assessment sessions and clinically significantly
smaller at two of the 80 (2.5%) assessment sessions. Stimulated VC was found to increase
clinically significantly during 17 of the 71 (23.9%) combined weeks of participation and
decrease clinically significantly between 11 (15.5%) of the weeks of participation. Of these
increases, 10 (58.8%) occurred during weeks where AFES was applied, while seven (63.6%) of
the decreases occurred during weeks when AFES was applied. Unstimulated VC was found to
increase clinically significantly during 15 (21.1%) of the 71 combined weeks of participation
and decrease clinically significantly between three (4.2%) of the weeks of participation. Of
these increases, nine (60.0%) occurred during weeks where AFES was applied, while three
(100%) of the decreases occurred during weeks when AFES was applied.
The combined mean of each participant’s VC/kg at each of the nine assessment sessions is
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shown in Figure 6.10. For the combined data there was no statistically significant difference
between either the stimulated and unstimulated VC/kg during any assessment session, or the
stimulated or unstimulated VC/kg recorded over the study duration. Both stimulated and
unstimulated VC/kg increased throughout the study duration.
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Figure 6.10: Mean weight corrected vital capacity (VC/kg) ± standard deviation for all
nine participants, recorded at nine weekly assessment sessions, where a blue line represents
stimulated, and a red line unstimulated, breaths. Solid black lines along the bottom of the
plot represent one week of AFES training and no line indicates one week with no training.
The group cumulative change in stimulated and unstimulated VC/kg during weeks with and
without AFES training is shown in Figure 6.11. Stimulated VC/kg increased to a greater
degree during weeks of AFES training than without, while the changes in unstimulated VC/kg
are similar throughout the study.
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Figure 6.11: Group cumulative change in stimulated and unstimulated Weight Corrected
(WC) Vital Capacity (VC/kg) ± standard deviation for all nine participants, recorded at
nine weekly assessment sessions, where a blue line represents weeks with AFES training and
a red line represents weeks without AFES training.
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6.5.3 Time to Wean
Participant 7, and the control participant matched to Participant 6, did not wean from
mechanical ventilation during the study. All other participants went through a standard
weaning procedure whereby after reaching short term (24 hours) weaned no further
mechanical ventilation was necessary. Figure 6.12(a) and Figure 6.12(b) show the group
time to achieve short term and long term weaning respectively, while Table 6.4 shows the
time to wean for each participant from the date of initial ventilation, with the group mean also
shown. From Table 6.4 it can be seen that five of the nine (55.6%) participants who received
AFES training weaned from mechanical ventilation at a faster rate than their matched control
participant. The intervention participants weaned from mechanical ventilation on average 11
days faster than the control participants. However, the group means were not found to be
statistically significantly different. It should be noted that the grouped data presented in
Table 6.4 and Figure 6.12 ignore the data for a participant in each group who did not wean
from ventilation.
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Figure 6.12: Boxplots showing time to wean for the Intervention (blue) and Control (red)
groups. Each box shows the median together with the inter-quartile range, with outliers
marked by a black +. a) shows the time to achieve 24 hours of ventilator free breathing,
denoted short term weaned. b) shows the time to achieve seven days of ventilator free
breathing, denoted long term weaned.
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Table 6.4: Time to wean for each participant who received AFES training from date of initial
ventilation. Also shown is the time to wean for their matched control. Short term weaned
is a period of 24 hours without ventilation and long term weaned is a period of seven days
without ventilation. Participants who did not wean from ventilation are denoted by N/A.
The means of each group ± standard deviation (s.d.) are also shown, which do not include
the data of Participant 7 and control Participant 6 due to these participants not weaning
from ventilation.
AFES Control
ID Short Term Long Term Short Term Long Term
Weaned Weaned Weaned Weaned
(days) (days) (days) (days)
1 58 64 42 48
2 22 28 33 39
3 12 18 34 40
4 32 38 86 92
6 30 36 N/A N/A
7 N/A N/A 45 51
8 25 31 8 14
9 21 27 12 18
10 17 23 44 50
Mean ± s.d. 27 ± 14 33 ± 14 38 ± 24 44 ± 24
6.6 Discussion
The primary aim of this study was to evaluate the feasibility of using AFES to assist acute
ventilator dependent tetraplegics in weaning from mechanical ventilation. The feasibility
of this intervention has been demonstrated here for the first time, by applying AFES in a
clinical setting with nine participants during four weeks, over an eight week period, without
any negative side effects and a high compliance of the participants to the training sessions
(see Section 6.6.2). The effectiveness of the intervention was demonstrated by the increases
in respiratory function that were observed throughout the study duration.
6.6.1 Improvements in Respiratory Function
Acute Effect The stimulated VT of each participant was statistically significantly greater
than unstimulated VT at 55.6 percent of the assessment sessions. While this agrees
with previous studies which also found an acute increase in VT during the application
of AFES [120, 121], the extent of this increase differs across studies. Sorli et al. [120]
applied AFES to the rectus abdominis muscles during quiet breathing with nine able bodied
participants. They found that the VT of the able bodied participants increased by 65% during
AFES. This increase is much greater than the average increase of approximately 15 percent
observed here. However, Sorli et al. do not report the stimulation intensity used to achieve
this increase. It may be that a much larger stimulation intensity was used than with the
participants in this study. As some of the participants in this study retained sensation of the
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abdomen, stimulation intensity was set at a level that achieved a visible muscle contraction.
It may be that a higher level of stimulation intensity would have achieved a greater increase in
VT . Stanic et al. [121] reported an increased in VT of 35 percent with the chronic tetraplegic
population, and 34 percent with the able bodied population, using a similar stimulation
intensity as was used in this study. While this is still a greater increase than observed here,
all three studies used different electrode locations to apply AFES. The difficulty in comparing
AFES studies caused by a lack of common clinical protocol is discussed in further detail in
Section 8.2. Finally, the participants in this study were ventilator dependent and were likely
to be suffering from muscle weakness associated with critical illness [125]. This may be
another contributing factor as to why the acute increase in VT during AFES observed here
was less than that observed with the able bodied and chronic tetraplegic population.
Stimulated VC was only clinically significantly greater (more than 200 mL) than unstimulated
VC at 11.3 percent of the assessment sessions. It may be that a value of 200 mL, which
represented a greater than 20 percent acute increase in VC for some participants, is too large
for this population and requires to be revised for future studies.
Longitudinal Effect Stimulated and unstimulated VT /kg and VC/kg increased through-
out the study. This agrees with previous studies that also showed an increase in VC after
AFES training [70, 73, 124]. However, neither of these changes were found to be statistically
significant. VT /kg was not expected to greatly increase as once a participant reaches a VT
at which they are able to breathe comfortably there is no need for further increase. The lack
of a statistically significant increase in VC/kg is largely due to the large standard deviation
of the data. A larger study may reduce this deviation, leading to a greater likelihood of
achieving a statistically significant increase in VC/kg after AFES training.
With any intervention study in the acute spinal cord injured population it is difficult to
distinguish between the effect of an intervention and ‘natural recovery’. By applying AFES on
alternate weeks it was hoped that it would be possible to identify improvements in respiratory
function caused by the intervention. It was found that stimulated and unstimulated VT
increased statistically significantly during 28 and 30 percent of weeks respectively. Of these
increases, 70.0 and 66.7 percent occurred during weeks where AFES was applied, indicating
that a statistically significant increase in VT is more likely to be observed after a week of
AFES training. Stimulated and unstimulated VC increased clinically significantly during 24
and 21 percent of weeks respectively. Of these increases, 58.8 and 60.0 percent occurred during
weeks where AFES training was applied, again indicating a greater likelihood of achieving a
clinically significant increase in VC during a week where AFES training was applied. These
results indicate that there may be an effect from AFES training, although further work is
required to quantify this effect.
Liaw et al. [113] found a statistically significant 27 percent increase in Forced Vital Capacity
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(FVC) over a six week period for sub-acute tetraplegics who received no intervention. In this
eight week intervention study it was found that unstimulated VC/kg increased by 48 percent.
This is greater than the increase observed by Liaw et al. and suggests that there may
be an intervention effect from AFES training. Rather than natural recovery, the increases
in respiratory function observed during non treatment weeks may be caused by an acute
carry over effect from the previous week’s AFES training. Although there is no literature
investigating the duration, or presence, of the carry over effect from AFES, previous studies
have found a carry over effect from FES training of the lower limbs to correct foot drop [57,
167]. However, the duration of such a carry over effect has not been established and is
disputed in the literature. There are two possible approaches to determine whether there
is a carry over effect from AFES training. The first approach would be to randomise the
order of treatment, i.e. AFES training may commence in either week one or week two of
the study, which will give an indication as to whether respiratory function increases in the
first week of the study when no AFES training is applied. A second approach would be to
increase the duration of the control periods. By having a one week treatment period and
a two week control period any acute carry over effect of the AFES training should have
diminished to a greater extent than in this study. The drawback of this approach is an
increased study duration and a reduction in AFES application in the early stages when it
is thought to be most beneficial. The majority of participants in this study weaned from
mechanical ventilation in the first few weeks. An increased control duration would reduce
the amount of AFES training that each participant received while dependant on mechanical
ventilation. This may reduce the benefit of the intervention for this patient group.
Ventilator Weaning It was found that five of the nine (55.6%) participants who completed
the intervention weaned from mechanical ventilation at a faster rate than their matched
controls, with one participant in each group not weaning from mechanical ventilation. When
these two participants were ignored it was found that participants who received AFES training
weaned from mechanical ventilation on average 11 days faster than their matched controls.
While the numbers in this study are too small for this difference to be statistically significant,
this finding indicates that the application of an AFES training program may enable faster
weaning from mechanical ventilation.
Clinically, a value of 500 mL is often used as the VT at which people are predicted to
wean from mechanical ventilation. However, this does not take into account a persons body
weight, with a greater body weight inherently leading to an increased VT and VC . This was
highlighted by Participant 1, whose weight was 50 kg, weaning from ventilation despite their
VT being less than 500 mL for the whole study duration, while Participant 7, whose weight
was 82 kg, did not wean from ventilation despite achieving similar VT values. In this study
all of the participants, except Participant 7 who did not wean from ventilation, achieved a
VT /kg of greater than 5 mL/kg, suggesting this may be an indicator for weaning success in
the tetraplegic population.
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6.6.2 Other Observations
For electrical stimulation to be successful the LMNs, which carry motor information from
the spinal cord to a muscle, must be intact (See Section 1.3 for further information). It was
later established that Participant 5, who was a non responder to stimulation, had suffered
LMN damage, either at the time of SCI or due to a large edema (extra cellular fluid [168])
which was later observed in the spinal cord. This participant was discharged from hospital
requiring full time ventilatory support. The impact of LMN damage on electrical stimulation
is discussed in further detail in Section 8.4.
Participant 7 did not wean from ventilation during the study, which may be attributed to this
participant’s poor health after injury. Additionally this participant, along with the chronic
participant who took part in the case study described at the start of this chapter, had a
large amount of edema in the abdomen. This resulted in these participants requiring a much
larger amount of stimulation current to initiate a contraction of the abdominal muscles (see
Table 6.3 and Section 6.2.1), which may pose a problem for participants who retain sensation
of the abdomen. The impact of edema on the effectiveness of AFES is discussed in further
detail in Section 8.4. Interestingly Participant 7 had a cardiac pacemaker, with no negative
effects of stimulation observed. This agrees with the findings of Shade [169]. Despite these
problems the finding that two out of 10, or 20 percent, of the acute participants did not
wean from mechanical ventilation agrees with the findings of Gay [81], who states that every
year in the USA 2700 acute tetraplegics require ventilation in the acute stage of injury but
ultimately wean, while 500 (18.5%) require permanent mechanical ventilation. These results
are similar to those reported by Martin et al. [87] who applied inspiratory muscle training,
using a pressure threshold device, to assist weaning from mechanical ventilation for 10 able
bodied participants. They found that nine out of the 10 (90%) participants weaned from
mechanical ventilation within a six week intervention protocol.
Participant 1 developed pneumonia during week four of the study and was unable to
participate in AFES training for one week. During this time the participant returned to
being ventilator dependant, with SBTs resuming after the pneumonia had cleared. For this
participant the study duration was extended to take account of the missed week. Of the eight
participants who weaned, Participant 1 had the lowest absolute value of VT (although not
the lowest VT /kg) for the first three assessment sessions. They also took the longest time to
wean from mechanical ventilation and were the only participant to suffer from a respiratory
complication during the study. This suggests that a low VT may be an indicator of increased
weaning time and increased susceptibility to respiratory complications. The impact of AFES
on respiratory complications is discussed in further detail in Section 8.2.2.
The development of this respiratory complication highlights the challenges of attaining a
high compliance in a study with the acute tetraplegic population. However, except for this
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week of pneumonia for Participant 1, and Participant 7 missing the final assessment session
due to poor health, all other training sessions were met. This represented a compliance
rate of 96.7 percent. McBain et al. [73] report a similar compliance rate of 97.8 percent
when conducting AFES training with the chronic tetraplegic population. While McLachlan
et al. [70] present no compliance rate, they indicate that one of the chronic patients missed
an assessment session due to ‘personal time constraints’. Such problems are inherent with
conducting studies with the chronic tetraplegic population. However, in this study all patients
were less independent and were heavily reliant on caregiver support. For this reason AFES
training could be incorporated as part of their normal daily rehabilitation program, making
missed sessions for any other reason than poor health unlikely.
Another interesting observation was that AFES training sessions tended to lead to an
increased demand for removal of secretion from the airways, both during the training sessions
and for a short period after. Although this outcome could not be quantified and the evidence
was largely anecdotal, it was observed by the researchers, clinicians and participants. This
observation is not entirely surprising as AFES causes the abdomen to move in a similar
motion as during a manually assisted cough (see Section 2.3.2.1). The use of AFES to
aid secretion removal, and hence improve respiratory health, may improve the effectiveness
of mechanical insuﬄation-exsuﬄation. This possibility was further investigated in Chapter 7.
Lee et al. [122] used AFES to assist ventilator weaning and tracheostomy decannulation for
one chronic C4 tetraplegic patient. The results observed here when using AFES with the
acute tetraplegic population, and with a chronic tetraplegic participant in the case study
reported at the start of this chapter, suggest that for ventilator dependant tetraplegics who
retain some diaphragm function (i.e. an injury level of C3 and below) the principles described
here may be used to increase respiratory function and aid faster weaning from mechanical
ventilation. This would in turn lead to a significant improvement in this patient groups
quality of life, reduce susceptibility to respiratory complications and result in a cost saving
for the local health care provider.
6.6.3 Limitations
A number of limitations of this study were identified. Firstly, from a clinical viewpoint, a
continuous training protocol may be more beneficial for patients than the week on week off
protocol adopted here, as patients would receive a higher dose of the intervention. However,
this protocol was used to highlight the effectiveness of AFES, which should aid its clinical
introduction. As a result of this study, a continuous training protocol will shortly be
introduced at the QENSIU to assist all acute ventilator dependent tetraplegic participants
in weaning from mechanical ventilation. Additionally, many of the participants in this study
had a VC of less than 1 L. The ATS/ERS standards for spirometry [129] suggest that
for a person with a VC of less than 1 L, their VC should be the maximum breath that is
within 0.1 L of another. Although the ATS/ERS standards have been shown to be applicable
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for chronic (in this case greater than one year post injury) tetraplegic participants [130],
a repeatability value of 0.15 L was used for all participants in this study to allow for the
large variations in values that were observed when McLachlan et al. [70] performed a VC test
with the sub-acute and chronic tetraplegic population. Participant 6 suffered a stroke that
is thought to have occurred during week two or three of their participation in this study.
This stroke left the participant with a slightly impaired ability to follow instructions, making
the recording of accurate VC results more difficult. However, with encouragement from the
participants regular caregiver, it was possible to record a VC measurement that was believed
to be accurate as it met the ATS/ERS standards.
This study aimed to recruit participants as soon as possible after ventilation. While
Participant 10 started the study two days after ventilation commenced, they were the only
participant recruited in the first five days after ventilation. Many of the participants in this
study spent time on a high dependency ward outside the QENSIU before being admitted
to the QENSIU for specialist SCI care. In the cases of Participant 2 and Participant 4 this
initial care was provided outside of the United Kingdom, resulting in these participants being
recruited slightly after the four week acute injury period. Participant 7 was recruited for this
study 22 days post injury. However, due to repeated poor health this participant did not
actually commence on the study until 43 days post injury. Due to the apparent reduction
in time spent dependent on mechanical ventilation after an AFES training program, earlier
recruitment may lead to a greater benefit from the intervention.
A previous study by Girard et al. [166] suggests a SaPO2 of 88 percent as the point at which
heterogeneous participants in an intensive care unit should be reconnected to mechanical
ventilation during SBTs. However, in line with current clinical procedures at the QENSIU,
a SaPO2 of 92 percent was deemed the appropriate level at which participants should be
reconnected to mechanical ventilation during this study. Using SaPO2 of 88 percent as the
point at which participants were reconnected to mechanical ventilation would have increased
the time that participants spent breathing independently, which may have led to a greater
improvement in respiratory function.
Finally, many of the participants had their tracheostomy removed during the study, which
often left a large stoma. Although this stoma quickly healed, its presence could make
assessment sessions difficult. The removal of Participant 6’s tracheostomy, during week seven
of the study, left a large stoma from which there was a large amount of air leakage during
assessment session seven (A7). This assessment was repeated the following day after the
stoma had been sealed by a trained clinician, which greatly reduced the air leakage and led
to a 200 mL increase in the measured VT . The stoma had healed significantly by assessment
session eight (A8), during which there was not deemed to be any air leakage. Participant 1 had
their tracheostomy cuff removed during week eight of the study. At assessment session eight
(A8) the tracheostomy was capped and the respiratory flow was measured using a spirometer
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coupled with a full face mask. However, with the participant in the supine position there
was a large amount of air leakage under the mask. This assessment session was repeated the
following day with the spirometer coupled with a mouthpiece rather than a face mask. This
method proved to be more effective and was adopted to measure the respiratory flow of all
participants who no longer had a cuffed tracheostomy.
6.7 Conclusion
The results of this study indicate that AFES is a feasible technique for assisting ventilator
weaning for people with acute tetraplegia. AFES training was also shown to improve
the respiratory function of this population, with an associated decrease in the time spent
dependant on mechanical ventilation observed.
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Chapter 7
Abdominal FES to Improve
Respiratory Function in Sub-acute
Tetraplegia
“The scientific man does not aim at an immediate result. He does not expect that his
advanced ideas will be readily taken up. His work is like that of the planter - for the future.
His duty is to lay the foundation for those who are to come, and point the way. He lives and
labors and hopes.”
Nikola Tesla
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7.1 Summary
Previous research has shown that an Abdominal Functional Electrical Stimulation (AFES)
training program can improve the respiratory function of people with tetraplegia. The optimal
training protocols, in particular the training duration that achieves the greatest improvement
in respiratory function, have yet to be established. Additionally, findings outlined in the
previous chapter indicate that AFES may cause increased loosening of lung secretions. In this
chapter, a randomised crossover study is presented that investigates the feasibility of applying
an extended AFES training program with the sub-acute tetraplegic population. Three non
ventilator dependent tetraplegic patients participated in pilot experiments outlined in this
chapter. Forced Vital Capacity (FVC), Peak Expiratory Flow (PEF) and Forced Exhaled
Volume in one second (FEV1) were measured fortnightly, with and without AFES. The
feasibility of combining AFES with Mechanical Insuﬄation-Exsuﬄation (MI-E) was assessed
with one tetraplegic participant by measuring respiratory function during MI-E, again with
and without AFES. The application of AFES led to an acute increase in FVC, PEF and FEV1.
FVC, PEF and FEV1 increased throughout the study, with FVC increasing at a greater rate
during the AFES training period than during the control period. Combining AFES with
MI-E led to an acute increase in respiratory function at the majority of assessment sessions.
While the feasibility of these two novel protocols was demonstrated, additional participants
are required to fully assess the effectiveness of these interventions and establish the optimum
AFES training duration.
7.2 Background
Respiratory complications are a leading cause of morbidity and mortality for the tetraplegic
population [29]. People with tetraplegia have poor respiratory function and are unable to
generate an effective cough (see Section 1.4.3). Therefore, these respiratory complications
are primarily attributed to respiratory infections caused by the build up of secretions in the
lungs and airways. Previous work within our group [70] indicated that a three week AFES
training program led to a statistically significant increase in the FVC of 12 participants with
sub-acute and chronic tetraplegia. This increase in FVC was associated with improved cough
generation, which should reduce the likelihood of respiratory infection. The results of this
study showed that FVC had not plateaued by the end of the three week intervention period,
indicating that a longer training period may lead to further improvements in respiratory
function.
Clinically, the problem of secretion removal for the tetraplegic population is often addressed
by using tracheal suctioning, where suction is applied via a patients tracheostomy tube to
remove secretions. While tracheal suctioning can be used to successfully remove secretions,
it is uncomfortable for the patient, often misses the left bronchus and does not directly
loosen secretions. To aid the loosening of secretions assisted coughing, which is designed to
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simulate a cough, is often employed. Assisted coughing is usually delivered in one of two ways,
namely a manually assisted cough or Mechanical Insuﬄation-Exsuﬄation (MI-E). A manually
assisted cough involves a caregiver applying pressure to the thoracoabdominal cavity during
the exhalation phase of a voluntary cough. The requirement for a care giver to apply this
approach has cost and resource implications for the local health care provider [91, 92]. The
force used by the caregiver to generate an effective cough is subjective, leading to a variability
in the success of this approach. MI-E applies alternating positive and negative pressure to
the user’s airway to simulate a cough and loosen secretions, with suction applied after each
simulated cough to remove these secretions. This mechanical system provides a cheaper and
easier to implement alternative to manually assisted coughing. During the study presented
in Chapter 6 it was observed that AFES led to an increased need for secretion removal,
indicating that AFES was loosening lung secretions. The combination of AFES with MI-
E, hypothesised to lead to an additional improvement in cough generation and secretion
clearance compared to MI-E alone, is investigated here.
The aims of this study were i) to evaluate the feasibility and effectiveness of an
extended AFES training program to improve the respiratory function of sub-acute tetraplegic
participants and ii) to evaluate the feasibility of combining AFES with MI-E.
7.3 Methods
Four tetraplegic inpatients at the Queen Elizabeth National Spinal Injuries Unit (QENSIU)
were recruited for this study, with the participant demographics shown in Table 7.1. Ethical
approval was granted by the National Health Service West of Scotland Research Ethics
Committee (Local Code: 13/WS/0002). All procedures conformed to the Declaration of
Helsinki and all participants gave written informed consent. It should be noted that the
sub-acute phase of injury begins approximately four weeks after injury (see Section 1.2.3.2),
with three of the participants recruited for this study before this point. However, due to half
of the participants undergoing a four week control period before any intervention is applied,
coupled with the eight week duration of the intervention period (meaning participants will
only receive a small dose of the intervention in the acute period of injury), all patients in this
study will be regarded as sub-acute.
Participants were recruited according to the following inclusion and exclusion criteria.
Inclusion criteria:
1. Men or women over 16 years of age;
2. Reduced respiratory function as a result of tetraplegia;
3. No reliance on mechanical ventilation;
4. Good visual response to surface electrical stimulation of the abdominal muscles,
suggesting that lower motor neurons are intact.
Exclusion criteria:
1. Under 16 years of age;
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Table 7.1: Participant demographics showing sex, age, injury level, American Spinal Injuries
Association Impairment Scale (AIS) level (see Section 1.2.3.2), weight and time post injury
at recruitment.
Participant Sex Age Injury AIS Weight Time post
(years) level level (kg) injury (days)
1 M 69 C6 A 74 26
2 M 19 C6 A 80 22
3 M 24 C5/6 C 83 19
4 M 20 C5 C 69 29
2. Female participants who are pregnant;
3. Significant history of autonomic dysreflexia;
4. No visual response to surface electrical stimulation of the abdominal muscles, suggesting
that lower motor neurons are not intact;
5. Unstable chest or abdominal injury;
6. Bulbar dysfunction;
7. Participant unable to give informed consent.
As with the clinical study outlined in Chapter 6, participants were recruited by consultants
at the QENSIU, based on the inclusion and exclusion criteria outlined above. However, the
ultimate decision for inclusion was based on the clinical judgement of the consultant.
7.3.1 Experimental Procedures
The study took the form of a randomised crossover design, consisting of a four week control
period and an eight week training period, with this training period followed by a two week
follow up/wash out period, resulting in a total duration of participation of 14 weeks. The
order of the control and training periods was randomised for each participant. At a pre-study
assessment, and at the end of every second week, an assessment session was conducted. An
effort was made to perform all procedures at the same time of day and all procedures were
performed at the participant’s bedside with the participant in a supine position. The study
timeline is shown in Figure 7.1 and described in further detail below.
7.3.1.1 Pre-study Assessment
After recruitment each participant took part in a pre-study assessment, which also served as a
familiarisation session. At this session AFES was applied to the rectus abdominis and external
oblique muscles to ascertain whether these muscles responded to electrical stimulation. If
a contraction was achieved the optimum stimulation current and pulsewidth required to
induce a visible contraction of these muscles was established. After the optimum stimulation
parameters had been established, a full assessment session (see Section 7.3.1.4) was conducted
CHAPTER 7. AFES IN SUB-ACUTE TETRAPLEGIA 141
Figure 7.1: Study timeline indicating control (red), training (black) and follow up/wash out
(blue) periods. Assessment sessions are also indicated.
(denoted on Figure 7.1 as A0).
7.3.1.2 Training Sessions
AFES training sessions were conducted five times per week (Monday to Friday) for a total
of eight weeks. During each training session AFES was applied to the rectus abdominis and
external oblique muscles for 40 minutes, using the stimulation current established at the pre-
study assessment. Pulsewidth was adjusted throughout each training session to account for
muscle fatigue. The aim of these training sessions was to strengthen the abdominal muscles.
7.3.1.3 Follow up/Wash out Period
Each training period was followed by a two week follow up period. If the training period
preceded the control period the follow up also served as a wash out period, used to minimise
the impact of any carry over effect from the training to the control period. During this
follow up period no AFES training was performed, but a scheduled assessment session was
conducted at the end.
7.3.1.4 Assessment Sessions
Fortnightly assessment sessions were conducted throughout the 14 week study duration. At
each assessment session a series of FVC manoeuvres were performed with and without AFES,
with the success of each manoeuvre judged using the protocol described in Section 3.2. To
conduct an FVC manoeuvre participants were instructed to inhale to maximum lung capacity
and exhale as fully and as forcibly as possible, with verbal encouragement provided. This
manoeuvre was repeated up to five times, both with and without stimulation, to form one
run. A second run of FVC manoeuvres was performed after a rest period of approximately
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two minutes, providing a total of up to 10 stimulated and unstimulated FVC attempts in
each assessment session. Whether stimulation was applied during the first or second set of
five FVC manoeuvres within each run was randomised for each participant at each session.
FVC is the largest exhaled volume, of at least three successful FVC manoeuvres, which is
within 0.15 L of another attempt. From the FVC manoeuvres FEV1 and PEF were also
calculated. FEV1 is the largest volume recorded during the first second of an exhalation, of
at least three successful FVC manoeuvres, which is within 0.15 L of another attempt. PEF is
the largest exhaled flow rate, from at least three successful FVC manoeuvres, which is within
0.67 L/s of another attempt.
7.3.1.5 MI-E Sessions
Participant 1 also took part in fortnightly MI-E sessions (on alternate weeks to the assessment
sessions outlined above), at which cycles of MI-E were applied both with and without AFES.
Each MI-E cycle had an insuﬄation pressure of 20 cmH2O and an exsuﬄation pressure of
−20 cmH2O. The exsuﬄation period was three seconds, the insuﬄation period two seconds,
with a pause of two seconds between each cycle.
During each MI-E cycle the participant was asked to inhale as fully as possible during the
insuﬄation phase and exhale as fully and as forcibly as possible during the exsuﬄation phase.
This provided a measure of Exhaled Volume (EV). Following the protocol used by Gonalves
et al. [95], and the standard clinical protocol at the QENSIU, five insuﬄation-exsuﬄation
cycles were applied during both unassisted and AFES assisted MI-E, to form one run. This
provided five stimulated and five unstimulated measures of EV. A second run of MI-E was
then conducted after a rest period of approximately two minutes, providing a total of 10
stimulated and 10 unstimulated measures of EV at each assessment session. From these
10 breaths the participant’s maximum EV and the Peak Flow (PF) measured during these
exhalations were calculated. EV is the largest exhaled volume which is within 0.15 L of
another attempt. PF is the largest exhaled flow rate which is within 0.67 L/s of another
attempt. It should be noted that due to the short insuﬄation and exsuﬄation periods, FVC
and PEF, which require the participant to inhale and exhale as fully as possible without any
limitation put on the length of these periods, could not be recorded. Whether stimulation
was applied during the first or second set of five MI-E cycles within each run was randomised
at each session.
7.3.2 Equipment
During AFES training sessions the participant’s respiratory activity was detected using a
respiratory effort belt positioned around the abdomen. During assessment sessions respiratory
activity was recorded using a spirometer, which was attached to a mouthpiece. These methods
are described in further detail in Section 3.3. Data was collected and pre-processed using the
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methods described in Section 3.3.
7.3.2.1 MI-E
MI-E was applied using a commercially available MI-E system (Cough-Assist, Phillips
Respironics, Netherlands), via a mouthpiece, which was connected to the MI-E tubing as
shown in Figure 7.2. A nasal clip was used to prevent air leakage at the nose, with participants
instructed to form a seal at the mouth to prevent air leakage there. A pressure sensor was
fitted in line with the MI-E tubing to detect the insuﬄation and exsuﬄation periods of the
MI-E device. During the MI-E assessment sessions the participant’s respiratory function was
measured using a spirometer as described in Section 3.3. This spirometer was attached to a
respiratory flow head, which was fitted in line with the MI-E tubing as shown in Figure 3.8.
Figure 7.2: Mechanical Insuﬄation-Exsuﬄation (MI-E) system showing the MI-E device, the
tubing connecting the device with the user, a filter used to prevent secretion entering the
machine and the mouthpiece.
7.3.2.2 Stimulation System
The stimulation system described in Section 3.4.1 was used to apply AFES during this study.
Stimulation was applied in synchrony with the participant’s respiratory activity: i) during
training sessions using the signal from a respiratory effort belt positioned around the abdomen
ii) during assessment sessions using the signal from a spirometer, and iii) during MI-E sessions
using the signal from the pressure sensor fitted in line with the MI-E tubing (automatic
stimulation methods are explained in more detail in Section 3.4.3). Electrodes were positioned
at the motor points of the rectus abdominis and external oblique muscles, located using
the protocol outlined in Chapter 5. The stimulation current required to achieve a visible
muscle contraction at the pre-study assessment (with a pulsewidth of 100 µs) was used at all
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subsequent sessions and is shown for each participant in Table 7.2. Stimulation pulsewidth
was varied between 100 and 500 µs within each session to account for muscle fatigue.
Table 7.2: Stimulation currents applied to the External Oblique (EO) and Rectus Abdominis
(RA) muscle groups to achieve a visible contraction for each participant at the pre-study
assessment session. These stimulation currents were used at all subsequent sessions.
Participant Right EO Left EO Right RA Left RA
(mA) (mA) (mA) (mA)
1 40 30 60 40
2 80 80 80 80
3 30 30 30 30
4 50 50 35 35
7.3.3 Analysis and Outcome Measures
The primary outcome measure in this study was respiratory function, which was quantified
using FVC, PEF and FEV1. Individual results recorded from each participant are presented
as FVC, PEF and FEV1, with FVC and FEV1 measured in litres (L) and PEF measures
in litres per second (L/s). Group results are normalised by weight and are presented as
weight corrected FVC (FVC/kg), weight corrected PEF (PEF/kg) and weight corrected
FEV1 (FEV1/kg).
Participant 2 withdrew from the study, and their results were not used for analysis. Each
of the remaining three participants took part in eight assessment sessions, giving a total of
24 assessment sessions. Conducting fortnightly assessment sessions over the 14 week study
duration provided seven longitudinal comparisons for each participant (i.e. A0 compared to
A1), giving a total of 21 longitudinal comparisons. The longitudinal change in respiratory
function over the total study duration, the eight week intervention period and the four week
control period was assessed by calculating i) the absolute change over the period ii) the
percentage change over the period, defined as the change over the period divided by the
initial value, and iii) the absolute change normalised by the total number of weeks within
each period.
The unstimulated FVC data recorded during the 24 assessment sessions was tested for
normality using the Shapiro-Wilk test. Based on the results of this test a two-way analysis
of variance (ANOVA) was used to test for longitudinal changes in FVC/kg, PEF/kg and
FEV1/kg. A one-way ANOVA was used to test for a statistically significant difference
in the FVC/kg, PEF/kg and FEV1/kg recorded at each assessment session. In the case
of significance (p-value of less than 0.05), post hoc multiple comparisons were performed
using the Tukey-Kramer honest significant difference test to identify statistically significantly
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different pairs. As FVC is the maximum value recorded at an assessment session, it
was not possible to test for a statistically significant difference between the stimulated
and unstimulated FVC recorded at any individual assessment session, or for longitudinal
changes in stimulated and unstimulated FVC, for each participant. On the advice of clinical
colleagues, it was agreed that an increase in FVC of 200 mL was regarded as clinically
significant.
For the participant who took part in the MI-E session their respiratory function was quantified
using EV and PF, which were measured in L and L/s, respectively.
7.4 Results
Participant 2 complained of abdominal discomfort after the pre-study assessment session
(discussed in more detail in Section 7.5) and was removed from the study at this point. Their
data was not used for analysis.
The results of a Shapiro-Wilk test showed that 21 (87.5%) of the unstimulated FVC data sets
were normally distributed, validating the use of a parametric test for significance testing.
7.4.1 AFES Training
In this randomised crossover design, Participant 1 completed the training period before the
control period, while Participants 3 and 4 completed the control period first. Participant 1’s
stimulated and unstimulated FVC, PEF and FEV1, recorded at each of the eight assessment
sessions, are shown in Figure 7.3, with the data recorded from Participants 3 and 4 shown in
Appendix C. Participant 1’s FVC and PEF increased over the study duration, while FEV1
was found to be more variable.
Stimulated FVC was found to be clinically significantly greater than unstimulated FVC at
five of the 24 (20.8%) assessment sessions and clinically significantly smaller at three of the 24
(12.5%) assessment sessions. Stimulated FVC increased clinically significantly during eight
of the 21 (38.1%) combined fortnights of participation and decreased clinically significantly
during three (14.3%) of the fortnights of participation. Of these increases, six (75.0%)
occurred during AFES training, while one (33.3%) of the decreases occurred during AFES
training. Unstimulated FVC was found to increase clinically significantly during nine (42.9%)
of the 21 combined fortnights of participation and decrease clinically significantly during four
(19.0%) of the fortnights of participation. Of these increases, eight (88.9%) occurred during
AFES training, while two (50%) of the decreases occurred during AFES training.
The grouped changes in respiratory function over the 14 week study duration, as well as over
the four week control and eight week AFES training periods, are shown in Table 7.3. All
measures of respiratory function increased during the study. The effect size (see Section 3.5.4)
for the changes over the entire study duration, as well as during the control and training
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Figure 7.3: Forced Vital Capacity (FVC), Forced Exhaled Volume in one second (FEV1)
and Peak Expiratory Flow (PEF) of Participant 1 recorded at eight fortnightly assessment
sessions, where a blue line represents stimulated, and a red line unstimulated, breaths. Solid
black line along the bottom of the plot represents the eight week period of AFES training
and no line indicates no training.
periods, is shown in Appendix C, with a large effect size observed for all measures. When
taking into account the shorter (four week) control period, stimulated and unstimulated
FVC/kg increased to a greater degree during the AFES training period than the control
period, while stimulated and unstimulated PEF/kg and FEV1/kg increased to a greater
degree during the control period. None of the longitudinal changes in respiratory function
observed over the whole study duration, over the control period or over the training period,
were statistically significant. Due to the small number of participants who completed this
study it was not possible to assess whether respiratory function plateaued within the study
duration.
7.4.2 AFES with MI-E
Participant 1 also took part in eight MI-E assessment sessions. Figure 7.4 shows Participant
1’s EV and PF recorded during unassisted and AFES assisted MI-E at each of the eight MI-E
sessions.
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Table 7.3: Change (mean ± standard deviation) in Stimulated (Stim) and Unstimulated
(Unstim) Weight Corrected Forced Vital Capacity (FVC/kg), Weight Corrected Peak
Expiratory Flow (PEF/kg) and Weight Corrected Forced Exhaled Volume in one second
(FEV1/kg), calculated from three participants, over the 14 week study duration, the eight
week AFES training period and the four week control period. Results are presented as the
absolute change and the change normalised per week for each period. Baseline values for
each measurement are also given.
Variable Stim Baseline Mean change Mean change Mean change
over study over control over training
Absolute
FVC/kg (mL/kg) Stim 29.8 ± 3.5 14.1 ± 7.5 4.9 ± 4.3 10.9 ± 5.1
Unstim 28.5 ± 5.5 15.4 ± 9.7 4.9 ± 6.9 12.2 ± 5.2
PEF/kg (mL/kg/s) Stim 27.6 ± 7.9 24.5 ± 27.1 12.4 ± 16.5 11.8 ± 10.3
Unstim 26.5 ± 6.9 27.6 ± 26.3 12.9 ± 16.0 12.0 ± 9.6
FEV1/kg (mL/kg) Stim 20.9 ± 5.4 11.6 ± 14.9 5.1 ± 7.8 7.8 ± 7.4
Unstim 18.2 ± 4.7 15.0 ± 14.0 8.6 ± 7.2 8.5 ± 5.8
Normalised per week
FVC/kg Stim - 1.0 ± 0.5 1.2 ± 1.1 1.4 ± 0.6
(mL/kg/week) Unstim - 1.1 ± 0.7 1.2 ± 1.7 1.5 ± 0.6
PEF/kg Stim - 1.7 ± 1.9 3.1 ± 4.1 1.5 ± 1.3
(mL/kg/s/week) Unstim - 2.0 ± 1.9 3.2 ± 4.0 1.5 ± 1.2
FEV1/kg Stim - 0.8 ± 1.1 1.3 ± 2.0 1.0 ± 0.9
(mL/kg/week) Unstim - 1.1 ± 1.0 2.1 ± 1.8 1.1 ± 0.7
When comparing the results achieved with MI-E combined with AFES to those achieved
with MI-E alone the application of AFES led to an acute increase in EV and PF at six of the
eight (75%) assessment sessions. The results recorded at assessment four (A4) appeared to
be outliers, with the EV and PF recorded at that assessment much greater than the results
obtained at any other assessment session. However, these results did meet the repeatability
criteria outlined in the ATS standards (see Section 3.2) and can therefore be assumed to have
been recorded correctly.
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Figure 7.4: Stimulated (blue) and unstimulated (red) Exhaled Volume (EV) and Peak Flow
(PF) for Participant 1 over the 14 week study duration when using MI-E. The solid black
line along the bottom of the plot indicates the eight week period of AFES training.
7.5 Discussion
The aims of this study were i) to evaluate the feasibility and effectiveness of an
extended AFES training program to improve the respiratory function of sub-acute tetraplegic
participants and ii) to evaluate the feasibility of combining AFES with MI-E.
While ethical approval to recruit 10 participants for this study has been granted four
participants were recruited within the time frame of this thesis. Participant 2 withdrew from
the study after the familiarisation session due to abdominal pain. It is believed this pain
was caused by this participant’s regular rehabilitation therapy, rather than the intervention
applied here. Therefore, only three participants completed AFES training. Additionally,
due to this time frame and a number of practical problems, AFES combined with MI-E was
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only tested with one participant. These practical problems are discussed in further detail in
Section 7.5.3.
7.5.1 AFES Training
The feasibility of using an extended AFES training program with the sub-acute tetraplegic
population was demonstrated by the 100 percent compliance of the three participants to the
training sessions.
Acute Effect AFES led to an acute, clinically significant (greater than 200 mL), increase
in FVC at 21 percent of the assessment sessions.
Longitudinal Effect FVC, PEF and FEV1 increased throughout the study, however only
unstimulated FVC increased at a faster rate during the AFES training period than the control
period. While this may suggest that the improvements in PEF and FEV1 observed in this
study can be attributed more to natural recovery than the training intervention, anomalies
within this study could explain the apparent lack of training effect. As two of the three
participants completed the control period before the training period, with natural recovery
expected to be greatest in the early weeks of the study, the natural recovery observed during
the control period may mask any training effect. This natural recovery was particularly
evident in Participant 3 (see Appendix C) whose unstimulated FVC (45%), PEF (164%)
and FEV1 (128%) greatly increased during the control period before increasing to a lesser
degree (FVC 28%, PEF 44% and FEV1 37%) during the intervention period. It was found
that for Participant 1, who completed the AFES training period first, FVC, PEF and FEV1
increased by 33, 8 and 10 percent during the intervention period and 9, −2 and 34 percent
during the control period and for Participant 4, who completed the control period first, FVC,
PEF and FEV1 increased by 53, 48 and 29 percent during the intervention period and −2,
16 and 27 percent during the control period. These results, which show a greater increase in
FVC and PEF during the intervention period than the control period, suggest that there may
be a training effect from the intervention. The large increase in the respiratory function of
Participant 3 over the control period may mask this training effect in the grouped data. The
recruitment of additional participants is required to clarify the presence of this training effect.
McLachlan et al. [70] demonstrated that a three week AFES training program led to a
statistically significant increase in FVC with 12 tetraplegic participants. In Chapter 6
a statistically significant increase in VC was demonstrated over an eight week period,
where AFES was applied on alternate weeks with nine acute, initially ventilator dependant,
tetraplegic participants. In this study no statistically significant differences in longitudinal
measures of respiratory function were found. This can be attributed to low participant
numbers.
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While stimulated and unstimulated FVC only increased by a clinically significant amount
between 38 and 43 percent of the assessment sessions respectively, 75.0 and 88.9 percent of
these improvements occurred during weeks when AFES training was applied. This suggests
that while it is not always possible to achieve a clinically significant improvement in FVC in
a two week period, the probability is greater when AFES training is applied. One motivation
for this study was to establish the optimum duration for AFES training, denoted as the point
at which respiratory function begins to plateau. Due to the small number of participants it
was not possible to establish this optimum training duration.
Ethical approval has been granted for a total of 10 participants to take part in this study,
however only four were recruited, and three completed the study, within the time frame of
this thesis. The continuation of the study with an additional six participants may make it
possible to demonstrate statistically significant gains in respiratory function over the AFES
training period.
7.5.2 AFES with MI-E
The feasibility of combining AFES with MI-E was demonstrated by the successful integration
of the technology at the eight MI-E sessions. At these assessment sessions it was possible
to measure EV and PF during MI-E, with and without AFES. The results show that at
75 percent of the MI-E sessions stimulated EV and PF were greater than unstimulated EV
and PF. This suggests that the addition of AFES to MI-E may provide an additional boost
to cough power. This should lead to more effective secretion clearance compared to the
application of MI-E alone. As AFES is non-invasive, the integration of AFES with MI-E is
worth considering for all future uses of MI-E. The development of an inexpensive and practical
AFES device, which can easily be synchronised with MI-E and used by a caregiver, would
make this even more practical. The development of such a device is discussed in Section 8.5.
The EV and PF results recorded at MI-E session four (A4) were very different to the results
recorded at all other MI-E and assessment sessions. The fact that these values met the
ATS/ERS guidelines, and the fact the stimulated and unstimulated values are similar, suggest
that this was not a measurement error. One possibility is that the MI-E device was on a
different setting at this session compared to the other sessions. As the controls for this device
are analogue it is difficult to guarantee the same pressures were applied at each MI-E session.
It is also possible that the participant managed to form a different/better seal around the
mouthpiece at this session, although it is unlikely this would cause such a large deviation in
the results.
A large difference was observed between the PF measured with and without MI-E. This is
attributed to the spirometer at the MI-E sessions measuring the PF produced by the MI-E
device, rather than the PF generated by the participant. This is due to the large change in
flow rate when MI-E alternates between positive and negative pressure. As the spirometer
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needs to be placed in line with the MI-E tubing to accurately measure flow this can not be
avoided. Therefore, a true measure of a persons PF can not be established when measuring
PF from MI-E. Additionally, when measuring respiratory function the participant was unable
to inhale to total lung capacity and exhale fully due to the short inhalation and exhalation
duration used with an MI-E device. This means that a true measure of FVC can not be
obtained when measuring the volume exhaled during MI-E.
7.5.3 Limitations and Future Work
One of the greatest challenges when conducting a study with the sub-acute tetraplegic
population is effective patient selection. This is due to the vastly different rates of recovery
and levels of respiratory function observed in this population. In this study the inclusion
criteria was sub-acute tetraplegic patients with reduced respiratory function, as judged
by a consultant at the QENSIU. However, due to the limited number of patients at the
QENSIU, and a fear of excluding otherwise eligible participants, no quantitative measure
of this reduction in respiratory function was used. If conducting a larger trial, with access
to greater patient numbers, it may be worth considering the use of a quantitative measure
of reduction in respiratory function to enable greater patient matching in this population.
Such patient matching may reduce some of the intersubject variability in respiratory function
observed in this study.
To fully compare the effectiveness of combining AFES with MI-E it would be desirable to also
compare respiratory function during MI-E combined with manually assisted coughing (see
Section 7.2). However, as the force required to successfully apply a manually assisted cough
is subjective the same caregiver should apply all manually assisted coughs in a longitudinal
study. Due to shift rotations it was not possible to have the same caregiver attend all
assessment sessions in this study and a comparison between the use of AFES and manually
assisted coughing with MI-E was not made.
Participant 2, who did not complete the study, had a large amount of edema in the abdomen
which made it difficult to achieve a strong muscle contraction using AFES, requiring around
50 percent more current to achieve a visible muscle contraction compared to the other
participants (see Table 7.2). This agrees with the findings in Chapter 6 and is discussed
further in Section 8.4.
The effectiveness of combining AFES with MI-E was only assessed with one participant. This
was for two reasons. Firstly, it was originally intended only to use MI-E with participants
who were receiving this treatment as part of their regular rehabilitation. However, MI-E was
only routinely being used in the QENSIU with ventilated patients, who were not included
in this protocol. This meant that the device and experience of MI-E was unfamiliar for the
participant in this study. The use of MI-E with participants who have experience using the
device may improve the results. Secondly, the participant indicated that they did not feel
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that they were always actively contributing during MI-E. As the feasibility of combining
AFES with MI-E had been shown, and the novel use of a pressure sensor to automatically
synchronise AFES with MI-E had been successfully demonstrated, no further assessments
were carried out. A larger trial that measures the difference between FVC with AFES assisted
and unassisted MI-E, and incorporates manually assisted coughing, may further demonstrate
the effectiveness of this technique.
A further limitation of this study is that an FVC test, from which the results were derived,
relies on the maximum effort of the participant. It is possible that participants did not make
as much effort at certain assessment sessions, which may account for some of the variability
observed in the results. Finally, a control period of four weeks and a training period of eight
weeks were used in this study. These durations were chosen as it was felt that, based on
the results observed by McLachlan et al. [70], a training period of eight weeks may lead to
a plateau in respiratory function. Due to the small number of participants recruited in this
study it was not possible to establish whether such a plateau had occurred. Although it would
have been desirable to also have an eight week control period, it was highlighted at the study
conception phase that this would have increased the study duration to 18 weeks, and would
have led to some participants being discharged from the QENSIU before the final assessment
sessions. Rather than have incomplete results, it was decided to shorten the duration of the
control period. In further experiments it may be beneficial to increase the duration of the
control period.
7.6 Conclusion
This study has shown that FVC, PEF and FEV1 increase in the weeks after a spinal cord
injury, with FVC increasing at a greater rate during an eight week AFES training program
than during a four week control period. It was also shown that AFES could be combined
with MI-E to generate an acute increase in respiratory function compared to MI-E alone.
However, to show statistical significance, more participants are required.
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Chapter 8
Discussion and Recommendations
for Future Work
“I think that in the discussion of natural problems we ought to begin not with the Scriptures,
but with experiments, and demonstrations.”
Galileo Galilei
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8.1 Summary
The main findings of this thesis are summarised in this chapter. An evaluation of the
techniques and protocols developed to improve the effectiveness of Abdominal Functional
Electrical Stimulation (AFES) in improving the respiratory function of people with tetraplegia
is provided. This chapter also outlines possible future directions for research involving the use
of AFES as a treatment modality. Important outstanding issues that require to be addressed
before AFES becomes a standard clinical technique are discussed.
8.2 Evaluation of AFES to Improve Respiratory Function
The patients who would benefit most from the application of AFES have yet to be clearly
identified. AFES is commonly used with any tetraplegic patient, however the response from
patient to patient can vary significantly. The difference in response is further complicated
by the lack of common protocol between AFES studies, especially with regard to electrode
placement as described in Section 2.4.4.3. While motor point charts exist for many muscle
groups [155], relatively little attention has been given to mapping the abdominal motor
points. In Chapter 5 the use of Neuromuscular Electrical Stimulation (NMES) to establish
the position of the motor points of the abdominal muscles is described. By using this
technique the motor points of the abdominal muscles were quickly and easily detected in
both able bodied and tetraplegic participants. These motor point positions were found to
differ between participants, suggesting that empirically derived electrodes positions are too
general to accurately target the motor points and achieve the optimum muscle contraction.
In this study it was also established that the position of the motor points could be detected
with good repeatability, suggesting that this technique only needs to be performed once for
each user. If future AFES studies were to identify the motor points of the abdominal muscles
using NMES, application of AFES at these motor points would help achieve the optimum
muscle contraction. This should lead to the greatest improvement in respiratory function and
should ensure a consistent electrode placement across studies. While the results achieved in
different AFES studies is influenced by a wide range of factors, and is more complex than
just ensuring that electrodes are placed in the same location, a consistent electrode placement
will remove one variable for these studies, enabling an easier comparison.
8.2.1 Clinical Studies
In this thesis it has been shown that AFES is a feasible technique for use with acute ventilator
dependant (see Chapter 6) and sub-acute, non-ventilator dependant, tetraplegic patients (see
Chapter 7). It was also shown that AFES led to an acute and a longitudinal increase in
respiratory function.
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8.2.1.1 Acute Effect
In the two clinical studies conducted in this thesis, documented in Chapters 6 and 7, it
was shown that the application of AFES led to an acute increase in Vital Capacity (VC)
and Forced Vital Capacity (FVC) compared to unassisted measurements. This agrees with
Langbein et al. [71] and Lee et al. [122] who both found an acute increase in FVC during
the application of AFES. In Chapter 6 it was also shown that that the application of AFES
led to an acute increase in Tidal Volume (VT ), agreeing with previous studies that also
demonstrated acute improvements in VT during the application of AFES [72, 120, 121].
This indicates that the use of AFES can lead to an immediate improvement in respiratory
function. This could be beneficial for tetraplegic patients who require an acute improvement
in respiratory function to aid cough generation or combat a respiratory infection.
It should be noted that results in Chapter 6 are expressed as VC rather than FVC as,
at early assessment sessions, participants could not always exhale as ‘forcibly as possible’
due to sedation levels and poor respiratory muscle coordination. However, as explained in
Section 1.4.2, there is very little difference between the values of VC and FVC. It should
also be noted that for the purpose of these tests patients were assumed to be inhaling to the
maximum lung volume that they could achieve, denoted as their functional lung capacity,
rather than their total lung capacity which is typically used for an FVC and VC manoeuvre
with the able bodied population. Inhalation to functional lung capacity provided both a
measure of the impairment of the respiratory muscles and the improvement in respiratory
function over the study duration.
8.2.1.2 Longitudinal Effect
In Chapters 6 and 7, VC and FVC were found to increase over the study duration,
agreeing with previous studies that used an AFES training protocol with the tetraplegic
population [70, 73, 124]. The increase in Peak Expiratory Flow (PEF) and Forced Exhaled
Volume in one second (FEV1) observed in Chapter 7 also agrees with these previous studies.
The clinical studies described in Chapters 6 and 7 included control periods, used to estimate
the effect of natural recovery. This was necessary as Liaw et al. [113] showed a statistically
significant increase in FVC (27%) and FEV1 (21%) over a six week period for tetraplegic (C4
to C7) participants who were less than six months post injury and received no intervention.
While they also found an increase in PEF (23%), this was not statistically significant. These
increases in FVC, FEV1 and PEF are equivalent to 4.5, 3.5 and 3.8 percent per week. In
Chapter 7 it was found that unstimulated FVC, FEV1 and PEF increased by an average of
3.9, 5.9 and 7.4 percent per week and in Chapter 6 unstimulated VC was found to increase
by an average of six percent per week over the eight week study duration. While these results
were found to vary from week to week and between participants, they suggest that the
improvements in respiratory function reported in this thesis may be larger than those caused
by natural recovery alone. However, it is difficult to effectively quantify the intervention effect
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with the small number of participants recruited for the studies documented in this thesis.
In clinical studies the most common way to estimate the effect of natural recovery during
an intervention protocol is to conduct a Randomised Control Trial (RCT) which includes a
control group, with the changes in the intervention and control groups compared. A number
of issues surround the use of RCTs in studies that recruit patients with Spinal Cord Injury
(SCI). Firstly, the large variations in function and recovery after SCI make it difficult to
establish control and intervention groups that have similar characteristics, especially in the
case of respiratory function. When conducting studies that involve an intervention, such
as AFES, which has been shown to be potentially useful, and importantly not harmful,
there is also an ethical concern as to whether denying the control group this treatment is
ethically responsible. Therefore, RCTs may not be the most suitable design for studies in
tetraplegia, with a randomised cross-over design (as used in Chapter 7) potentially more
appropriate. Due to the low number of participants available for the studies documented in
this thesis (see Section 8.4), each participant acted as their own control. By conducting similar
multicentre studies, which would provide access to more participants, it may be possible to
include a control group. Large scale clinical trials investigating the effect of AFES training on
respiratory function have yet to be conducted, with the only such study conducted by Cheng
et al. [124] recruiting only 13 participants for each of the intervention and control groups.
When investigating the effect of an extended AFES training program in Chapter 7, FVC
was found to be the only measure of respiratory function that increased to a greater extent
during an AFES training period than during the control period. As explained in Section 7.5,
the respiratory function of one participant in this study improved significantly during the
control period, with a much greater improvement in respiratory function during this period
than observed for the other two participants who also completed this study. When comparing
the group results it is possible that this participants large increase in respiratory function
during the control period is masking any increase in respiratory function that was caused by
the intervention. The recruitment of additional participants should clarify this effect. When
applying AFES with acute ventilator dependent tetraplegia patients in the study documented
in Chapter 6 VT was found to increase over the study duration, although this change was
not found to be statistically significant. Stimulated VT was the only measure of respiratory
function that was found to increase to a greater extent during weeks where AFES training
was applied compared to control weeks. As explained in Section 6.6, the apparent lack of
difference between intervention and control weeks may be caused by an acute carry over effect
from AFES training, rather than a lack of an intervention effect. Further investigations will
be required to quantify this carry over effect.
AFES training was found to lead to a clinically significant (greater than 200 mL) increase in
stimulated and unstimulated FVC between 33.3 and 37.5 percent of assessment sessions in
Chapter 7 and between 21.1 and 23.9 percent of assessment sessions in Chapter 6. In both
studies the majority of these clinically significant increases in stimulated and unstimulated
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FVC were found to occur during weeks where AFES training was applied (75.0 and 88.9
percent in Chapter 7 and 60.0 and 58.8 percent in Chapter 6). This provides another
indication that there may be a positive longitudinal training effect from AFES with the
tetraplegic population.
In Chapter 6 the use of an AFES training program with the acute ventilator dependant
tetraplegic population was shown to decrease the time that the participants were dependant
on mechanical ventilation by an average of 11 days compared to matched controls. While this
study only recruited tetraplegic participants in the acute stage of injury, a single participant
case study, also reported in Chapter 6, investigated the use of an AFES training program to
assist a chronic tetraplegic participant to wean from mechanical ventilation. This case study
demonstrated that AFES was a feasible technique for assisting chronic ventilator dependant
tetraplegics, who retain some diaphragm function, in weaning from mechanical ventilation.
The time this participant spent breathing independently of mechanical ventilation increased
from zero minutes per day before a three week AFES training intervention, to 90 minutes
per day after. While these results suggest that an AFES training program may be suitable
to assist all tetraplegics who retain diaphragm function to wean from mechanical ventilation,
further work is required to establish the effectiveness of this treatment modality with the
chronic tetraplegic population.
8.2.1.3 Technological Aspects
In Chapter 4 it was shown that a respiratory effort belt positioned around the chest could be
combined with a Support Vector Machine (SVM) algorithm to classify respiratory activity,
with an acceptable classification performance compared to that achieved using the signal
from a spirometer. The integration of this algorithm into an AFES device would allow the
correct stimulation parameters for different breath types to be automatically applied at the
correct point in the respiratory cycle. It was also shown in Chapter 4 that the signal from
a respiratory effort belt positioned around the abdomen could be used to detect the start
of exhalation at approximately the same time as when using the signal from a spirometer,
indicating that this sensor could be used to automatically apply AFES at the correct point in
the respiratory cycle. In Chapters 6 and 7 the respiratory effort belt used to detect respiratory
activity had to be placed around the abdomen. This was because many acute tetraplegics
require a halo or back brace to stabilise their SCI, limiting access to their chest. Therefore, the
combination of a respiratory effort belt positioned around the chest with a SVM may not be
a suitable method for classifying the respiratory activity of the acute tetraplegic population.
Despite this, the signal from the respiratory effort belt positioned around the abdomen was
used to automatically apply stimulation at the start of exhalation in Chapters 6 and 7, with
high accuracy. For the clinical application of AFES training, where it can be assumed all
breaths will be quiet breaths, the automatic application of AFES using the signal from a
respiratory effort belt placed around the abdomen could be integrated into an automatic
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AFES system.
Pressure ulcers, or pressure sores, develop when pressure is applied to the same are of
skin over an extended period of time [170]. To avoid the development of pressure ulcers
tetraplegic patients are normally turned in their bed every few hours, changing their centre
of pressure. This meant that the respiratory effort belts used to record respiratory activity
in the clinical studies documented in this thesis were applied with tetraplegic patients in
a number of different positions, ranging from the patient lying on their pelvis through to
the patient being in a fully supine position. While it was shown in Section 3.3.3.1 that the
largest signal magnitude was observed when the respiratory effort belt was under the greatest
displacement, the pre-processing methods employed (discussed in Section 3.3.2) led to a very
low level of signal noise. Therefore, the position of the patient, and hence the position of the
respiratory effort belt, did not affect its performance for the automatic application of AFES.
The successful automatic application of AFES indicates that the patient’s respiratory activity
was detected successfully, no matter their position. The statistical classification algorithm,
described in Chapter 4, relies on successful detection of respiratory activity. Therefore, it
is believed that the patient position would not affect the classification performance of this
algorithm. However, this hypothesis remains to be tested with tetraplegic participants.
Both of the clinical studies described in this thesis (Chapters 6 and 7) included the use of
the motor point detection technique described in Chapter 5 to select the optimum electrode
position. The inclusion of this technique in all AFES studies should achieve a consistent
muscle contraction and enable an easier comparison of the effectiveness of the intervention.
Positive findings in such studies would add support to the use of AFES as a standard clinical
intervention.
In summary the use of AFES to improve the respiratory function of the tetraplegic patient
group is non-invasive and easy to apply, making it suitable for a clinical setting. Further
evidence of the effect of AFES on respiratory function is required before it becomes an
accepted treatment modality.
8.2.2 Respiratory Complications
Of the 12 tetraplegic participants who received AFES training in this thesis, only one (8%)
developed a respiratory complication (pneumonia). These participants were recruited in the
acute or sub-acute stage of injury, with nine of these participants observed for eight weeks
(mean 22 ± 12 days post injury [range 10 to 39 days]) and three observed for 14 weeks
(mean 24 ± 4 days post injury [range 19 to 29 days]). This respiratory complication rate
is much lower than that observed in other studies with the acute tetraplegic population.
Fishburn et al. [79] reported that of 30 tetraplegic patients studied in the first 30 days post
injury, 17 (57%) suffered from a respiratory complication while Jackson and Groomes [80]
report that in the first six weeks after injury 175 of the 261 (67%) tetraplegic participants
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studied suffered from a respiratory complication. While these studies began observing the
participants slightly earlier than in this thesis, none of the participants recruited in this
thesis had, to date of recruitment, developed a respiratory complication. The low numbers
of respiratory complications reported here agrees with the finding of Cheng et al. [124]
who observed a reduction in the number of respiratory infections after an AFES training
program. This suggests that the improvements in respiratory function achieved using an
AFES training protocol may be beneficial in preventing respiratory infection and subsequent
respiratory complications. It should be noted that patients who were severely unwell were not
recruited for the studies in this thesis, which may reduce the observed number of respiratory
complications.
8.3 Clinical Significance
The results of this thesis have led to AFES shortly being introduced as a standard treatment
to assist ventilator weaning for acute ventilator dependent tetraplegic participants at the
Queen Elizabeth National Spinal Injuries Unit (QENSIU). The use of AFES to assist all
chronic ventilator dependent tetraplegics who retain some diaphragm function to wean from
mechanical ventilation is also being piloted. This clinical implementation makes use of some
of the technology described in Chapter 4 and the motor point detection technique outlined in
Chapter 5, as well as the clinical protocols developed in Chapters 6 and 7. The results in this
thesis add further evidence to support the clinical introduction of AFES. Despite this, AFES
continues to suffer from a poor clinical uptake. Reasons for this are discussed in Section 8.5.
8.4 Limitations of AFES in People With Tetraplegia
In many critically ill patients there is a marked increase in body water which leads to an
increase in extra cellular fluid volume, termed edema [168]. A study by Harper et al. [171]
showed that when using FES to induce a contraction of the wrist muscles, stimulation current
had to be approximately doubled in the presence of edema. It is hypothesised that this
increase is caused by edema decreasing the current density of the stimulation and, in turn,
decreasing the amount of charge reaching the nerve. During the clinical studies documented
in Chapters 6 and 7 three participants who had a large amount of edema in the abdomen were
found to be poor responders to AFES. Harper et al. describe a significant lowering of the
current required to induce a contraction in the presence of edema when pressure was applied
to the stimulating electrodes. It is believed that this is because when pressure is applied to
the electrodes it brings the nerve closer to the stimulating electrode, increasing the charge
delivered to the nerve resulting in a greater muscle contraction. This finding was supported
in the three poor responders in this thesis, with the application of pressure to the stimulating
electrodes found to induce a muscle contraction at lower stimulation currents than when
pressure was not applied. In the clinical study documented in Chapter 6 a stimulation current
of approximately 100 mA was required to achieve a muscle contraction with the participant
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who had edema. The neuromuscular stimulator used in this thesis is limited to 120 mA.
Therefore, in the presence of edema a muscle contraction may not be able to be achieved in
all patients, with the presence of adipose tissue heightening this effect. Additionally, such
high stimulation currents are likely to activate the pain receptors in incomplete patients who
retain sensation in the abdomen, resulting in the application of AFES being painful. The
presence of abdominal edema may need to be considered as an exclusion criteria in future
AFES studies.
For FES to initiate a muscle contraction the Lower Motor Neurons (LMNs), which carry
motor information from the spinal cord to a muscle (see Section 1.3 for more information),
must be intact. If the LMNs are not intact the pathway between the nerve and a muscle
is damaged. This means that the nerve can no longer be electrically stimulated to cause a
muscle contraction, with the muscle said to be denervated [51]. One participant in Chapter 6
was found to be a non responder to AFES. It was later discovered that this participant
had LMN damage. As LMN damage is often difficult to detect in the acute stage of injury,
and as function can sometimes return after time in SCI when the LMNs are not damaged
(largely attributed to spinal shock), this participant was followed up for eight weeks, with
AFES being applied on a weekly basis. Over this eight week period no abdominal muscle
contraction was achieved when using AFES and the participant never recovered the ability
to breathe independently of mechanical ventilation by the time they were discharged from
hospital. With this participant the presence of LMN damage was not established until a
considerable time after injury. Therefore, the use of LMN damage as an exclusion criteria
for AFES studies with the acute tetraplegic population may not be practical. While there
are stimulators available that can stimulate denervated muscle by stimulating the muscles
directly [172], as opposed to the nerve, they have not been used to apply AFES in the case of
LMN damage. This may be a potential solution for the use of AFES for patients with LMN
damage.
It is well known that the use of Functional Electrical Stimulation (FES) leads to faster
muscle fatigue than natural recruitment (see Section 1.5.1 for further explanation). To allow
for the effect of abdominal muscle fatigue within the clinical studies outlined in this thesis,
stimulation pulsewidth was increased manually by approximately 20 µs per five minutes of
AFES training. There is currently no automatic way to detect this fatigue in the context of
an AFES system, meaning that an automatic AFES system would rely on either a manual
intervention or time signal to increase pulsewidth. Al-Mulla et al. [173] suggest ultrasound
or electromyography (EMG) signals combined with a statistical classification algorithm as a
potential solution for the real-time detection of muscle fatigue. Spivak et al. [90] used an
EMG signal from the respiratory muscles to automatically apply AFES during exhalation to
assist coughing. It may be that this EMG signal changes over time due to muscle fatigue,
and that a statistical classification algorithm, such as that developed in Chapter 4, could be
used to automatically adjust stimulation pulsewidth to account for respiratory muscle fatigue
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in the context of an AFES system.
One of the greatest challenges in this thesis was participant recruitment. As can be seen in
Figure 8.1, recruitment of the 10 participants in Chapter 6 took 20 months, with large breaks
in recruitment. This is a problem inherent with studies involving the SCI population. As
outlined in Section 1.2.1 there are around 100 patients admitted to the QENSIU per year,
with a low number of these patients requiring mechanical ventilation. Due to these patients
having a large number of comorbidities and a poor state of health, coupled with the number of
patients who only require ventilation for a few days, the recruitment rates seen in Chapter 6
were in line with expectation. The benefit of AFES may be further highlighted by greater
participant recruitment. To achieve this it may be necessary to establish multicentre trials,
as the patient numbers seen in single SCI units are insufficient for such studies.
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Figure 8.1: Participant recruitment for the studies reported in Chapter 6 and 7. Recruitment
for the study reported in Chapter 6 started in January 2012 and recruitment for the study
reported in Chapter 7 started in April 2013.
8.5 Future Work
“The inventor looks upon the world and is not contented with things as they are. He wants
to improve whatever he sees, he wants to benefit the world; he is haunted by an idea. The
spirit of invention possesses him, seeking materialization.”
Alexander Graham Bell
This thesis adds further support to the efficacy of AFES to improve respiratory function, yet
the uptake of AFES with the tetraplegic population is still very low. While larger studies
would add weight to support the use of AFES, the number of eligible participants for studies
within any one spinal injuries unit is small, making the implementation of large studies within
any one spinal injuries unit difficult. Collaborations in multicentre studies should lead to
larger recruitment figures. After larger studies have been conducted that show the benefits of
AFES, AFES may become a standard clinical procedure for the tetraplegic population. One
problem with conducting such multicentre studies is ensuring all locations apply stimulation
in the same way. This may be achieved by the steps outlined below.
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8.5.1 Clinical Uptake of AFES
The lack of an easy to use clinical device, established clinical AFES protocols that allow a
patient’s regular caregiver to set up and use the system and a lack of clinical evidence are three
major factors contributing to the poor clinical uptake of AFES and may be an important
factor in the lack of multicentre AFES studies. The development of a statistical classifier
that uses the signal from a non-intrusive sensor to distinguish between quiet breathing and
coughing (see Chapter 4), allowing the appropriate stimulation parameters to be applied
at the correct point in the breathing cycle, is a major step towards the development of a
stand alone AFES device. In Chapter 5 it was shown that the position of the motor points
of the abdominal muscles, around which it is desirable to place the stimulation electrodes,
had a large intersubject variability. By using the technique described in Chapter 5 motor
point positions can be found quickly, with the good repeatability of this method meaning
that the positions of the motor points only require to be identified once for each user. A
technique that ensures a consistent electrode placement is an important step towards the
establishment of a clinical AFES protocol. Once the motor points have been detected it may
be possible to develop a garment for each participant that allows electrodes to be positioned
around the motor points, possibly by using velcro or buttons to attach the electrodes. The
use of such a garment would avoid the time consuming process of donning and doffing
electrodes, would avoid loose wires and would make the application of AFES much more
compact. This garment could be integrated with a stand alone AFES device. Such a
garment and device may enable the combination of AFES with mechanical ventilation (see
Chapter 6) or Mechanical Insuﬄation-Exsuﬄation (MI-E) (see Chapter 7) as standard clinical
practice. Effective clinical protocols for the use of AFES with acute ventilator dependent
and sub-acute tetraplegic patients were demonstrated in Chapters 6 and 7, respectfully. A
stand alone AFES device and effective AFES protocols should enable easier execution of
multicentre trials, as all researchers would be using the same equipment, and would mean
that, given proper training, AFES could be applied by nurses or physiotherapists as part of
a regular care plan. This should increase the likelihood of AFES being adopted as a clinical
intervention. The willingness of a company to develop such a system without the results
from a multicentre study may make this difficult to achieve, meaning that a greater amount
of clinical evidence may be needed before AFES becomes a standard clinical treatment for
the tetraplegic population.
8.5.2 New Applications of AFES
The motivation for the use of AFES with the tetraplegic population has largely been that
an improvement in respiratory function should lead to a reduction in respiratory infections
and subsequent respiratory complications [70, 72, 73], a leading cause of rehospitalisation
for this patient group. To date, Cheng et al. [124] are the only people to use an AFES
training program to directly assess the impact of an AFES training program on the number of
respiratory infections. While they did show a decrease in the number of respiratory infections
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after an AFES training program, this was only evaluated in 13 treatment and 13 control
patients. This effect may be further demonstrated by a large control study, with the number
of respiratory infections developed by the control and intervention groups assessed to give an
indication of the effectiveness of AFES in reducing respiratory infections, which, if proven,
would add support to the adoption of AFES as a standard clinical treatment modality.
The use of FES as a treatment modality for critically ill, able bodied, patients in an intensive
care unit is gaining interest, with a number of studies being conducted in the last few
years [174]. In these studies FES has been applied to the muscles of the arms or the legs
to prevent muscle atrophy and maintain muscle strength during periods of illness. The
application of FES to the leg muscles of able bodied patients in an intensive care unit has
been shown by Routsi et al. [125] to lead to faster weaning from mechanical ventilation,
leading to a significant cost saving for the health care provider. The fact that the abdominal
muscles are involved in respiration, whereas the muscles of the leg are not, might suggest that
the application of AFES in the critically ill able bodied population may lead to faster weaning
from mechanical ventilation. The large number of critically ill, able bodied, patients in an
intensive care unit make it an ideal location to conduct a large RCT into the effectiveness of
this intervention, yet, to date, no studies have used AFES with this patient group. Such a
study may reveal a new and diverse area for AFES research.
In summary there are a number of areas in which the application and availability of AFES
for the tetraplegic population can be developed. These developments should promote further
research into the effectiveness of AFES with the tetraplegic population, which should further
highlight the improvements in respiratory function that can be achieved using this treatment
modality.
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Chapter 9
Conclusions
“To succeed, jump as quickly at opportunities as you do at conclusions.”
Benjamin Franklin
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This thesis describes the development and implementation of novel protocols and technologies
designed to enhance the effectiveness of Abdominal Functional Electrical Stimulation (AFES)
to improve the respiratory function of the tetraplegic population. The development of such
technologies and protocols is required to allow AFES to be implemented as a treatment
modality in the acute and sub-acute care setting. As such, a key contribution of this thesis
is proof of feasibility.
One approach which would improve the effectiveness of AFES is the development of a
stand alone AFES device, capable of stimulating different breath types with different
stimulation parameters. As a first step towards this aim a non-intrusive respiratory effort
belt positioned around the chest was used to record the respiratory activity of 10 able bodied
participants. This signal was used to develop a novel support vector machine algorithm
for non-intrusive real-time respiratory activity detection, which produced an acceptable
classification performance compared to that achieved using the signal from a spirometer.
It was also demonstrated that the signal from a respiratory effort belt could be used to apply
stimulation at the correct point in the breathing cycle. The use of a non-intrusive sensor,
coupled with an improved classification algorithm, improves on previous work, where the
signal from an intrusive spirometer was used to detect and classify respiratory activity.
While it is known that when using electrical stimulation the optimum muscle contraction
is achieved when stimulation is applied close to the motor point, current AFES studies use
a range of empirically derived electrode positions to initiate a muscle contraction, with no
consensus over the optimum electrode location. In this thesis a novel use of neuromuscular
electrical stimulation to detect the position of the motor points of the abdominal muscles
was developed. By applying single pulse electrical stimulation to the rectus abdominis and
external oblique muscles, the position of the motor points of these muscles were successfully
located in 10 able bodied and five tetraplegic participants. It was demonstrated that while
motor point position changed little over time, they were posture dependent with a degree
of intersubject variability. By using this new technique the motor points could be detected
with an adequate repeatability. Placement of electrodes at the motor points found using
this method is therefore believed to improve upon the use of empirically derived electrode
locations and is recommend for all future AFES studies.
The feasibility of using AFES to improve the respiratory function of acute ventilator
dependant tetraplegics is demonstrated in a clinical study. A novel AFES protocol, combined
with novel engineering solutions to allow AFES to be synchronised with a mechanical
ventilator or a user’s respiratory activity, are presented. The respiratory function of nine
tetraplegic participants increased throughout an eight week AFES training protocol. These
gains in respiratory function suggest that these protocols are feasible for this patient group,
indicating a new treatment group who may benefit from the use of AFES. It was also shown
that the participants who received AFES training weaned from mechanical ventilation on
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average 11 days faster than their matched controls. This suggests that the improvements in
respiratory function achieved using this protocol may enable faster weaning from mechanical
ventilation. The feasibility of using AFES to assist ventilator weaning for the chronic
tetraplegic population who retain some diaphragm function is also demonstrated.
During the aforementioned clinical study it was observed that AFES appeared to lead to
an increased demand for secretion clearance, necessary to avoid respiratory infections. This
suggested that traditional methods of secretion loosening and clearance may be enhanced by
combining them with AFES. To investigate this a novel engineering solution was developed
to integrate Mechanical Insuﬄation-Exsuﬄation (MI-E) with AFES, and the feasibility of
this integration demonstrated with one tetraplegic participant. The results show that the
application of AFES led to an acute increase in respiratory function compared to when
using MI-E alone, indicating that with further refinement of the protocol and technology
the integration of these two treatment modalities could be used to more effectively remove
secretions for people with tetraplegia.
Finally, the feasibility of using an eight week AFES training program to improve the
respiratory function of people with tetraplegia is demonstrated. Respiratory function was
shown to increase throughout the study duration, although further participant recruitment is
required to clarify the effect of natural recovery in this increase. This training effect provides
further evidence for the clinical use of an AFES training program to improve the respiratory
function of tetraplegic participants.
In conclusion a number of novel technologies and protocols have been developed which can
be used to enhance the effectiveness of AFES to improve the respiratory function of the
tetraplegic population.
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Appendix A
Classification of Respiratory
Activity
A list of the features used with the classification algorithm in Chapter 4 that were found
to have a statistically significantly different median for quiet breathing and coughing, and
stimulated and unstimulated breaths, is presented here. The quiet breath and cough
sensitivities achieved using the classification algorithm described in Chapter 4 with different
kernels and training methods are presented here. The classification accuracies that could be
achieved when classifying only stimulated or unstimulated breaths are also given.
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Table A.1: Features that were found to have a statistically significantly different median for
quiet breathing and coughing, for all 10 participants, using the signal from a spirometer and
respiratory effort belts positioned around the chest and abdomen. Statistical significance was
determined using a Wilcoxon signed-rank test.
Sensor Statistically significant Features
Spirometer Length
Sum
Minimum value
Maximum value
Number of peaks
Mean
Mean magnitude (power spectral density)
of Fast Fourier Transform (FFT)
Sum of magnitude (power spectral density) of FFT
Maximum magnitude (power spectral density) of FFT
Minimum magnitude (power spectral density) of FFT
Sum of magnitude (power spectral density) of FFT,
divided by signal length
Index of minimum value
Mean gradient
Minimum gradient
Maximum gradient
Sum of gradient
Cross correlation with a quiet breath
Cross correlation with a cough
Mean of autocorrelation
Maximum value of autocorrelation
Minimum value of autocorrelation
Chest belt Length
Sum
Minimum value
Maximum value
Number of peaks
Mean
Mean magnitude (power spectral density)
of Fast Fourier Transform (FFT)
Sum of magnitude (power spectral density) of FFT
Maximum magnitude (power spectral density) of FFT
Minimum magnitude (power spectral density) of FFT
Sum of magnitude (power spectral density) of FFT,
divided by signal length
Mean gradient
Minimum gradient
Maximum gradient
Sum of gradient
Cross correlation with a quiet breath
Maximum value of autocorrelation
Minimum value of autocorrelation
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Abdominal belt Length
Minimum value
Maximum value
Mean
Mean magnitude (power spectral density)
of Fast Fourier Transform (FFT)
Minimum magnitude (power spectral density) of FFT
Sum of magnitude (power spectral density) of FFT,
divided by signal length
Mean gradient
Minimum gradient
Maximum gradient
Sum of gradient
Cross correlation with a quiet breath
Maximum value of autocorrelation
Table A.2: Features that were found to have a statistically significantly different median
for stimulated and unstimulated breaths, for all 10 participants, using the signal from a
spirometer and respiratory effort belts positioned around the chest and abdomen. Statistical
significance was determined using a Wilcoxon signed-rank test.
Sensor Statistically significant Features
Spirometer Sum
Minimum value
Number of peaks
Mean
Mean magnitude (power spectral density)
of Fast Fourier Transform (FFT)
Sum of magnitude (power spectral density) of FFT
Maximum magnitude (power spectral density) of FFT
Sum of gradient
Mean of autocorrelation
Chest belt Minimum gradient
Abdominal belt Index of minimum value
Minimum gradient
Sum of gradient
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Table A.3: Mean percentage quiet breath (q) and cough (c) sensitivity (Se) (± standard
deviation) achieved using the signals from the respiratory effort belts placed around the
abdomen (abdo) and the chest, a combination of respiratory effort belt signals and the signal
from a spirometer (spiro). The SVM was trained for each participant using the data collected
during session one (Train1 ). Classification was performed on the data collected during session
two using: a linear kernel with a boxconstraint value of 0.1, a linear kernel with an optimised
(opti) box constraint value for each participant, a RBF kernel with a boxconstraint value of 1
and an a RBF kernel with an optimised boxconstraint value for each participant. ∗ indicates
statistically significantly different from spirometer when using the same training data and †
indicates statistically significantly different from results achieved using a linear kernel and
box constraint of 0.1.
Sensor Linear & 0.1 Linear & opti RBF & 1 RBF & opti
Sec (%) Seq (%) Sec (%) Seq (%) Sec (%) Seq (%) Sec (%) Seq (%)
Spiro 93.9 98.2 97.8 97.0 96.9 91.5† 96.9 92.3†
± 9.2 ± 2.2 ± 2.7 ± 3.4 ± 5.6 ± 5.9 ± 5.6 ± 5.9
Chest 96.6 90.6∗ 96.9 91.2 96.8 74.5∗† 96.1 80.2†
Belt ± 5.8 ± 13.3 ± 5.9 ± 13.4 ± 11.8 ± 16.9 ± 8.2 ± 16.0
Both 93.8 84.4∗ 95.4 86.7 - - - -
Belts ± 9.5 ± 15.1 ± 7.5 ± 14.0 - - - -
Abdo 79.3∗ 88.9∗ 84.2∗ 89.3∗ 58.1∗ 91.8 86.6∗† 75.7∗†
Belt ± 14.9 ± 7.4 ± 12.1 ± 9.0 ± 27.7 ± 7.4 ± 9.7 ± 14.2
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Table A.4: Mean percentage quiet breath (q) and cough (c) sensitivity (Se) (± standard
deviation) achieved using the signals from the respiratory effort belts placed around the
abdomen (abdo) and the chest, a combination of respiratory effort belt signals and the signal
from a spirometer (spiro). The SVM was trained for each participant using the data collected
during session two (Train2 ). Classification was performed on the data collected during session
one using: a linear kernel with a boxconstraint value of 0.1, a linear kernel with an optimised
(opti) box constraint value for each participant, a RBF kernel with a boxconstraint value
of one and an a RBF kernel with an optimised boxconstraint value for each participant. ∗
indicates statistically significantly different from spirometer when using the same training
data and † indicates statistically significantly different from results achieved using a linear
kernel and box constraint of 0.1.
Sensor Linear & 0.1 Linear & opti RBF & 1 RBF & opti
Sec (%) Seq (%) Sec (%) Seq (%) Sec (%) Seq (%) Sec (%) Seq (%)
Spiro 84.5 99.0 88.7 99.1 80.9 93.0† 87.4 90.5†
± 16.4 ± 1.2 ± 13.8 ± 1.1 ± 21.3 ± 5.4 ± 19.4 ± 6.5
Chest 82.5 97.5 86.0 97.3∗ 84.6 88.6† 85.9 91.7
Belt ± 14.7 ± 4.2 ± 12.6 ± 4.2 ± 16.9 ± 5.6 ± 13.6 ± 4.0
Both 74.5 94.2∗ 78.6† 94.1∗ - - - -
Belts ± 15.5 ± 6.7 ± 14.2 ± 6.5 - - - -
Abdo 76.2 90.9∗ 78.3† 91.8∗ 61.8∗ 85.2 74.7 80.8†
Belt ± 12.7 ± 7.8 ± 13.1 ± 7.7 ± 32.8 ± 12.0 ± 20.3 ± 13.0
Table A.5: Mean percentage cough (c) and quiet breath (q) sensitivity (Se) (± standard
deviation) of stimulated (stim) and unstimulated (unstim) breaths using the signals from
respiratory effort belts placed around the abdomen (abdo) and the chest, a combination
of these signals, and the signal from a spirometer (spiro). The SVM was trained for each
participant using the data collected during session one (Train1 ). Classification was performed
on the data collected during session two using a linear kernel and a boxconstraint value of
0.1.
Sensor Stim Unstim Stim Unstim
Sec (%) Sec (%) Seq (%) Seq (%)
Spiro 93.4 94.3 97.7 98.7
± 9.9 ± 8.9 ± 2.8 ± 1.8
Chest Belt 96.5 97.1 87.6 94.3
Belt ± 6.8 ± 6.2 ± 19.1 ± 6.5
Both Belts 95.0 94.3 80.7 90.2
Belts ± 9.7 ± 10.2 ± 22.5 ± 10.0
Abdo 79.1 79.8 87.3 91.6
Belt ± 18.1 ± 15.7 ± 9.1 ± 8.0
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Table A.6: Mean percentage cough (c) and quiet breath (q) sensitivity (Se) (± standard
deviation) of stimulated (stim) and unstimulated (unstim) breaths using the signals from
respiratory effort belts placed around the abdomen (abdo) and the chest, a combination
of these signals, and the signal from a spirometer (spiro). The SVM was trained for each
participant using the data collected during session two (Train2 ). Classification was performed
on the data collected during session one using a linear kernel and a boxconstraint value of
0.1.
Sensor Stim Unstim Stim Unstim
Sec (%) Sec (%) Seq (%) Seq (%)
Spiro 85.8 83.6 99.3 98.5
± 18.1 ± 17.2 ± 0.8 ± 1.7
Chest 83.3 82.0 97.4 97.3
Belt ± 19.6 ± 13.0 ± 5.0 ± 5.3
Both 77.3 74.6 93.4 95.3
Belts ± 19.5 ± 14.7 ± 7.9 ± 6.1
Abdo 74.2 79.5 89.9 92.3
Belt ± 20.2 ± 8.6 ± 8.0 ± 9.0
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Appendix B
Ventilator Weaning Study Data
The Tidal Volume (VT ) and Vital Capacity (VC) results of Participants 2 to 4 and 6 to 10
from the clinical study presented in Chapter 6 are given here.
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Figure B.1: Tidal Volume (VT ) ± standard deviation of Participants 2 to 4 and 6 to 10,
recorded at nine weekly assessment sessions, where a blue line represents stimulated, and
a red line unstimulated, breaths. The solid black line along bottom of plot represents one
week of AFES training and no line indicates one week with no training. Black x indicates
stimulated VT was statistically significantly different to unstimulated VT , blue ∗ indicates
that stimulated VT was statistically significantly different to stimulated VT recorded at
previous assessment and red ∗ indicates that unstimulated VT was statistically significantly
different to unstimulated VT recorded at previous assessment.
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(b) Participant 3.
APPENDIX B. VENTILATOR WEANING STUDY DATA 191
Assessment
Vi
ta
l C
ap
ac
ity
 (L
)
A0 A1 A2 A3 A4 A5 A6 A7 A8
0.6
1.2
1.8
2.4
3.0
5
10
15
20
25
Tim
e off vent (hours/day)
(c) Participant 4.
Assessment
Vi
ta
l C
ap
ac
ity
 (L
)
A0 A1 A2 A3 A4 A5 A6 A7 A8
0.4
0.8
1.2
1.6
2.0
5
10
15
20
25
Tim
e off vent (hours/day)
(d) Participant 6.
Assessment
Vi
ta
l C
ap
ac
ity
 (L
)
A0 A1 A2 A3 A4 A5 A6 A7
0.2
0.4
0.6
0.8
1.0
5
10
15
20
25
Tim
e off vent (hours/day)
(e) Participant 7.
Assessment
Vi
ta
l C
ap
ac
ity
 (L
)
A0 A1 A2 A3 A4 A5 A6 A7 A8
0.5
1.0
1.5
2.0
2.5
5
10
15
20
25
Tim
e off vent (hours/day)
(f) Participant 8.
Assessment
Vi
ta
l C
ap
ac
ity
 (L
)
A0 A1 A2 A3 A4 A5 A6 A7 A8
0.8
1.6
2.4
3.2
4
5
10
15
20
25
Tim
e off vent (hours/day)
(g) Participant 9.
Assessment
Vi
ta
l C
ap
ac
ity
 (L
)
A0 A1 A2 A3 A4 A5 A6 A7 A8
0.5
1.0
1.5
2.0
2.5
5
10
15
20
25
Tim
e off vent (hours/day)
(h) Participant 10.
Figure B.2: Vital Capacity (VC) of Participants 2 to 4 and 6 to 10, recorded at nine weekly
assessment sessions, where a blue line represents stimulated, and a red line unstimulated,
breaths. The solid black line along bottom of plot represents one week of AFES training
and no line indicates one week with no training. Green line represents time spent breathing
without ventilator support per day, while broken black line represent a VC of 500 mL, the
VC at which participants were expected to wean based on clinical experience. The dashed
magenta line represents the time point at which the participant achieved 24 hours of ventilator
free breathing, while the dashed cyan line represents the time point at which the participant
achieved seven days of ventilator free breathing.
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Appendix C
Cough Assist Study Data
The Forced Vital Capacity (FVC), Peak Expiratory Flow (PEF) and Forced Exhaled Volume
in one second (FEV1) of Participants 3 and 4 from the study presented in Chapter 7 are given
here, along with the effect size of these measures.
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Figure C.1: Forced Vital Capacity (FVC) of Participants 3 and 4 recorded at eight fortnightly
assessment sessions, where a blue line represents stimulated, and a red line unstimulated,
breaths. Solid black line along the bottom of the plot represents the eight week period of
AFES training and no line indicates no training.
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Figure C.2: Peak Expiratory Flow (PEF) of Participants 3 and 4 recorded at eight fortnightly
assessment sessions, where a blue line represents stimulated, and a red line unstimulated,
breaths. Solid black line along the bottom of the plot represents the eight week period of
AFES training and no line indicates no training.
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Figure C.3: Forced exhaled volume in one second (FEV1) of Participants 3 and 4 recorded
at eight fortnightly assessment sessions, where a blue line represents stimulated, and a red
line unstimulated, breaths. Solid black line along the bottom of the plot represents the eight
week period of AFES training and no line indicates no training.
Table C.1: Effect sizes (ES) and lower (LI) and higher (HI) confidence intervals for changes
in stimulated (stim) and unstimulated (unstim) weight corrected Forced Vital Capacity
(FVC/kg), weight corrected Peak Expiratory Flow (PEF/kg) and weight corrected Forced
Exhaled Volume in one second (FEV1/kg) across the 14 week study duration, four week
control period and eight week intervention period.
Measure Stim Study Control Training
LI ES HI LI ES HI LI ES HI
FVC/kg Stim 0.97 1.90 2.83 0.76 1.67 2.58 0.29 1.15 2.01
Unstim 0.75 1.65 2.56 0.26 1.12 1.98 0.29 1.16 2.02
PEF/kg Stim 0.72 1.62 2.52 0.59 1.47 2.36 −0.05 0.78 1.62
Unstim 0.86 1.78 2.69 0.68 1.58 2.48 −0.06 0.77 1.61
FEV1/kg Stim 0.36 1.22 2.09 0.07 0.92 1.76 0.05 0.89 1.73
Unstim 0.80 1.71 2.63 0.84 1.76 2.68 0.11 0.96 1.80
